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Abstract
The enzymes of the ribonuclease (RNase) family catalyze the hydrolysis of ribonucleic acid
(RNA). There is a wide interest in therapeutic interventions of human RNases (hRNases) due to
their critical role in host defense, cancer cell proliferation and neurodegenerative diseases.
Development of structure-based therapeutics targeting individual members of a closely related
enzyme family is difficult. The structural conservation among hRNases cannot explain a millionfold difference in the catalytic efficiency of these enzymes. We hypothesize, this ambiguity in the
structure activity relationship of hRNases can be explained by their dynamical behavior. The rate
of substrate turnover in RNases correlates strongly with the rates of conformational dynamics.
Moreover, catalytic efficiency is also linked to the ability of an enzyme to sample conformational
sub-states that promote specific interaction between reactants at various stages of catalysis.
Detailed characterization of the structure-function-dynamics relationship in hRNases can help in
determining similarities and differences in the motions associated to catalysis thereby enhancing
the possible druggability of this enzyme family.
This study investigates the role of functionally relevant conformational sub-states and dynamics
in each step of the RNase members catalytic cycle; apo, substrate-bound, the chemical step, and
product release. Computer simulations and nuclear magnetic resonance (NMR) relaxation
dispersion experiments indicated an increased dynamics in distal loop regions of RNases in their
apo state. Similar dynamical patterns were observed within the members of an individual subfamily, while dynamics were different across sub-families. Nucleotide binding properties probed
using computer simulations indicated diverse binding preferences in hRNases. Additionally,
structural and dynamical properties of hRNases varied significantly with subtle change in
temperature. Quasi anharmonic analysis revealed sampling of separate conformational substates in product release step of RNases. Further, NMR chemical shift titrations along with the
chemical shift projection analysis revealed distinct conformational rearrangements in hRNases
upon binding of ligands that mimic cleaved products. Steady-state kinetics experiments showed
million-fold difference in the catalytic efficiency of hRNases. Finally, hybrid quantum
mechanical/molecular mechanics calculations identified conformational sub-states associated
with the chemical step in bovine RNase A. Broadly, these results strongly support our hypothesis
that dynamics modulates catalytic efficiencies of structurally related enzyme super-families like
RNases.
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Introduction
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1.1 Enzymes and ribonuclease A superfamily
Enzymes are biological macromolecules that catalyze cellular reactions essential to sustain life.
Enzyme have the ability to enhance the rate of a chemical reaction by more than 1020 folds,
making them the most efficient catalysts occurring naturally.1 The molecules upon which enzymes
act are called as substrates; with each enzyme recognizing and acting upon a defined list of
substrates. Upon completion of an enzymatic reaction, substrate(s) are converted into product(s).
Enzymatic reactions occur in a cycle of multistep process, called as the catalytic cycle, which
includes substrate(s) binding, chemical step and product(s) release. All these steps can occur
within a few milliseconds or even less. During an enzymatic reaction the smallest fraction of time
is spent in the most important part of the catalytic cycle, called the transition state (TS).2 TS is the
highest energy transitory structure in a reaction which is no longer a substrate but not a product
as yet. The energy required to reach the TS is the minimum energy required to convert a reactant
into product, in this case also called as the activation energy. Compared to reaction in water or
gas-phase, enzymes decrease activation energy by shaping their active site such that it binds to
the transition state even better than the substrate.3 Most enzymes are tailored to bind a specific
substrate(s) and perform a specific function (reaction). Enzymes' specificity comes from their
unique three-dimensional (3D) structures. Enzymes are proteins, and their structure comprises of
unbranched chain of amino acids that adopts a specific three-dimensional fold. Enzymes that
share a common fold and catalyze same/similar reaction belong to a same protein family. A
number of protein families together form a super family. In other words, protein super family refer
to a group of structurally or functionally related proteins that may or may not have a common
evolutionary origin.
Ribonuclease A superfamily is a group of enzymes that catalyze the hydrolysis/degradation of
ribonucleic acid (RNA) molecules into smaller components. Ribonucleases A enzymes specific to
vertebrates are found in high quantity in the pancreas of certain mammals and some reptiles, and
therefore are also called as pancreatic-type ribonuclease superfamily, hence forth called as
RNase family.4-6 RNases have a marked preference for cleavage of RNA at the P-O5’ bond on
the 3’ side of the pyrimidine residue and do not require any metal ion or cofactor (Figure 1.1).7
The sequence identity among the RNase family members is sometime as low as ~20%.8 However,
two histidine and one lysine residues essential for the RNase function are conserved (Figure
1.2).8,

9

Structural information for several RNase homologs has been obtained by X-ray

crystallography. The members of RNase superfamily are small proteins with ~130 amino acids
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(~13-15 kilodaltons, kDa). In addition, they generally also have a short signal peptide of ~25 amino
acids. Signal peptides are short segments usually at the N-terminal end of a newly synthesized
protein, with a function to prompt the cell to translocate the synthesized protein usually to cell
membranes. Even with a low primary sequence identity RNases adopt a common ⍺+𝛽𝛽 kidney

shaped fold (Figure 1.3 A). The protein secondary structure elements (⍺ helix and 𝛽𝛽 sheets) are

conserved, and variations can be observed only in loop regions (Figure 1.3 B). RNases have 6 to
8 cysteine residues in their primary sequence that form three to four disulfide bonds in their three-

dimensional structure (Figure 1.3 A). Two antiparallel 𝛽𝛽 -sheets define the V1 and V2 domains
linked by a hinge region in their kidney shaped structure. They have a well-defined binding cleft
between the two V1 and V2 domains.

Figure 1.1: Schematic representation of Ribonuclease A function. RNA substrate is shown
on left. The phosphodiester bond cleaved during RNase reaction is marked with an arrow. The
cleave products formed after the RNase reaction are shown on right.

3

Figure 1.2: Multiple sequence alignment of RNases. Sequence for human RNases and bovine
RNase A is included. Fully conserved residues are highlighted in red boxes. Catalytic residues
are marked with blue stars. Gaps in the alignment are represented using dotted lines. Consensus
sequence number is shown at the top and bovine RNase A sequence numbering is shown at the
bottom. Sequence alignment was performed in Clustal Omega 10 and rendered in ESPript 11

4

Figure 1.3: Structure and structural alignment of RNases family members. (A) Ribbon
diagram of the crystal structure of bovine RNase A (PDB ID 7RSA); cysteine residues are
represented as purple sticks and the disulfide bonds are shown in yellow. V1 and V2 domain is
represented in dashed line. (B) Structural alignment of representative RNases. Structures include
1QMT (violet), 2K11(orange); 1ANG (cyan) and 1RNF (green). Catalytic residues are displayed
as sticks and labeled. Loops L1, L3, L4, L6 and L7 are marked.
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1.2 Human RNases and their role in health
RNase superfamily has remarkably high rates of gene duplication and gene loss, resulting in
variable numbers of genes in different species.12 In humans, there are thirteen RNase type genes
located on chromosome 14 within cluster 14q11.2 (Figure 1.4).13 Eight of these human RNases
(hRNases 1-8) have the RNases function (i.e. can hydrolyze RNA molecule) and are referred to
as canonical RNases. The other five open reading frames (ORFs), i.e. RNase 9-13 encode
proteins that lacks the catalytic residues (two histidine and one lysine) essential for RNase
function.5 The canonical hRNases are secretory protein, i.e. they are released from the cells
where they were produced and translocated to target cells when they perform their designated
function. These proteins are secreted by various innate immune cells, from blood cells to epithelial
cells.14 They exhibit diverse expression pattern and are widely distributed in various organs,
tissues and body fluids. The levels RNases in our body fluids correlate with infection and
inflammation processes ensuring tissue health and body homeostasis.15 Apart from hydrolysis of
dietary RNA, these enzymes participate in a wide variety of biological functions, including
neurotoxicity, angiogenesis (blood vessel formation), immuno-modulatory, anti-pathogen and
anti-tumor activities.8, 16, 17 Described below are the highlights of common features of the eight
canonical hRNases with regard to their respective sequences, structure, biochemical
characterization, regulation and role in human health and disease.

Figure 1.4: Location of hRNases on human chromosome 14. hRNase1-8 perform
ribonuclease function and degrade RNA molecules. hRNases 9-13 lack the residues required for
enzymatic function and therefore do not catalyze RNase reaction. hRNase10 is towards the
centromere; hRNase8 is towards the telomere; ps (pseudogene). (Adapted from 5)
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Human RNase 1 (hRNase1) is expressed in a wide variety of human organs and tissues.
22

14, 18-

Apart from hydrolysis of RNA, hRNase1 has significant physiological implications in the

regulation of vascular homeostasis due to its wide extracellular distribution.8, 23 In addition to
cleavage of single-stranded RNA (ssRNA) this enzyme has been reported to hydrolyze doublestranded RNA (dsRNA) molecule as well as DNA (deoxyribonucleic acid):RNA hybrids. 24 Due to
its catalytic versatility, hRNase1 is reported to act as an extracellular RNA scavenger and
inactivates human immunodeficiency virus

(HIV),25 participate in inflammatory and immune

response by promoting maturation and activation of dendritic cells as well as subsequent
production of different cytokines.26 Evidence indicate that hRNase1 important for normalization of
serum viscosity and clearance of perivascular pathogenic polynucleotides. Further, it is reported
that hRNase1 enters human cells and catalyze the cleavage of RNA, leading to cell death.27, 28
Utilizing this ability, Raines and co-workers have demonstrated the potential of hRNase1 as a
chemotherapeutic agent that is toxic to tumor cells.29
Human RNase 2 (hRNase2), also known as eosinophil-derived neurotoxin (EDN) is found in
spleen, liver, kidney, placenta, and urine.30-34 It has also been found in the secondary granules
of eosinophil granulocytes. hRNase2 shares ~32% primary structure identity to hRNase18. It is
reported to be inactive towards poly (A) and dsRNA and does not hydrolyze 2’:3’-cyclic
nucleotides.35 hRNase2/EDN show neurotoxic potency and has a specific antiviral action against
respiratory syncytial virus (RSV) 36, 37, HIV-I 38 and hepatitis B DNA virus 39. Its anti-viral activity is
reported to be dependent on its ribonucleolytic activity. However, it does not display any
bactericidal activity. Studies also suggest that hRNase2 might trigger an inflammatory response
that activates killer cells or cell death pathways.16 Alternatively, hRNase2 can participate in further
modulating the immune response by degrading the viral RNA in the cytoplasm of infected cells.15
Human RNase 3 (hRNase3), also known as eosinophil cationic protein (ECP) is the other major
secretory

protein

of

the

human

eosinophil

granule

and

is

released

upon

cell

activation/stimulation.40 hRNase3 shares ~26% primary structure identity to hRNase1 while it is ~
67 % similar to hRNase2.8 It is about two orders of magnitude less active on yeast tRNA as
compared to hRNase1 and hRNase2.35, 41 hRNase3 displays anthelminthic, bactericidal, antiviral
and antiparasitic activities.42 The ribonucleolytic activity of hRNase3 does not appear to be
necessary for cytotoxicity or bactericidal activity, while it is essential of the antiviral activity.
hRNase3’s high toxic activity has been demonstrated in vitro against Schistosoma mansoni,
Plasmodium falciparum, Brugia pahangi, and Trichinella spiralis.43 The bactericidal action of
7

hRNase3/ECP is reported to correlate with its membrane disruption capability and is linked to
aromatic and cationic residues located on the surface of the protein.42, 44 Although not completely
understood, a stepwise mechanism of hRNase3 antibacterial activity is proposed.15, 45 hRNase3
binds to the surface of bacteria promoting conformational changes in the protein. All rearranged
hRNase3 molecules bind to each other leading to agglutination of bacteria. The protein then forms
amyloid-like aggregation that disrupts the lipopolysaccharide bilayer, resulting in possible
membrane disruption in bacteria.
Human RNase 4 (hRNase4), is detected in several somatic tissues including liver, pancreas,
lung, heart, kidney, and placenta.8,

43

Cytoplasmic granules of monocytes also express this

enzyme. This enzyme has the shortest amino acid sequence (119 residues) in this family and
shares about 90% sequence identity with bovine ribonuclease A (bRNaseA), the prototypical
member of the RNase superfamily. It is structurally more like hRNase1 (43% identity) than to
hRNase2 (31% identity) but shares some catalytic properties with both RNase types. Like
hRNase1 it shows hydrolytic activity towards 2’:3’-cyclic nucleotides.46 Although considerable
work has been undertaken to interpret its biological properties, its specific biological function
remains unknown. Nearly ubiquitous distribution of hRNase4 suggests a housekeeping role for
this enzyme. Interestingly, hRNase4 has also been found in the soluble factors secreted by Tcells showing anti-HIV activity further suggesting its involvement in host defense activities.47
Additionally, it is reported that hRNase4 prevent the degeneration of neuron by promoting
angiogenesis, neurogenesis, and promotes the neuronal survival under stress.48 Expression of
hRNase4 is reduced in amyotrophic lateral sclerosis (ALS) affected patients,48 however a direct
link between ALS and hRNase4 is yet to be established.
Human RNase 5 (hRNase5), was first isolated from tumor cells and later found in a wide variety
of tissues and organs.49, 50 This enzyme is a potent inducer angiogenesis, and therefore it is also
called as angiogenin. hRNase5 is structurally similar to bRNaseA and hRNase1 however it has a
million-fold lower ribonucleolytic activity than that of bRNaseA.8 Although hRNase5 exhibits
extremely weak ribonucleolytic activity, it is still essential for angiogenesis. Studies report that
hRNase5 undergoes nuclear translocation to stimulate blood vessel growth and plays an essential
role in cell proliferation.51 A recent work correlated elevated hRNase5 expression in some tumor
cell lines with the promotion of cell proliferation and development of malignant cancer.52 An
association between ANG and cancer has been observed in more than 20 clinical studies to date.
hRNase5 is also reported to be involved in motor neuron physiology, and genetic deficiencies in
8

hRNase5 can lead to immune-related diseases, such as ALS.53 Recent studies report the
involvement of hRNase5 in cell defense against stress and microbicidal activities.
Human RNase 6 (hRNase6), also referred to as RNase K6, is found in neutrophils and
monocytes and therefore proposed to have host defense functions.54 The amino acid sequence
of hRNase6 is ~43% identical to hRNase2 and ~38% identical to hRNase1. Its ribonucleolytic
activity towards yeast tRNA is 40 folds lower than hRNase2.8 RNase6 has been reported to
display a high antimicrobial activity in vivo and it showed very low cytotoxicity levels against
mammalian cells.55 It is also suggested to play an essential role in bacterial clearance at the
urinary tract. Boix et al. recently proposed the antimicrobial mechanism of action.56 Highly cationic
hRNase6 first interacts with the negatively charged envelopes of the bacterial cell subsequently
leading membrane destabilization and bacterial agglutination. The investigators also found that
the N-terminal domain of the protein retains the antimicrobial properties of the whole protein.57
This suggests the possibility of using the scaffold of hRNase6 for developing peptide-based
antimicrobial agents in the future.
Human RNase 7 (hRNase7), is expressed in various epithelial tissues and organs. It was
detected in skin as well as in the respiratory tract, genitourinary tract, liver, kidney, skeletal
muscle, and heart.58, 59 The catalytic activity of hRNase7 is 50 fold higher hRNase3 and 8 fold
lower than hRNase1.8 hRNase7 is reported to have potent bactericidal activity against several
Gram-positive and Gram-negative bacteria. It is therefore called as epithelial-derived
antimicrobial protein.55 Recent studies have reported the ability of hRNase7 to permeate the
bacterial membranes. Specific lysine residues (K1, K3, K111, and K112) were identified to be
crucial for its antimicrobial mechanism of action, and ribonucleolytic activity was not essential for
its antibacterial action.60, 61
Human RNase 8 (hRNase8), is the most recently discovered active human RNase and is
expressed uniquely in the placenta. It is reported to have antimicrobial activity against various
bacteria including Candida albicans and does not affect the human cells, suggesting that it plays
a role in protecting the placenta against infections.62 Its reported ribonucleolytic activity against
yeast tRNA is two folds lower than that of hRNase7.8 At present, no information regarding
structure or catalytic properties are available for this enzyme.
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1.3 Biochemical and biophysical characterization of RNases
The physical, chemical and enzymatic properties of the bovine RNase (bRNaseA) have been
extensively characterized.7,

63, 64

However, comparatively lesser information is available for

recently discovered human RNases. In this section, the biochemical and biophysical properties
bRNaseA and hRNases is summarized. bRNaseA is a catanionic protein (pI = 9.63) at
physiological pH. It has several positively charged residues (10 lysine and 4 arginine residues)
that enable its binding to RNA (a polyanion). In other words, bRNaseA has smaller number of
hydrophobic groups, especially aliphatic ones. Its low hydrophobic content may also serve to
reduce the physical repulsion between highly charged groups (its own and those of its substrate
RNA) and regions of low dielectric constant (the nonpolar residues). Similar to bRNaseA,
hRNases also have high isoelectric points and net positive charges (with pI values between 8.69
– 10.12).16 These properties are associated with antibacterial activity and strong interactions with
their negatively charged polynucleotide substrates. However, each hRNases varies in its
nucleotide substrate preference and ribonucleolytic activity.

1.3.A Substrate binding and specificity
Binding of single-stranded nucleotides to bRNaseA involves up to seven coulombic interactions
suggesting that the enzyme-substrate interaction extends well beyond the scissile bond.7
Structural and kinetic studies, using different oligonucleotides substrates and polynucleotides (as
homologous to the RNA substrate) reveal the existence of several substrate binding sub-sites 65
that make up the active site in the structure of RNases as shown in Figure 1.5. The amino acid
residues that form the sub-sites for bRNaseA have been well defined. The B1 sub-site consisting
of residues Thr45 and Asp83 appear to bind only pyrimidine bases. Thr45 sterically hinders the
binding of purine base in B1 sub-site and mediates pyrimidine specificity by forming a hydrogen
bond. Thr45 can act as a donor or acceptor depending upon the binding nucleotide, and the
conformation of Asp83 is responsible for switching this role of Thr45.66 Additionally, Phe120
contributes to pyrimidine binding in B1 sub-site by forming a van der Waals contact and acts as a
hydrophobic mattress for the base. Phe120 also plays an important role in stabilizing the TS
intermediate in catalysis by forming a hydrogen bond with non-bridging oxygen of the reactive
phosphoryl group.7 The B2 sub-site, comprising of residues Gln69, Asn71 and Glu111, has a
preference of adenine base.9, 67 The difference in the specificities of B1 and B2 sub-sites makes
RNases a distributive enzyme, that binds a polymeric substrate, catalyzes a chemical reaction
and releases a polymeric product to the solvent.
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Three other enzymatic sub-sites P0, P1, and P2 interacts with the phosphoryl groups of the bound
RNA substrate. The P1 sub-site comprising of residues Gln11, His12, Lys41, His119, and Asp121
forms the active site in bRNaseA (Figure 1.5). The phosphoryl group bound at the P1 site
participates in the reaction mechanism.7, 9 Site-directed mutagenesis has shown that residues
Lys7, Arg10, Gln11, His12, Lys41, Thr45, Lys66, Asn71, Asp83, Glu111, His119, Phe120, and
Asp121 contribute towards substrate binding or turnover in bRNaseA. Substitution of these
residues has resulted in reduced catalytic activity by ~ 104 fold.7
Sequence alignment for canonical hRNases and bRNaseA show that the residues of main
phosphate binding P1 sub-sites sites are conserved (Figure 1.2) in all members. The threonine
residue of B1 sub-site and asparagine of B2 sub-site are also conserved. However, variability is
observed in other residues of base binding sub-sites which attributes to substrate preference and
cleavage pattern in RNase homologs. Further, nucleotide binding recognition patterns for
hRNases has been deduced based on the available protein-ligand complexes in the Protein Data
Bank (PDB).9 The base preference of select hRNases and bRNaseA is reported in Table 1.1.
bRNaseA and hRNase1, has a higher preference for cytosine containing substrates. It is reported
that bRNaseA can hydrolyze cytosine containing substrates at-least 2 folds faster than uridylyl
substrates.7 Table 1.1 reports that hRNases 2 - 4 have a clear preference for uracil containing
substrates. Asn71 (bRNaseA numbering) can contribute as both acceptor and donor while
bonding to adenine base,68 and all hRNases share this purine recognition trait.9, 57, 69, 70 However,
variations are observed in pyrimidine binding. In hRNase4 the aspartate residue of B1 sub-site is
not flexible to move and therefore locks the threonine residue as a hydrogen bond acceptor
facilitating interaction mainly with uracil nucleotide.71 This substitution of Arg101 (in place of
Lys104 in bRNaseA) prevents the binding of cytosine base in B1 sub-site of hRNase4. Substitution
of this lysine residue is also found in hRNase2 and 3 increasing their preference for uracil base.72
In hRNase5, Gln117 is oriented towards the active site in the solved crystal structure and hinders
the access of the substrate to the pyrimidine binding site suggesting the requirement of
conformational rearrangement to allow the main base binding.73 Moreover, specific orientation of
catalytic residues is not favorable for cleavage of RNA resulting in million-fold lower catalytic
efficiency in hRNase5. Therefore, non-conserved substitutions at binding sub-sites might explain
the distinct substrate specificities in these homologs reported in Table 1.1. These observations
should, however, be considered with caution; as many complex structures were solved in nonphysiological conditions and limited data was available for pyrimidine bases and some homologs.
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Table 1.1: Sub - site base preference in RNases. Preference of B1 and B2 sub-sites is deduced
from crystal structure and kinetic studies (Adapted from 9)
Preference at
B1 sub-site

Preference at
B2 sub-site

Ref

Poly(C), Poly(U)

C>U

A

74

hRNase2

UpA, UpG Poly(C), Poly(U)

U>C

A>G

74, 75

hRNase3

CpA, UpA, UpG
Poly(C), Poly(U)

U>C

A

74, 76

hRNase4

UpA, CpA
Poly(C), Poly(U)

U >>> C
(10:1)

A

46, 74

bRNaseA

CpA, UpA,
CpG, UpG
Poly(C), Poly(U)

C > U (2:1)

A >>> G

77, 78

Enzyme

Substrates investigated

hRNase1
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Figure 1.5: Nucleotide binding sub-sites in ribonucleases. either uracil or cytosine can bind
to B1 sub-site. B2 sub-site has a preference for adenosine in RNase A family. The catalytic
residues form the phosphate binding sub-site P1. The phosphodiester bond cleave during RNase
reaction is marked with an arrow. bRNaseA residues that interact with the substrate RNA
molecule at distinct sub-sites are shown. (Adapted from 7).
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1.3.B Catalytic mechanism of phosphodiester bond cleavage
RNase catalyze the cleavage of phosphodiester bond (P-O5’) found in the RNA backbone. The
mechanism of catalysis by RNases has been studied by a number of biochemical and biophysical
approaches.7, 79-84 The overall RNase reaction have been proposed to involve two separate steps.
The ﬁrst (transphosphorylation) step, 3',5'-phosphodiester bond of RNA molecule is cleaved to
give an oligonucleotide terminating in a pyrimidine 2′,3′-cyclic nucleotide and a 5’ hydroxyl
terminated fragment; in the second (hydrolysis) step this 2′,3′-cyclic nucleotide is hydrolyzed, by
water attack, and a terminal 3′-nucleotide is formed (Figure 1.6).7 Two types of mechanisms for
the transphosphorylation step have been extensively discussed in the literature.7, 85-89 The first is
the widely accepted classical mechanism that follows a minimal acid/base mechanism with a dianionic TS (Figure 1.7).88, 89 The second type of mechanism that has been proposed is based on
a tri-ester mechanism leading to a monoanionic TS (Figure 1.8).86 This mechanism has received
less acceptance. The difference in the two proposed mechanisms of transphosphorylation is the
destination of protons as well as the sequence in which they are transferred.85
The widely accepted mechanism of transphosphorylation step proposes that the reaction is
catalyzed by concerted general acid/base catalysis by His12 and His119 (in bRNaseA).90, 91 The
imidazole group of His12 acts as a base that abstracts a proton from the 2’-O of a substrate
molecule. This nucleophilic oxygen attacks the electrophilic phosphorous and forms a pentavalent
intermediate. Lys41 directly interacts with the phosphate moiety and stabilizes the pentavalent
TS intermediate.7, 92 The imidazole group of His119 acts as an acid for the cleavage reaction and
protonates the 5’O of the leaving group.
An alternative tri-ester mechanism has also been proposed.93 Evidence from experimental
observations and gas-phase quantum chemistry calculations support this method.94 In this
mechanism, a proton originating via migration from the O2' hydroxide coordinates with one of the
nonbridging phosphate oxygen rendering the phosphate neutral, which facilitates nucleophilic
attack by the 2’-alkoxide to form a phosphate tri-ester like intermediate structure. After the
formation of the trigonal bipyramidal phosphorane structure, the catalytic proton is abstracted
from the nonbridging oxygen by the catalytic base His119, leading to the expulsion of the leaving
group. Such a mechanism has also been proposed as the reaction path for a similar Ribonuclease
T1 enzyme.95
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Figure

1.6:

Mechanism

of

Ribonuclease

function.

bRNaseA

catalyzed

(A)

Transphosphorylation of 3',5'-phosphodiester bond of RNA molecule leading to a 2′,3′-cyclic
nucleotide and 5’ hydroxyl terminated fragment. (B) Hydrolysis of 2′,3′-cyclic nucleotide to a
terminal 3′-nucleotide is shown. (Adapted from 7)
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Figure 1.7: Widely accepted general acid/base mechanism for transesterification step.
The reactant, product and transitions state (TS) are shown. His12 acts as a general base and
His119 acts as a general acid. Catalytic residues are numbered according to bRNaseA (This
figure is adapted from 85)

After the transphosphorylation step each histidine residues is protonated appropriately to catalyze
the hydrolysis (Figure 1.6 B) of the bound cyclic intermediate. In the second hydrolysis step, the
2’,3’ cyclic phosphate is hydrolyzed to a 3' terminal nucleotide.96 The catalytic roles of His12 and
His119 are now reversed. His119 activates the attack of water by acting as a general base while
His12 protonates the leaving group acting as a general acid. His119 abstracts the proton from a
water molecule, activating it for nucleophilic attack. The activated water molecule then attacks the
cyclic phosphate resulting in the cleavage of the 2',3’ cyclic phosphate intermediate.
Simultaneously, His12 donates a proton to the leaving group, which is the 3’ oxygen of the cyclic
intermediate. Finally, the truncated nucleotide with a 3’ terminal phosphate group is released.
After the process of hydrolysis, the histidine residues return to their initial protonation states
completing the catalytic cycle. bRNaseA, however, can release the cyclic intermediate rather than
hydrolyzing it.96, 97 Under such instances, the protonation states of the two histidine residues are
interconvert by an iso mechanism that does not involve substrate molecule.
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Figure 1.8: Calculated low energy path for tri-ester like mechanism. This pathway is
calculated based on a first principle quantum mechanics/molecule mechanics (QM/MM) with
density function theory (DFT/B3LYP) level of electronic structure calculations. Catalytic residues
are numbered according to bRNaseA (This figure is adapted from 85)
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1.3.C Catalytic efficiency
The rate of enzymatic reaction has been measured for RNases using steady-state kinetics
experiments. The kinetic parameters; the rate of catalytic turnover (kcat), the amount of substrate
needed for the enzyme to obtain half of its maximum rate of reaction (KM) and catalytic efficiency
(ratio of kcat/KM) for bRNaseA and hRNases is reported in Table 1.2. The data in Table 1.2
indicates that binding affinities differ over several orders of magnitude between these RNases.
Further, catalytic efficiencies for these homologs differ by as much as 106-fold. However, these
kinetic assays have been performed under different experimental conditions (pH, temperature,
buffer) and using variety of substrates with different nucleotide sequences with variable lengths
resulting in diverse binding affinities and catalytic efficiencies. Therefore, these differences should
be carefully considered when comparing the efficiency in these homologs.

1.4 Role of dynamics in enzyme function
The role of enzyme structure as a scaffold to facilitate the catalyzed reaction is well established.
The active site of enzyme provides a complementary structural and electrostatic environment to
preferentially bind specific substrates and/or cofactors and subsequently stabilize the TS allowing
the reactions to proceed at a much faster rate than in solution.98 This perspective, however, fails
to explain many phenomena observed in enzyme structure and function; First, the allosteric and
cooperative effects of residues outside the active site; many studies report significant changes in
catalytic efficiency of enzymes pertaining to mutations in distal residues. 99, 100 Second, the impact
of bulk and hydration shell in enzyme activity.101 Third, large rate-enhancement achieved by
structurally similar enzymes, for example, the members of the RNase family share conserved
structural scaffold and catalytic machinery, yet their catalytic efficiency differs by a million folds
(Table 1.2). And finally, efforts towards designing proteins with active sites environment similar to
natural enzymes have not been very successful.102 Therefore, the rate enhancements by
enzymes and their reaction mechanisms cannot be fully explained by the structural effects alone.
In addition to the role of direct structural interactions, several other factors contribute to catalysis
for example networks of hydrogen bond and long-range effects.103, 104
The emergence of new information has allowed enzymes to be viewed beyond a single rigid
structural scaffold. Evidence from multiple experimental and computational techniques show
that enzymes are flexible and exist as an ensemble of inter-converting structures called as
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Table 1.2: Summary of reported substrate binding affinities and enzyme activity. In addition
to hRNases 1-6, the parameters for bRNaseA are also shown for comparison. tRNA denotes
substrate of non-specific sequence obtained from cellular tRNA.

Protein

Substrate

hRNase1
hRNase1
hRNase2

Poly(C)
tRNA
tRNA

hRNase2
hRNase2
hRNase2
hRNase2
hRNase2
hRNase2
hRNase3
hRNase3
hRNase3
hRNase3
hRNase3
hRNase3
hRNase3
hRNase3
hRNase3
hRNase3
hRNase3

KM (mM)

0.10 ± 0.013
4.0
0.0007
0.00336 ±
tRNA
0.00015
tRNA
0.0128
Poly(U)
80 ± 7
tRNA
2.5 ± 0.21
0.0036 ±
tRNA
0.00015
Poly(U)
53.05 ± 4.04
CpA
1.7±0.3
UpA
2.7±0.66
C>p
3±0.53
C>p
1.5
U>p
1.0
CpA
2.4
UpA
5.4
(Up)2 U > p
1.4
(Up)3 U > p
0.7
(Up)4 U > p
0.17
ytRNA
0.0041

hRNase3

Poly(U)

hRNase4
hRNase4

UpA
CpA

hRNase5

CpA

hRNase5

CpG

hRNase5

CpC

hRNase5

CpU

hRNase5

UpA

hRNase5

UpG

hRNase5

UpC

hRNase5

UpU

253 ± 10

kcat (s-1)
2416.67 ± 33.3
64.8
0.91

kcat/KM (s-1M-1) x
Temp. (K)
106
1.48 ± 0.11
310
0.0.162
0.13

Ref.
105
106
107

31.37 ± 0.96

9.34 ± 0.17

3.7
190 ± 11
20 ± 0.65

3.2

31.37 ± 0.96

9.34 ± 0.17

70

1248.93 ± 12.10
0.55±0.06
1.22±0.12
0.0032±0.00051
0.014
0.0043
4.2
6.2
0.56
1.2
1.4
0.0024

4.79 ± 0.52
0.000323
0.000447
1.07×10−6
0.000011
0.000004
0.001750
0.001150
0.000400
0.001714
0.008235
0.000590
0.00014 ±
0.000005
0.25
0.00066
0.0000122 ±
0.0000002
0.000004 ±
0.0000001
0.0000013 ±
0.0000001
0.0000006 ±
0.0000001
0.0000007 ±
0.0000001
0.00000013 ±
0.00000002
0.00000006 ±
0.00000001
0.000000031 ±
0.000000007

70

36 ± 0.4
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108

310

109
108
108

298
298
298
298
298
298
298
298
298
298
298

57
57
57
110
110
110
110
110
110
110
110
111

298

112

298

69, 113

298

69, 113

298

69, 113

298

69, 113

298

69, 113

298

69, 113

298

69, 113

298

69, 113

Table 1.2 continued
KM (mM)

kcat (s-1)

Protein

Substrate

hRNase5

pCpA

hRNase5

CpAp

hRNase5

CpApG

hRNase5

CpApA

hRNase5

CpApU

hRNase5

CpApC

hRNase5

CpA

hRNase5

CpAp

hRNase5

CpApG

hRNase5

CpA

hRNase5

CpAp

hRNase5

CpApG

hRNase6
hRNase6
hRNase6
hRNase6
hRNase7
bRNaseA
bRNaseA
bRNaseA
bRNaseA
bRNaseA
bRNaseA
bRNaseA
bRNaseA
bRNaseA
bRNaseA
bRNaseA
bRNaseA
bRNaseA

tRNA
UpA
CpA
C>p
ytRNA
UpA
UpA
UpA
UpA
CpA
C>p
Poly(C)
Poly(C)
Poly(C)
Poly(U)
Poly(C)
Poly(U)
Poly(C)

0.005
2.63±0.3
1.22±0.2
2.06±0.3
0.0022
0.20 ± 0.06
0.33
0.62 ± 0.09
0.7
0.5
1.06±0.1
0.047 ± 0.011
0.089 ± 0.009
0.0331 ± 2.6
0.06
0.034
0.06 ± 0.01
0.034 ± 0.002

0.13
12.9±1.1
1.08±0.1
0.00325 ± 0.06
5.1
347 ± 40
1920
1400 ± 150
2690
2300
2.28±0.18
190 ± 11
507 ± 15
368.0 ± 11.0
24
510
24 ± 15
510 ± 10

bRNaseA

Poly(A)

0.080 ± 0.009

0.023 ± 0.001
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kcat/KM (s-1M-1) x
Temp. (K)
106
0.000019 ±
298
0.000001
0.000110 ±
298
0.000005
0.000055 ±
298
0.000002
0.000044 ±
298
0.000002
0.000030 ±
298
0.000001
0.000021 ±
298
0.000001
0.0000024 ±
298
0.0000001
0.000017 ±
298
0.0000001
0.0000117 ±
298
0.0000003
0.0000040 ±
298
0.0000001
0.000033 ±
298
0.0000002
0.000016 ±
298
0.0000004
0.000026
298
0.0049
298
0.000885
298
−6
1.6 ×10
298
2.3
310
1.7 ± 0.3
298
5.8
298
2.3 ± 0.4
298
3.0 ± 0.1
298
6.4 ± 0.7
298
0.00215
298
4.0 ± 1.0
283
5.7 ± 0.5
298
11.2 ± 0.6
0.4
298
15
298
0.4 ± 0.3
298
15 ± 1
298
0.00028 ±
298
0.00004

Ref.
69, 113
69, 113
69, 113
69, 113
69, 113
69, 113
69, 113
69, 113
69, 113
69, 113
69, 113
69, 113
54, 57
57
57
57
58
114
115
116
117
117
57
118
114
119
115
115
116
116
116

conformations.120-122 Alternate conformations are sampled as a result of internal motions in the
enzymes driven by the surrounding environment and temperature.123 Internal protein motions
occurring at all time scales is known as protein dynamics. These motions associated with protein
dynamics occur on a wide range of time-scales ranging from femtosecond to millisecond (fs - ms).
Fast motions governing side chain and backbone rearrangements occur at picosecond to
nanosecond (ps - ns) time scales and allow sampling of conformations in the near vicinity. Large
conformational changes are slow motions that occur mainly at longer time-scales microsecond to
millisecond (μs - ms) and are associated with overcoming large energy barriers allowing interconversion between different group of populations (Figure 1.9).104, 124, 125
Studies report that enzyme landscape is full of conformational states, which are sampled over
different time-scales.126, 127 The conformational fluctuations occurring at the time scale of reaction
allow the enzyme to access the region of conformational landscape that contains the correct
structural and dynamical features to promote specific interactions between reactants.128 In other
words, the rate of the various events in the enzyme cycle is connected to the rate of sampling of
correct motions/conformations. Only a small fraction of the conformations sampled by an enzyme
facilitate in substrate (and/or cofactor) binding, reactant ground state stabilization, the chemical
step of conversion, and product release along the catalytic cycle. These function promoting
conformations are called as conformational sub-states.129 Conformational sub-states promote
specific interactions between reactants in various stages of the catalytic cycle. Accessing such
conformational sub-states is not a random event but form an integral part of enzymes function.
A number of studies summarizing the contribution of dynamical motions and conformational
fluctuations in enzyme catalysis have reported the presences of complex residue networks in
enzyme structure that connects the surface loop regions to the active site by a series of hydrogen
bonds and hydrophobic interactions.103,

130, 131

Conformational fluctuations in these network

residues introduce favorable changes in the active site allowing the enzyme to become more
productive. Another vital role of these network pathways is to couple the surrounding solvent to
enzyme function. The motions on the surface of the enzyme harness energy from the surrounding
solvent which is eventually fed into the global conformational fluctuation of the enzyme providing
energy for overcoming the activation energy barrier.104, 132 The presence of such networks and
motions is an integral part of enzymes structure and function that has been conserved during
evolution.133
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Figure 1.9: Schematic representation of conformational landscape of protein. The arrows
correspond to the conformational fluctuations within and between the distinct sub-states. Faster
time-scales (ps - ns) allow conformational sampling within a well. Conformational fluctuations at
slower time-scales (µs - ms) allow interconversion between two conformational states A (lower
energy ground state) and B (excited state). 𝝆𝝆A and 𝝆𝝆B represent respective populations and 𝝆𝝆A
>> 𝝆𝝆B.
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1.4.A Dynamics in ribonucleases
The effect of protein motion on different aspects of enzyme function and protein complex
formation in a variety of systems has become accessible through NMR relaxation experiments.134,
135

Based on NMR dispersion relaxation experiments Loria and coworkers found that bRNaseA

was rigid (absence of internal motions) at lower time-scales (ps - ns). However, residues in
bRNaseA were dynamic at the µs to ms time-scale and showed chemical exchange in 15N-CPMG
NMR experiments, i.e., displayed dynamic behavior. These residues also included the residues
that form the B1, B2 and P0 sub-sites in bRNaseA. The average chemical exchange rate (kex)
quantified for dynamic residues in CPMG experiments was 1640 s-1 which is similar to the rate of
catalytic turnover in bRNaseA (1900 s-1), suggesting a possible correlation between enzyme
dynamics and catalysis in bRNaseA.136
Further Loria and coworkers identified that mutations in distal residues His48 and loop1 (Figure
1.3) residues resulted in the loss of ms motions and 10-fold decrease in catalytic activity of
bRNaseA suggesting that motions in RNase A were functionally relevant and more widespread
than the active site.137 Additionally, their studies highlight the importance of H-bonding interactions
in the propagation of functional motions in bRNaseA. His48 was eventually shown to be an
important conformational switch that controls distal motions that are essential for optimal product
release.138 Doucet et al. in their work demonstrated that altering one methyl ~10 Å away from the
active site significantly alters conformational dynamics of bRNaseA on ns - ms time-scale. This
change in the dynamics of the enzyme affects ligand binding and specificity.139 Further studies on
bRNaseA motion using NMR and computer simulations reveal that RNase does not undergo large
conformational changes as observed in highly flexible proteins/enzymes. Flexibility in bRNaseA
propels subtle movements of the loops and secondary structure elements. The movements play
a crucial role in important steps of enzymatic cycle which is substrate recognition, catalysis, and/or
product release. Human homologs of bRNaseA have also been subjected to dynamic
investigation.139-143
Global and local motions in hRNases are closely related to dynamics observed in bRNaseA, and
similar motions are observed for the conserved catalytic residues in some members.140 In
hRNase1, catalytic residue His119 is flexible and undergoes chemical exchange. NMR studies
revealed that loop 4 in hRNase1 is highly flexible in the absence of ligand consistent with motions
observed in bRNaseA; however, it becomes rigid upon inhibitor binding.141 NMR studies of
hRNase3 show that loop4 residues undergo conformational exchange and MD simulations show
23

higher-than average residue motion of this loop consistent with bRNaseA.142, 144 However, their
rate of conformational exchange varies significantly from bRNaseA. Further, experimental
evidence also illustrates that the millisecond motions essential to product release in bRNaseA are
absent from hRNase3. In hRNase5 the V1 and V2 domains undergo large breathing motions on
the ns time-scale, like the hinge-bending motions observed in the bRNaseA143. Like bRNaseA
His114 (bRNaseA His119) and Lys40 (bRNaseA Lys41) residues were dynamic, while His13 was
found to be very rigid on NMR time-scales.145 Considerable flexibility is observed in loop4 on the
ns time-scale which contributes towards purine selection in hRNase5. However, at ms time-scale,
hRNase5 is a more conformationally restrained as compared to other homologs.146 While the
conservation of global, collective flexibility manifested by RNases has been appreciated for this
enzyme fold, the differences in their dynamical signatures at functionally relevant time-scale have
not yet been analyzed in detail. Correlating the subtle difference in the dynamics of these human
homologs with their catalytic efficiency would provide a better understanding of the role of
conformational motions in enzyme functions.

1.5 Methods for studying protein dynamics
Internal dynamics and conformational sub-states associated with the function of an enzyme can
be identified and characterized using experimental and computer simulations discussed below

1.5.A Molecular dynamics simulations
Experimental techniques like NMR,147, 148 single molecule Fröster Resonance Energy Transfer
(smFRET),149 small angle scattering (X-ray and neutron),150, 151 electron paramagnetic resonance
(EPR) spectroscopy,152 hydrogen/deuterium exchange mass spectroscopy (HD/X-MS)153 have
been useful in identify global motions and conformational fluctuations in proteins. However, these
techniques cannot capture the behavior of proteins at the full atomic detail and over time.
Molecular dynamics (MD) is a computer simulation method for studying the physical movements
of individual atoms in a biological macromolecule that cannot be observed directly in laboratory
experiments. MD simulations have played an important role in increasing our understanding of
the dynamical aspects of protein structure and function.154-156
MD simulations provides a detailed picture of atomic-level motions or particles and molecules as
a function of time guided by Newton's laws of motions.157 Based on the forces calculated, position
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and velocity of each atom are updated, and this process is iteratively repeated through time. The
inter-atomic forces between the particles are calculated using interatomic potentials collectively
referred to as molecular mechanics force fields.158 A typical force field incorporates electrostatic
(coulombic) interactions between atoms, spring-like terms that model the preferred length of each
covalent bonds, angles, dihedrals and other types of non-bonded interactions. The timestep
between each step in a MD simulation is in femtoseconds. Therefore, interactions between atoms
are computed for millions and billions of steps to understand the structurally important motions at
functionally relevant time-scales. This makes MD simulations computationally demanding.
Conformational motions in proteins are observed over a wide range of time scales (fs-s).159
Historically, the time-scales accessible by MD simulation have been shorter than the time-scales
at which biomolecular events of interest take place. However, recent advances in computer
hardware, software, and simulation algorithms have enabled sampling of biomolecules at the
functionally relevant μs - ms time-scales in a regular manner. Improvements in force fields and
advances in sampling techniques have also made significant contributions towards overcoming
barriers and sampling the vast conformational landscape of biomolecules.160-162 Careful analysis
of the conformational snapshots sampled during MD simulation can provide information about
underlying low-frequency motions which corresponds to significant conformational changes
relevant to the function of biomolecule under investigation. MD simulations can also be used to
understand how a biomolecule will respond to perturbation like removal or change of ligand,
mutation of residues, post-translational modifications, change in protonation state of important
amino acids, temperature, pressure, pH, voltage etc. MD simulations can further capture elements
required for understanding the molecular basis of important functional processes like ligand
binding,163 protein folding,164 and allostery.165
Simulations have proven valuable in deciphering functional mechanisms of biomolecules, in
uncovering the structural basis function, however, a number of choices have to be made when
using MD simulations.166 Starting from the hardware to use (central processing unit (CPU) vs.
graphical processing unit (GPU)), the software package and its version, the forcefield (AMBER,158
CHARMM,167 GROMOS,168 OPLS169) to simulation conditions (like temperature or pressure) and
choice of starting structure can have a significant effect of the computed trajectory. While each of
these components has its own strengths and weaknesses, they could significantly affect the
results. Therefore, it is essential to perform multiple simulations and ensure reproducibility in the
behavior of biomolecule under investigation. It is also crucial to analyze MD simulations
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meticulously, considering various sources of error that might affect the results and results should
be compared with experimental data if available. Using MD simulation, we are interested in
understanding the biophysical and biochemical basis of substrate binding and product release in
human homologs of RNase family members.

1.5.B Hybrid QM/MM
Limitations of classical MD simulations include that no covalent bonds can be formed or broken
during the simulations. Therefore, MD simulations cannot be employed for modeling reactions
that involve changes to covalent bonds or chemical reaction. Quantum-mechanical (QM) methods
are used to model chemical reactions and other electronic processes in biomolecular systems.
However, QM methods are computationally expensive and can practically be applied to systems
which typically consists of up to a few hundred atoms at most. The modeling of enzyme reactions
(in explicit solvent) requires methods that can treat thousands of atoms. Thus, to model the
reaction mechanism of large biomolecules like enzyme systems the preferred approach is to use
the hybrid QM/MM approach.170-173 This approach combines the use of QM method for active site
region and an MM treatment for the surrounding protein and solvent. With a reasonable
computational effort hybrid QM/MM method provide the necessary accuracy to model reactive
biomolecular systems.
Like MD simulations proper design and execution of QM/MM simulations are very important.174,
175

A wide variety of QM methods is available, from fast semi-empirical methods (AM1,176 PM3,177

SCC-DFTB178), to highly accurate but computationally expensive electronic structure methods
(DFT

179

and ab-initio180). It is equally important to carefully choose the MM force field that can

accurately treat the atoms outside the QM region and their interactions with the QM atoms. The
method to treat covalent bonds that cross the QM/MM boundary is an important consideration in
QM/MM simulations. Methods like introducing additional link atoms, hybrid orbitals on MM atoms
or a pseudobond to replace the QM-MM covalent bond has provided reasonable results.170, 181, 182
Further depending on the scientific question, (relative) potential energies, or alternatively free
energies, for the reaction can be obtained. A potential energy profile or the minimum energy
pathway of a reaction can be determined by minimizing the energy of the system at several points
along the reaction coordinate. Deriving free energy profiles using QM/MM methods are generally
expensive. One strategy to reduce the computational cost of QM/MM simulations is to treat the
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QM region using cheap approximate methods that reduces the computational effort considerably.
Unfortunately, such methods have been subjected to a critical and often controversial discussion
in the literature. There is a need to further improve the accuracy and sampling achieved by
QM/MM methods, but the existing methods are already good enough to provide realistic modeling
of biomolecular reactions.
QM/MM studies have provided detailed mechanistic insights into the enzymatic reactions of
cytochrome P450,183 peroxidases,184 nitric oxide synthase,185 horseradish peroxidase,186
chorismite mutase,187,

188

DHFR

146

and many other enzymes. The information obtained from

QM/MM studies is increasingly allowing the designing of better drug leads, predicting drug
metabolism, understanding drug resistance, and understanding the effect of mutations (in activesite and distal) on reactivity.175 In RNases, determination of enzyme reaction pathway and TS
using accurate QM/MM methods will significantly assist in the design of enzyme for specific
application, structure-based drug design, and improving structure-activity relationship methods.
Additionally, obtaining conformational fluctuations associated with the reaction mechanism from
QM/MM methods will aid in allosteric regulation of enzymatic processes and designing allosteric
drugs.

1.5.C Quasi Anharmonic Analysis (QAA)
Experimental techniques, including neutron scattering, have indicated that protein motions are
anharmonic with multiple wells in the conformational landscape.189 These anharmonic structural
changes activate functionally relevant motions in proteins. Second order clustering methods are
unable to identify conformational sub-states of anharmonic protein motions, the use of higherorder methods is necessary for identifying them. Quasi anharmonic analysis (QAA) uses fourthorder statistics to describe the atomic fluctuations and summarizes the internal motions relevant
to protein function.129
In QAA, a coupling matrix which encodes an anharmonic mode of motion describing the higherorder correlations between different regions of the protein is computed. Anharmonic sources are
fully decorrelated, and higher-order dependencies in positional fluctuations are minimized.
Additionally, a linear model is used which ignores any non-linear coupling that may exist in the
fluctuations between different parts of a protein. The motions described along QAA basis vectors
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are more relevant to the intrinsic motions of atom-pairs in proteins since the directionality of the
motions lead to energetically homogeneous sub-states.
In their work Chennubholta, Agarwal and co-workers, have shown that using QAA it is possible
to identify and characterize conformational sub-states that have low populations in the
conformational landscape.122, 129 They have demonstrated that the QAA has unique ability to
distinguish energetically homogenous sub-states. Further QAA allows clean separation between
the conformational sub-states by projecting the conformations sampled during the MD simulations
in a lower dimensional space represented by QAA vectors. These conformational sub-states can
be characterized for any relevant biophysical properties (such as internal energy, distance order
parameter, or reaction coordinate).
Using series umbrella sampling simulations Chennubholta, Agarwal and co-workers modeled the
cis/trans isomerization catalyzed by enzyme cyclophilin A (CypA).129 They obtained the
conformational sub-states along the reaction pathway of CypA by applying QAA to all
conformations generated from simulations (Figure 1.10). Characterization of conformational substates in CypA indicates the enzyme's intrinsic ability is to explore conformations correspond to
various sections of the reaction pathway, corresponding to low energy reactant and product states
as well as the high energy transition state. Analysis of movements that allow interconversion
between sub-states revealed the structural and dynamical features required to attain the transition
state.

1.5.D Carr-Purcell-Meiboom-Gill (CPMG) - NMR relaxation dispersion
NMR spectroscopy represents a powerful technique for studying dynamical features of proteins.
NMR utilizes the magnetic properties of certain 1H,

C,

13

N and

15

P nuclei commonly found in
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proteins.190 These isotopically nuclei are inserted in the protein structure in a non-invasive manner
serving as site-specific probes of local structure and dynamics.191 Depending on the environment
of atoms within the protein, the nuclei of individual atoms will absorb different frequencies of radio
signals. The absorption signals of different nuclei may be perturbed by change in their chemical
environment over time or in presence of a ligand. The NMR probes are exposed to at least two
distinct chemical environment in a time dependent manner, a process called as chemical
exchange. NMR spectra affected by chemical exchange is then used to determine the change in
the behavior of individual nuclei, and the dynamics of the whole protein can be analyzed with
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collective behavior of individual nucleotide.192 Therefore NMR spectroscopy is uniquely suited to
study protein dynamics under equilibrium conditions, with no need for external perturbations such
as changes of temperature or pressure.
Many biochemical events (including the ribonucleolytic cleavage catalyzed by RNases) occur on
the µs - ms time-scale, and it is of considerable interest to characterize the conformational
transitions that are involved in such processes.138,

193-196

Motion in this time-scale window

generally includes side chain reorientation, loop motion, secondary structure changes and hinged
domain movements. CPMG relaxation dispersion is a powerful approach to obtaining kinetic,
thermodynamic and structural information for exchange processes in the 0.3 - 10 ms time window.
The principle of NMR-CPMG experiment is to refocus exchange broadening (i.e., reduce or
“disperse” Rex) by applying pulse elements to transverse magnetization during a special relaxation
delay.197 Relaxation describes how signals change with time. CPMG relaxation dispersion
experiments most often make use of backbone amide 1H or

N spin probes, focusing on proton

15

or nitrogen magnetization (single-quantum transitions), respectively.
Dynamics on the μs - ms time scale can be characterized in terms of an exchange contribution,
Rex, to the observed transverse relaxation rate, R2obs, using the following expression:
R2obs = Rex + R20

(1.1)

Where R20 is the intrinsic relaxation rate of the nuclei under investigation. For a two-site exchange
Rex depends on the population of the states (𝞺𝞺a, 𝞺𝞺b), the difference in chemical shifts (Δω), the

exchange rate constant (kex = kf + kr, where kf and kr are the forward and reverse rate constants,
respectively) and the pulse repetition rate. Primarily recorded as a series of

N- Heteronuclear

15

Single Quantum Coherence (HSQC) experiments, the technique has an extremely good atomicscale resolution, allowing the investigation of specific protons and other relevant atoms on
selected residues in any protein or enzyme amenable to NMR investigation. The chemical shift of
the investigated atoms can then be determined by combining Δω with information obtained from
an Heteronuclear Multiple-Quantum Correlation (HMQC) spectrum which in turn can be used to
determine the solution structure of the excited state.198 The experimental framework outlined
above has been used extensively to detect motions on the μs - ms time-scale within proteins and
understand their function.139, 199, 200
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Figure 1.10: QAA describes conformational sub-states leading to transition state during
catalysis in cyclophilin A. Two levels of sub-states are shown (A) level 1 and (B) level 2.
Conformational sub-states with homogenous populations are identified for the reactant (R),
transition state (T) and product (P). Each colored dot in the top panels corresponds to a single
conformation and is colored according to the reaction coordinate value in panel D. Arrows indicate
interconversion between other sub-states and T and the corresponding CypA motions are shown
below the plots. (C) The identified motions extend from the flexible surface region to the active
site connected by hydrogen bon networks. (D) Free-energy profile of the CypA reaction. The color
bar corresponds to reaction coordinate used for coloring conformations in panel A. (This figure is
published in 129)
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1.6 Proposed study
The overview of the biophysical, biochemical and physiological properties of RNases offer
promising therapeutic applications in several diseases including amyotrophic lateral sclerosis and
Parkinson’s Disease. However, an accurate understanding of the enzymatic properties of most
hRNases is still unavailable. Limited information is available about the mechanistic basis of
substrate binding and chemical step in various hRNases, while the atomistic details of product
release step has not yet been investigated. Moreover, the contributions of distal regions in the
steps of the enzymatic cycle of hRNases remain uncharacterized. It also unexplored which of the
two proposed mechanism is more relevant to catalysis by hRNases.
The similarity in range of enzyme efficiency and dynamics in these enzymes raises the question
of the role of dynamics in catalysis and provides a unique opportunity to investigate human
ribonucleases as prototypical systems for understanding relationship between dynamics and
enzyme catalysis. Using computational (Classical MD simulations and hybrid QM/MM approach)
and experimental (NMR, steady-state kinetics) approaches this study quantitatively characterizes
functionally important dynamics in the catalytic cycle of RNases. As the rate-determining step is
currently unclear, and also may be different for all hRNases, conformational dynamics is
characterized in each step of RNase catalytic cycle.
The four steps of the RNase catalytic cycle studied as a part of this thesis are organized in the
chapters 2-5 (Figure 1.11). Chapter 2 investigates µs - ms dynamics in 23 RNases in their apo
form using

N-CPMG NMR experiments and computer simulations. Chapter 3 focuses on

15

characterizing the nucleotide substrate binding properties in hRNases using computer simulations
at the µs time-scales. Chapter 4 concentrates on identifying conformational dynamics and substates associated with product release in RNase family members. Umbrella sampling simulations
along with quasi-anharmonic analysis (QAA) are employed for this study. In Chapter 5 additional
aspects of RNase enzyme mechanism are explored, the dynamic properties of RNases in
presence of ligands (product analogs) is determined using NMR titrations and chemical shift
perturbation analysis (CHESPA). Conformational fluctuations in the chemical turnover step are
identified for bRNaseA using hybrid QM/MM and Nudged Elastic Band (NEB) simulations. In
addition, kinetic parameters for hRNases are obtained using steady-state kinetic experiments.
Finally, the major findings of this thesis are summarized in chapter 6 with suggestion for future
studies.
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A

B

Figure 1.11: Schematic representation of the RNase catalytic cycle and proposed work. (A)
Simple scheme indicating steps involved in an enzyme’s catalytic cycle. MD = modeled using
classical simulations. QM/MM = modeled with hybrid quantum-classical simulations. (B) Summary
of proposed work.
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2.1 Abstract
Enzyme superfamily members that share common chemical and/or biological functions also share
common features. Conservation of structural features such as critical active-site residues and the
entire protein fold, even in cases of low sequence similarity, is well known. However, the link
between function and dynamics is not well understood. We present a systematic characterization
of the intrinsic atomic-scale dynamics of over twenty members of the pancreatic-type ribonuclease
(RNase) superfamily, which share a common structural fold. This study is motivated by the fact
that the range of chemical activity as well as molecular motions exhibited by RNase homologs
span >105 fold. Dynamics on the microsecond-millisecond time-scale was characterized using a
combination of nuclear magnetic resonance (NMR) relaxation dispersion experiments and
computer simulations. Phylogenetic clustering of the RNases led to the grouping of sequences
into sub-families, with members within sub-families sharing similar biological functions. Detailed
characterization of the dynamical properties of the diverse RNases showed conserved dynamical
traits for enzymes grouped into functionally distinct sub-families. These results suggest that
selective pressure for the conservation of dynamical behavior, among other factors, may be linked
to the distinct chemical and biological functions in an enzyme superfamily.

2.2 Introduction
The linkage between dynamics and enzyme catalysis has been intensely debated

. Enzymes,

201

like other molecules, experience internal motions over a wide range of time-scales. These motions
are driven by temperature and surrounding environment, including the solvent

. Evidence

202, 203

continues to emerge from an increasing number of systems emphasizing the involvement of
dynamics in enzyme function 127, 204-206. However, the presence of motions even near/in the active
site, or their occurrence at time-scales that coincide with rate-limiting events in enzyme
mechanisms, does not automatically imply that these motions play a role in enzyme function

.

207

One of the challenges associated with investigating enzyme dynamics is that structure and
dynamics are inter-related, thus making it difficult to decouple their individual contributions to
enzyme catalysis.
The enzyme fold has been proposed to serve as a scaffold which enables optimal positioning of
the catalytic residues to provide a unique environment, which is very different from solvent, and
provide structural and electrostatic features necessary for transition state stabilization
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.

208

Catalytically important residues are conserved across enzymes that share the same fold and
catalyze the same (or similar) chemical reaction 209. It has been suggested that if dynamics plays
a functional role in enzyme catalysis, then it must also be subjected to evolutionary pressure and
be conserved as a part of the enzyme fold topology

. Therefore, characterization of dynamics

210

of enzymes within a superfamily could provide vital information on the evolutionary conservation
of dynamics (or lack thereof) among structural and functional homologs that catalyze the same
chemical reaction. This approach could provide much needed information for teasing apart the
role of structure and dynamics in enzyme catalysis.
Pancreatic-type ribonucleases (RNases) are a superfamily of enzymes found in bacteria and
vertebrates that catalyze the hydrolysis and transphosphorylation of ribonucleic acid (RNA)
substrates 211-213. Nearly 650 sequences corresponding to members of this superfamily are found
in the Pfam database

. Eight catalytically active canonical RNases (and five supplemental

214

pseudo-genes that lack the conserved active-site residues essential for ribonucleolytic activity)
were identified in the initial sequencing of the human genome

. All structurally characterized

211

RNases display a conserved structural fold and share the common chemical function of cleaving
the phosphodiester bond of ribonucleic acid (RNA) substrates, albeit with varying degrees of
catalytic efficiencies and specificities. The canonical RNases have further been reported to
perform a variety of biological functions such as angiogenesis, anti-pathogenicity and immunosuppressivity, in addition to the common ribonucleolytic activity 211. While the biological functions
are broadly known and have been characterized for some members identified in the human
genome, a significant number of members remain largely uncharacterized to date. The unique
similarity in structure (fold), whilst displaying significant diversity in function, makes the RNase
superfamily an excellent candidate for characterizing the effect of conserved dynamics on
function.
A variety of biophysical, NMR and computational approaches have indicated the role of
conformational dynamics in regulating catalysis in bovine RNase A (BtRA), the archetypal
member of this family

215

. Millisecond motions of a loop located over 20 Å away from the active

site, suggested to be propagated by a conserved hydrogen-bonding network
shown to be essential for efficient catalysis

, were

136, 138, 215

. Mutations disrupting this hydrogen bonding

216

network were shown to result in the uncoupling of dynamics on the catalytic time-scale and a
corresponding decrease in the catalytic turnover 138. Further, reduced catalytic efficiency relative
to bovine RNase A was observed in two naturally occurring RNase A homologs lacking this
36

hydrogen bonding network

. Interestingly, the global conformational exchange rates of

137, 138, 216

the diverse RNase members vary over five orders of magnitude (microseconds to 100s of
milliseconds) coinciding with the range of substrate turnover (and chemical efficiency), which also
varies up to five orders of magnitude between the most efficient and least efficient members of
the human canonical forms

. For example, human RNase 5 (angiogenin), which lacks the

215

dynamical loop 4 region of RNase A shown to impact catalysis, displays 105 fold reduction in
ribonucleolytic activity compared to RNase A 217.
As a step towards characterizing the relationship between dynamics, chemical and biological
functions of various members of this broad vertebrate family, we performed a systematic
characterization of the intrinsic dynamics of over 20 RNase homologs. The selected RNases
correspond to a representative set of homologous vertebrate sequences whose structures have
been determined previously by X-ray crystallography or NMR and are available in the protein data
bank. Using a combination of NMR and computational approaches, we characterized the
dynamics of these proteins over the microsecond to millisecond (µs-ms) time-scale to probe the
relationship between sequence diversity and dynamics, and its correlation with the designated
biological functions. The present study focuses on characterizing and comparing the intrinsic
dynamics of apo proteins, as these enzymes bind to and catalyze a wide variety of RNA
substrates. Our results show that while the diverse RNase homologs used for the analysis share
a common structural fold, the dynamical properties of these proteins vary significantly. Clustering
superfamily members into evolutionarily distinct sub-families showed conservation of dynamical
properties within sub-family members and notable variations between different sub-families.
Categorizing homologous RNase superfamily sequences into sub-families, which also exhibit
similar dynamics, provides a unique opportunity for further investigation to tease apart the role of
structure and dynamics in enzyme function.

2.3 Materials and methods
Genes, Expression and Purification: Escherichia coli codon-optimized sequences of Pongo
pygmaeus ribonuclease 3 (PpR3) and Macaca fascicularis ribonuclease 3 (MfR3) (UniProt entries
P47781 and P47779) were synthesized in IPTG-inducible pJExpress414 vectors containing the
ampicillin resistance gene (DNA2.0, Newark, CA). These vectors were transformed into E. coli
BL21 (DE3) for all protein expression experiments. All human RNases were cloned, expressed,
and purified according to previous protocols

.

138, 142, 146, 218
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N- and [15N/13C]-labeled protein

15

expression and purification was conducted as described previously

, with the following

138, 142

modifications. The temperature was lowered to 30°C following addition of IPTG, the volume of
culture media was of 1 L, and bacteria were grown overnight before being harvested by
centrifugation. Protein concentrations were determined using extinction coefficients of 11,960 and
14,940 M-1cm-1, respectively, as estimated by ExPASy ProtParam.
Solution NMR Experiments: 2D

N-HSQC, 3D-HNCACB and 3D-CBCA(CO)NH assignment

15

experiments were performed on a Varian INOVA 500 MHz spectrometer (298 K), while 15N-CPMG
relaxation dispersion experiments were performed on the same spectrometer as well as a Varian
INOVA 800 MHz spectrometer (298 K), as described earlier
analysis was performed using NMRPipe

, CcpNmr Analysis

220

. NMR processing and

138, 142, 219

221

and Sparky 222.

Phylogenetic analysis: Multiple sequence alignment of the 23 RNase sequences was performed
using ClustalΩ 223. A complete list of sequences and sequence identifiers is provided in Table 2.1.
The phylogenetic tree of the aligned sequences was determined based on maximum likelihood
approach using RaxML v8.0.26 with the WAG amino acid substitution model 224. Reliability of the
branching was assessed using the bootstrapping method over 100 iterations. The resulting
phylogenetic

tree

in

Newick

format

was

visualized

using

Figtree

v1.4.2

(http://tree.bio.ed.ac.uk/software/figtree/).
System preparation for computer simulations: Coordinates of 21 RNases were obtained from
the corresponding PDB files for the apo model preparations (see Table 2.1). The structures for
two Hominidae RNase 3 are not available; therefore, homology models were generated as
described below. System preparation for molecular dynamics (MD) simulations were performed
using the leap module in AMBER

225

v14 and AMBER's ff14SB force-field. Equilibrated systems

were used for each of the 23 proteins to run a total of 1μs of production MD under constant energy
conditions (NVE ensemble). A PME cut-off of 8 Å was used as suggested by AMBER input files
for GPU-enabled simulations 226. To address an important concern regarding the possible bias of
results from a single MD trajectory and ensure reproducibility, for each of the 23 systems two
independent MD trajectories each 0.5 μs were performed.
Homology modeling of Hominidae RNase 3 sequences: Structures of two Hominidae RNase
3 sequences, Pongo pygmaeus (PpR3) and Macaca fascicularis (MfR3), were generated through
homology modeling using MODELLER v9.16

. The two Hominidae sequences share 84.3%

227

38

and 85.8% sequence identity with human RNase 3 (PDB ID: 1QMT), which was used as the
template for modeling. The automodel option in MODELLER was used to generate models, of
which two models with the lowest DOPE scores were chosen for each of the two sequences.
Molecular dynamics simulations: The protein systems were neutralized by the addition of
counter ions and the resulting systems were then immersed in a rectangular box of SPC/E water,
with a 10 Å minimum distance between the protein and the edge of the periodic box. The prepared
systems were equilibrated using a protocol described previously 129. The equilibrated system was
used for each of the 23 proteins to run a total of 1 μs of production MD (two independent 0.5 μs
MD trajectories, see details below) under constant energy conditions (NVE ensemble). The
Particle-mesh Ewald (PME) method was used for long-range electrostatics and a time-step of 2
femtoseconds was used during production runs. Coordinates of the system were saved every 5
picoseconds, for a total of 200,000 conformational snapshots for each protein (as a sum of
100,000 snapshots from each independent trajectory). All simulations were performed using
graphical processing units (GPU) enabled version of AMBER’s MD simulation engine pmemd
(v14). A PME cut-off of 8 Å was used as suggested by AMBER input files for GPU-enabled
simulations

. To address an important concern regarding the possible bias of results from a

226

single MD trajectory and ensure reproducibility, for each of the 23 systems two independent MD
trajectories each 0.5 μs were performed. The first trajectory after equilibration was used for
production at 300 K, while for the second trajectory the structure was slowly heated to 310 K using
MD with 50,000 steps and minimized to generate conformational and structural diversity.
Production run for the second trajectory was also performed at 300 K.
RMSF and RMSF10 calculations: All-atoms root-mean-square fluctuations (RMSF) were
computed based on the conformational snapshots collected during the MD simulations. To identify
global motions on slower time-scales from MD, for each of the 23 systems we separately
computed and aggregated the fluctuations associated with the first (slowest) 10 quasi-harmonic
modes (RMSF10). It is well known that slowest 10 modes contribute to the majority of fluctuations
in proteins (>80%) and the use of RMSF10, instead of all modes (RMSF), removes the faster
stochastic motions of the protein, allowing focus on intrinsic dynamics of proteins

. Both these

228

calculations were performed using AMBER’s ptraj analysis program. All trajectory conformations
were first aligned to a common structure, to remove any translation and overall molecular rotation
during the simulations.
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Table 2.1: PDB IDs of RNase homologs used for dynamical characterization
PDB code

Abbreviation

Species

RNase type

7RSA
2K11
3TSR
1RRA
1GQV
1QMT

BtRA
HsR1
MmR1
RnRA
HsR2
HsR3

Bos taurus
Homo sapiens
Mus musculus
Rattus norvegicus
Homo sapiens
Homo sapiens

RNase A
RNase 1
RNase 1
RNase A
RNase 2
RNase 3

PpECP*
MfECP*
2HKY
RNase6#1
1ANG
1AGI

PpR3
MfR3
HsR7
HsR6
HsR5
BtR5

Pongo pygmaeus
Macaca fascicularis
Homo sapiens
Homo sapiens
Homo sapiens
Bos taurus

RNase 3
RNase 3
RNase 7
RNase 6
Angiogenin
Angiogenin

2BWK
4QFI
3ZBV
3ZBW
1RNF
1KM9

MmR5
RnR5
MmR52
MmR53
HsR4
RcRx

Mus musculus
Rattus norvegicus
Mus musculus
Mus musculus
Homo sapiens
Rana catesbeiana

Angiogenin
Angiogenin
Angiogenin
Angiogenin
RNase 4
Bullfrog RNase

3SNF
4PER
2VQ9
3LJE
2ZPO

RpRx
GgR5
DrR1
DrR5
CmRx

Rana pipiens
Gallus gallus
Danio rerio
Danio rerio
Chelonia mydas

Onconase
Angiogenin
RNase ZF-3E
Angiogenin
Turtle RNase

* = Homology model, # = Structure not deposited
1

The crystal structure of human RNase 6 was obtained in our collaborators research group. While

this structure has not yet been deposited in the PDB, it shows a significant structural identity with
the structure available in the PDB (4X09), with the root mean square deviation of 0.20 Å.
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Quantitative comparison of dynamical properties: Pearson’s correlations were used for the
quantitative characterization of dynamical similarities (and differences) between protein pairs.
Correlation between RMSFs for each residue

ai and bi of RNases A and B, respectively, were

calculated using the equation:
n

∑ (a − a )(b − b )
i =1

n

i

i

n

∑ (a − a ) ∑ (b − b )
i =1

i

2

i =1

i

(2.1)
2

where n corresponds to the number of residues including the gaps in the alignment. a and b
correspond to the average RMSF values for RNase A and B. Pairwise-correlations were
calculated for each of the 23 RNases using RMSF10 excluding residues corresponding to gaps
in the pairwise alignment. Average correlations within and between sub-families were calculated
by averaging correlation coefficients of sequences being compared.

2.4 Results
2.4.A Phylogenetic analysis of ribonuclease superfamily
As a representative set of the pancreatic ribonuclease superfamily, 21 diverse RNases, whose
three-dimensional structures are available in the protein data bank, were selected for detailed
dynamical characterization. Human RNases 1-7 were included in this analysis. Additionally, two
Hominidae RNase 3 sequences that are closely related to human RNase 3 were also analyzed
using structures generated based on homology modeling. A list of all RNase sequences and
sequence identifiers is provided in Table 2.1. Comparison of the 23 RNase dataset shows that
the sequences share an average sequence identity of ~37.4%, and an average RMSD of 2.47 Å
for the alignment of all backbone atoms of the 21 members with solved structures. Sequence and
structural alignments indicated that most variable regions are, unsurprisingly, associated with loop
regions of the protein fold (Figure 2.1 A, B). Catalytic triad residues (H12, K41 and H119, bovine
RNase A residue sequence numbering), which are essential for the ribonucleolytic activity, are
conserved in all 23 proteins analyzed.
Phylogenetic analysis of the 23 RNase sequences led to the identification of four distinct
sequence clusters, henceforth referred to as sub-families (Figure 2.1 C). The RNase A-like subfamily (4 members) includes members that share similarity with bovine RNase A (BtRA), whose

41

primary function is associated with the cleavage of RNA substrates. Human and bovine
ribonucleases of this sub-family are the most efficient ribonucleolytic catalysts characterized to
date within the RNase superfamily. Members of the Eosinophil associated ribonuclease-like
(EAR-like) sub-family (6 members) are characterized by insertion of a loop (L7), and have been
suggested to play an important role in host defense and inflammatory response 229, 230, in addition
to preserving the common ribonucleolytic function. Members of this sub-family show catalytic
turnover rates 5- to >400-fold lower relative to BtRA, for those with known catalytic turnover rates
(data not shown).
The Angiogenin-like sub-family (6 members) is characterized by a truncated loop 4 (L4), a loop
region that displays conformational dynamics on the millisecond time-scale in bovine RNase A
and was shown to play an important role in its ribonucleolytic function. Catalytic efficiency of
human angiogenin (HsR5) is 105-fold lower than bovine RNase A. However, its ribonucleolytic
activity was shown to be essential for biological function (angiogenesis) 231.. Previous studies also
showed that replacing the truncated loop 4 of HsR5 with that of bovine RNase A increases
catalytic efficiency of this chimeric protein by over 200-fold 232, while swapping loop 4 from RNase
A with that of HsR5 reduced the activity of this chimera by 60-fold

. The other seven RNases
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not forming a part of the three groups described above were classified as Others, and include
sequences that are not necessarily closely related to each other. The functional characteristics of
this cluster are not well understood and could therefore display functional and dynamical
properties similar to the three sub-families described above.

2.4.B Conformational dynamics on the microsecond-millisecond (μs - ms) time-scale
The time-scale of catalysis varies widely in the RNase superfamily. BtRA is known to catalyze
cleavage of RNA with a kcat ~1700 s-1, with product release being the rate-limiting step of the
reaction

. Other members are slower catalysts, showing up to 105-fold weaker catalytic

137, 216

efficiency (kcat/KM). We used a combination of NMR relaxation dispersion CPMG experiments and
MD simulations to probe the μs - ms dynamical properties of these enzymes. Figure 2.2 shows
the conformational exchange of various RNases from each of the four sub-families probed using
N-CPMG relaxation dispersion experiments. Residues exhibiting conformational exchange on

15

the µs-ms time-scale are represented as spheres. Comparison of millisecond motions of these
selected RNases showed significant differences in regions displaying conformational exchange
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Figure 2.1: Structural and phylogenetic analysis of RNase homologs. (A) Consensus
sequence alignment of the 23 RNases, with respective sequence identifiers displayed to the left.
Detailed information about the sequences is provided in Table 2.1. The secondary structural
elements α-helices (orange rectangles), β-strands (cyan arrows) and loop regions (L),
corresponding to the bovine RNase A structure, are displayed above the alignment. Conserved
active-site residues H12, K41 and H119 (BtRA numbering) are identified with an asterisk above
the alignment. BtRA (PDB ID 7RSA) sequence numbering (BtRA#) is shown at the top and
consensus sequence numbering (Cons#) below the multiple sequence alignment. A list of all
consensus sequence positions is presented in Figure 2.10 (See Appendix 2.7). Gaps in the
alignment are represented using dotted lines. Alignment was prepared using EsPript

. (B)

11

Structural alignment of RNase homologs. Structures include 7RSA (green); 1QMT (blue), 2HKY
(cyan); 1ANG (salmon); 3SNF (yellow) and 1RNF (gold). The V1 and V2 arms as identified using
boxes with dotted lines. Active-site residues are displayed as sticks and labeled with BtRA
numbering. (C)

Phylogenetic clustering of the 23 RNases generated based on maximum

likelihood analysis. Sequences are classified into four clusters, identified using different colors.
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for members from different sub-families. In contrast, residues exhibiting conformational exchange
are clustered in the same regions for four members within a sub-family (Figure 2.2 A).Members
of the EAR-like RNase sub-family display motions primarily clustered in the V1 arm and loop 4.
In contrast, BtRA from the RNase A-like sub-family showed conformational exchange in both V1
and V2 arms, including loops L1 and L4 (Figure 2.2 B). Human RNase 5 (HsR5) of the angiogeninlike sub-family exhibits no conformational exchange on the CPMG time-scale (Figure 2.2 C),
confirming results from a previous report

. To investigate whether HsR5 experiences motions
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on a faster µs - ms time-scale window than the one probed by the CPMG experiment, we also
analyzed elevated transverse relaxation rates at short spin-echo pulse delays in the CPMG
relaxation dispersion profiles (i.e. R2, eff at νCPMG = 1600 s-1, or τcp = 0.625 ms). Analysis for apo
and ligand-bound HsR5 showed that only one residue per state exhibited elevated R2, eff values
(Asn68 in the apo form, and Asn109 in the ligand-bound form), which could indicate that these
two residues experience conformational exchange on a faster µs - ms time-scale (Figure 2.3).
Overall, these observations further confirm that HsR5 is a fairly rigid protein on the µs - ms timescale and that no significant conformational exchange is observed on this regime. Human RNase
4 (HsR4), from the Others cluster, displayed extensive conformational exchange throughout the
protein (Figure 2.2 D). NMR data from other members of the RNase sub-family is presently
unavailable on the μs - ms time-scale.
Interestingly, insertion of loop 1 (L1) from an EAR-like RNase (HsR3) into BtRA (BtRAHsR3, Figure
2.2 B) 138, 142 switched the dynamical profile of BtRA into that of HsR3 (Figure 2.2 A) in the chimeric
protein. The motivation for the design of this chimera was to develop and characterize a control
system for investigating the dependence of dynamics on a region based on type of residues rather
than secondary structure. Previous studies showed a detailed comparison of the rates of ligand
binding and release
HsR3

, in addition to conformational exchange profiles of BtRA, BtRAHsR3, and

138

. To gain insights into changes in the relaxation dispersion of these enzymes in the L1

142

region, here we compared the fitted relaxation dispersions for residues of loop 1 from HsR3 (EARlike sub-family) with BtRA (RNase A-like sub-family) and the chimera BtRAHsR3 (Figure 2.4 A). Our
results show that loop 1 residues of BtRA exhibit a two-site conformational exchange at these
positions, as observed from the presence of relaxation dispersion profiles (solid lines in Figure
2.4, left panel). In contrast, no motions on this time-scale were observed for loop 1 positions in
HsR3 and the chimera BtRAHsR3, as seen from the flat dispersion profiles (shown as dashed lines
in Figure 2.4 A, middle and right panels). Residues in structurally equivalent positions in the three
enzymes are represented using the same colors. Further, a chemical shift comparison between
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Figure 2.2: Millisecond conformational exchange in Hominidae and bovine RNases.
Cartoon representation of (A) EAR-like sub-family members - H. sapiens EDN (HsR2), H. sapiens
ECP (HsR3), P. pygmaeus ECP (PpR3), M. fascicularis ECP (MfR3); (B) RNase A-like sub-family
member B. taurus RNase A (BtRA) and the BtRAHsR3 chimera 210; (C) Angiogenin-like sub-family
member H. sapiens angiogenin (HsR5); and (D) H. sapiens RNase 4 (HsR4) from the Others
cluster. Structures are colored based on the phylogenetic group shown in Figure 2.1 C. Residues
identified by NMR as undergoing conformational exchange on the millisecond time-scale are
depicted as spheres and numbered according to their position in the sequence alignment (see
Figure 2.1) to facilitate comparison. Conformational exchange was probed by

N-CPMG NMR

15

relaxation dispersion experiments at 500 and 800 MHz (298 K). Residues were considered for
further analysis only if the difference in measured R2 (1/τcp) values at fast (τcp = 0.625 ms) and
slow (τcp = 10 ms) refocusing pulse delays was greater than 2 s-1, similar to previous reports

138,

. BtRAHsR3, which displays sub-sector conformational exchange similar to HsR3, is an artificial

142

chimeric hybrid of BtRA in which the 12-residue long loop 1 of BtRA (14-DSSTSAASSSNY-25,
BtRA numbering) was replaced by the 6-residue long loop 1 of HsR3 (17-SLNPPR-22, HsR3
numbering) 136, 142, 219. Structures color-coded based on conformational exchange rates are shown
in Figure 2.9 (See Appendix 2.7).
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Figure 2.3: Conformational exchange in HsR5 residues. Transverse relaxation rates (R2) at
νCPMG = 1600 s-1 (τcp = 0.625 ms) in free and ligand-bound HsR5. R2,eff values at νCPMG = 1600 s-1
are shown for all assigned residues of apo (left) and 3’-UMP-bound (right) HsR5. Dashed lines
indicate the average R2,eff value and dotted lines indicate standard deviation. Residues exhibiting
elevated R2,eff are identified on each graph. Upon closer examination of the full relaxation
dispersion curves for these residues, most were disregarded since their R2,eff values were either
inconsistently elevated and/or simply resulted from bad raw data. Only two residues displayed
consistently elevated values: Asn68 in the apo protein, and Asn109 in the 3’-UMP bound protein.
This could indicate the presence of dynamics at positions Asn68 (free form) and Asn109 (3’-UMPbound form) on a microsecond time-scale faster than that measurable by CPMG experiments.
These observations further confirm the lack of conformational exchange on the CPMG time-scale,
and the overall likelihood that no significant functional dynamics is observed on the faster
microsecond time-scale in HsR5.
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Figure 2.4: Dynamical effects of loop 1 swapping on BtRA. (A) Relaxation dispersion profiles
of various loop 1 residues obtained from 15N-CPMG experiments at 800 MHz and 25°C for bovine
RNase A (BtRA), human RNase 3 (HsR3) and a previously described

138

chimera of RNase A

(BtRAHsR3) in which loop 1 has been replaced by the corresponding residues of HsR3. 15N-CPMG
data was also acquired at 500 and/or 600 MHz for these proteins (not shown for clarity). Solid
curves are shown for residues displaying conformational exchange, and dashed curves belong to
non-exchanging residues. Curves of the same color represent structurally equivalent residues in
the sequence alignment. (B) Compounded 1H-15N chemical shift variations

234

induced on BtRA

by loop 1 swapping in BtRAHsR3. Residues in gray are either unassigned or belong to the swapped
loop. Chemical shift variations for each residue are indicated by both the color and the width of
the cartoon putty. Figure was made with PyMOL using the bovine RNase A structure (PDB ID
7RSA).
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BtRA and the chimera showed that chemical shift variations arising from loop swapping are
primarily localized in the V2 domain (Figure 2.4 B). However, residues that acquire conformational
exchange in the V1 domain (Figure 2.2 B) do not exhibit significant chemical shift variations.
These observations suggest that alterations in regions displaying functionally relevant motions
results in the modulation or loss of conformational exchange for residues in these regions. Overall,
these results suggest that conformational exchange profiles are conserved between members
within the EAR-like sub-family, perhaps suggesting a role in the shared biological or chemical
function, while distinctly different dynamical fluctuations are observed for functionally distinct
homologs from other phylogenetic clusters.

2.4.C Conformational dynamics on the microsecond (μs) time-scale
Atomic level dynamical properties of all 23 RNase homologs were probed using MD simulations
to determine the detailed dynamical characteristics on the μs time-scale (Figure 2.5). Root mean
square fluctuations (RMSF) associated with the slowest ten quasi-harmonic modes (RMSF10)
were used to characterize the intrinsic dynamics of the proteins. Previously, such an approach
was used for other family members and was shown to match the dynamics from NMR studies
and other techniques 210. One of the issues with comparing dynamical patterns between proteins
sequences of different lengths is the presence of gaps associated with insertions and deletions.
To address this, we represented dynamical profiles of consensus sequences that include gaps in
the multiple sequence alignment (Figure 2.1 A).
A comparison of the conformational dynamics on the μs time-scale showed similarity in the RMSF
profiles of RNases within the same sub-family members, while differences were observed
between sub-families (Figure 2.5), consistent with the qualitative comparison of the
conformational exchange profiles from experiments (Figure 2.2). The RNase A-like proteins,
which share significant sequence similarity with BtRA, showed greater similarity in dynamical
patterns between each other. Differences in the dynamical patterns were restricted to the loop L1
region (residues 20-30, consensus sequence numbering, Figure 2.10 (see Appendix 2.7)), which
showed the largest fluctuations for most members in this group except for the Mus musculus
(mouse) RNase A (MmR1), which showed diminished dynamics in this region relative to other
members. Characterization of hydrogen bonding lifetimes in MmR1 showed the interaction
between the side chains of Ser19 of loop1 and Thr82 of the β4 strand, occurring in ~81% of the
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simulation ensemble. This strong hydrogen bonding interaction may be dampening the dynamics
of loop1 observed for MmR1.
EAR-like sub-family members exhibit similar dynamical patterns in all regions. RNases of this
group are characterized by a truncated loop L1, which incidentally showed the largest fluctuations
in the RNase A-like sub-family. Swapping loop 1 from HsR3 into BtRA resulted in a chimera
(BtRAHsR3), which displayed a loss of dynamics in this loop, in addition to an overall reduction in
the dynamics throughout the protein relative to BtRA (Figure 2.6 A). Human RNase 7 (HsR7)
showed larger fluctuations throughout the protein while preserving the dynamical profile exhibited
by other members of the sub-family. Angiogenin-like members are characterized by a truncated
loop L4, and showed differences in dynamics of loop L2. Members not classified in the groups
above (clustered into Others), as expected, showed large variations within the group compared
to members within the other three sub-families. Large dynamical fluctuations were observed in
loops L2, L4 and L6 for some members of the group, while other members showed deletions in
these regions.

2.4.D Quantitative characterization of dynamical conservation
To determine if the similarities (and differences) observed within (between) sub-families are
statistically significant, we performed a quantitative comparison of the dynamical profiles of
sequences by performing pairwise correlations for all pairs of sequences (Figure 2.7). The
pairwise Pearson’s correlation coefficient for all 23 sequences (Figure 2.7 A) showed larger
correlations between members within, rather than between the three functionally distinct
phylogenetic sub-families, except the Others cluster which showed small intra-cluster
correlations. To better elucidate these comparisons within and between sub-families, we
calculated the average value for these correlations, with the standard deviations presented in
parentheses (Figures 2.7 B-D). Comparison of these averages showed that correlations within
sub-families are significantly larger than those between sub-families for the three functionally
distinct RNase sub-families (Figure 2.7 B). Overall, these observations highlight the conservation
of dynamical patterns in homologous sequences sharing distinct functional properties, further
supporting NMR experiments within and between sub-family members.
Sequence and structural alignments showed insertions/deletions of residue positions in different
regions along the primary sequence of the RNases (Figure 2.1). To determine if these insertions
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Figure 2.5: Microsecond conformational dynamics of RNase homologs. Root mean square
fluctuations corresponding to the Cα displacements in the top 10 quasi-harmonic modes
(RMSF10), for the 23 proteins grouped into the four phylogenetic clusters described in Figure 2.1.
A consensus sequence with gaps is used (see Figure 2.1 A), where gaps are represented as
dotted regions for each protein. The panel on the right shows representative RNase homologs
from each phylogenetic group using a tube representation where the thickness of the tube
corresponds to the flexibility of residues in each protein, with thicker tubes corresponding to
flexible regions and thinner tubes representing less flexible regions. The dynamical range
represented using the color spectrum is consistent across all sequences with the blue and red
ends of the spectrum corresponding to low and high dynamic regions, respectively. The
representative structures correspond to B. taurus RNase A (BtRA) and H. sapiens RNase 1
(HsR1); H. sapiens RNase 3 (HsR3) and P. pygmaeus RNase 3 (PpR3); H. sapiens angiogenin
(HsR5) and Mus musculus RNase 5 (MmR5); and H. sapiens RNase 4 (HsR4) and Rana pipiens
RNase (RpRx), respectively. N-terminal residues, which showed larger RMSFs (see left panel),
are hidden for clarity. Tube representations for all RNases are shown in Figure 2.11 (see Appendix
2.7).
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Figure 2.6: Dynamical properties of BtRAHsR3 chimera. (A) Comparison of the root mean
squared fluctuations of the ten slowest modes (RMSF10) between BtRA (black) and the chimera
(red). On the right, RMSFs are shown using a tube representation for BtRA and the chimera,
where the thickness of the tube corresponds to the flexibility of residues in each protein, with
thicker tubes corresponding to flexible regions and thinner tubes representing less flexible
regions. B) Dynamical cross-correlation maps (DCCMs) for BtRA (left), with regions displaying
significant (anti-)correlations displayed identified using boxes, and the BtRAHsR3 chimera (right).
Loops 1, 2, 4 and 6 are highlighted in yellow.
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and deletions influence the functional identity of these homologous sequences, we calculated the
average correlations for consensus and non-consensus residue positions separately. Consensus
positions correspond to residue positions that are preserved in all sequences (86 amino acid
positions) while non-consensus positions represent positions with insertions or deletions in at
least one of the sequences in the dataset (66 amino acid positions). A comparison of the
correlations within sub-families showed similar trends for both consensus and non-consensus
positions (Figure 2.7 C, D). Interestingly, a comparison of correlations between sub-families for
non-consensus residues showed markedly smaller correlations (grey in Figure 2.7) between the
three functionally distinct sub-families, except Angiogenin-like sub-family which showed similar
average correlations within the sub-family and with RNase A-like sub-family on this time-scale
(Figure 2.7 D).
Overall, these observations suggest that non-consensus positions influence the distinct
dynamical patterns observed among the functionally divergent phylogenetic sub-families. It could
potentially be counter-argued that dynamical patterns will always be most influenced at nonconsensus residue positions when comparing phylogenetically distinct proteins. However, it is
important to remember that the physicochemical identity of residues determines the extent and
nature of dynamical motions and rotameric conformer populations. Experimental characterization
of the BtRAHsR3 chimera (with L1 loop region from HsR3 inserted into BtRA) revealed significant
changes in the dynamics of this region and the V2 domain relative to BtRA (Figure 2.4). It is
tempting to speculate that as loop regions are flexible, any sequence in the L1 loop region of
BtRA could be expected to show large dynamical motions. On the contrary, the results from
chimera characterization indicate that L1 loop residues in BtRAHsR3 show dynamical behavior
similar to L1 in HsR3 rather than BtRA.
Analysis of MD simulations allow the characterization of atomic-scale details, including residue
level dynamical interactions. A comparison of dynamic residue-residue cross-correlations for the
different RNase homologs shows distinct variations among members. Detailed characterization
of dynamical cross-correlations was performed for members with experimental dynamical
information (correlation maps with black outlines in Figure 2.12 see Appendix 2.7). BtRA of the
RNase A sub-family showed strong anti-correlations (value < -0.4) for residues 65-72 of loop L4
(positions 75-84, consensus sequence numbering, Figure 2.10 in Appendix 2.7) with residues
near the active site and the catalytic K41 (position 51) and correlations (value > 0.4) with residues
near H119 (position 142). Anti-correlations were also observed between residues near K41 and
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Figure 2.7: Quantitative characterization of dynamical similarities. Pairwise Pearson’s
correlations for the 23 RNase homologs classified into four phylogenetic clusters. (A) Correlation
coefficients for each pair of sequences, color coded based on strong correlations (red) to weaker
or no correlations (grey). (B-D) Average correlations, calculated by averaging the correlation
coefficients for sequences compared for: all residue positions (B), consensus positions (C), and
non-consensus positions, corresponding to insertions or deletions in sequences (D). The diagonal
elements in B-D correspond to correlations within phylogenetic sub-families while off-diagonal
elements correspond to correlations between the sub-families. Standard deviations for average
correlation calculations (B-D) are shown in parentheses. Abbreviations R, E, A and O used in BD correspond to phylogenetic clusters RNase A-like, EAR-like and Angiogenin-like, and Others,
respectively.

54

residues 105-110 (positions 119-124) and those near catalytic H119. Further, strong correlations
were observed for residues near, and including H12 (position 17) and residues 13-23 of loop 1
(positions 18-29) with residues around H48 and T82 (positions 58 and 94, respectively), which
form a hydrogen bonding network shown previously to be involved in the allosteric modulation of
catalysis and product release in this enzyme 137, 216.
Interestingly, loop swapping in the chimera (BtRAHsR3) resulted in changes throughout the protein,
in regions far from loop 1, including significant changes near active-site residues. Specifically, we
observed a loss of correlated motions between loop 4 and the C-terminal region in the vicinity of
the active-site residue His119, and loss of anti-correlated motions of loop 4 and the vicinity of
Lys41 (another active-site residue) and between residues near His119 and Lys41 (Figure 2.6 B).
HsR3 of the EAR-like sub-family showed strong anti-correlations between residues near the
catalytic residue H15 and residues surrounding residues 86-97 of loop 6 (positions 99-110, Figure
2.12) and residues 27-38 (positions 36-51), while correlations were observed with residues 42-46
of β-strand 1 (positions 55-59). Residues in the vicinity of and including the catalytic K38 (position
51) showed anti-correlations near residues 60-65 of loop 4 (positions 73-78) and residues near
catalytic residue H128 (position 142). Further, H128 also showed correlations with residues near
H15 (position 17) and loop 4, and anti-correlations with residues near K38. Residues 28-36
(positions 37-49) showed anti-correlations with residues 98-102 (positions 111-115).
Contrary to members from the other phylogenetic sub-families, HsR5 of the Angiogenin-like subfamily showed significantly weaker (anti)correlations between residues. The lack of
conformational dynamics of HsR5 and the resulting absence of correlated motions is consistent
with our observations from relaxation dispersion experiments, which showed the absence of
motions on the millisecond time-scale in this enzyme (Figure 2.2 C). HsR4 of the Others subfamily showed numerous dynamic (anti)correlations between different regions of the protein,
suggesting enhanced correlated dynamics throughout the protein, consistent with NMR relaxation
dispersion experiments, which showed extensive conformational exchange in this protein (Figure
2.2 D). Dynamical correlations of all 23 RNase homologs is shown in Figure 2.12 (Appendix 2.7).
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2.4.E Faster time-scale conformational dynamics in functionally distinct RNase subfamilies
To determine if MD simulations capture the motions observed experimentally on the faster ps-ns
time-scale, we compared the square of the generalized order parameter (S2). Using ShiftX2 (Han
et al., 2011), we calculated the backbone chemical shifts for two representative members each
from the three functionally distinct sub-families defined in Figure 2.1 C. NMR chemical shifts for
the selected RNases were obtained from the BMRB (Ulrich et al., 2008). Order parameters were
calculated from the chemical shifts using TALOS+ (Shen et al., 2009). Comparison of the order
parameters showed qualitative agreement between the experimental (black) and MD (red) data
(Figure 2.8), suggesting that MD simulations capture the motions observed experimentally.

2.5 Discussion
Increasing evidence from characterization of discrete enzyme systems suggests the important
role of conformational motions in the catalytic function in these systems

. Despite

201, 206, 215, 235

tremendous progress in our understanding of the role of conformational motions in function,
evolutionary conservation of dynamical properties on functionally relevant time-scales among
structural and functional homologs within enzyme families remains largely uncharacterized.
Numerous studies using normal mode analysis have shown the conservation of backbone
flexibility in homologous proteins sharing a common structural framework 236-238. Experimental and
computational approaches further showed the conservation of dynamics in selected proteins
within enzyme families

. However, systematic characterization of superfamily-wide

142, 237, 239

conservation of dynamical properties on the functionally relevant µs - ms time-scales is limited.
In this study, we combined

N-CPMG NMR relaxation dispersion experiments and detailed MD

15

simulations to systematically characterize dynamical properties of diverse pancreatic-type
RNases on the μs - ms time-scale. Using a set of >20 representative RNases, chosen based on
the availability of three-dimensional structures in the protein data bank, we probed the
conservation of dynamical patterns in the homologous RNases. Phylogenetic analysis led to the
grouping of sequences into four clusters – 16 of these sequences forming part of three functionally
distinct sub-families (Figure 2.1 C), where individual members within sub-families also share
common biological function distinct from those of other sub-families. Little is known about the
biological function of the remaining seven members that were grouped into the Others cluster.
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Figure 2.8: Faster time-scale motions in representative RNases. Comparison of the
calculated order parameters for the experimental (black) and MD (red) data for two representative
RNases each from the three functionally distinct RNase sub-families (RNase A-like, EAR-like and
Angiogenin-like) defined in Figure 2.1 C.
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Slowest dynamical modes were previously shown to display the largest evolutionary conservation
, with these modes being the most robust to amino acid substitutions

238

. Through quantitative

240

characterization of the dynamical properties of the slowest modes from MD simulations, we show
distinct variations in the dynamical patterns between different members of the RNase superfamily.
Conservation of dynamical patterns was observed for sequences clustered into phylogenetic subfamilies (Figure 2.5) that incidentally also shared similar biological functions. This conservation in
the dynamical profiles within sub-families was also observed on the ms time-scale probed by
NMR for select RNases (Figure 2.2). These observations are consistent with previous studies
which showed that enzymes sharing similar functions also share similar reaction-promoting
dynamics 241-243.
Rapid changes through evolution in dynamical properties were previously shown to be linked to
functional divergence in proteins 244. Sequence and structural alignments of RNases used in this
study showed variations, corresponding to insertions/deletions, in different regions along the
primary sequence of RNases (Figure 2.1). A comparison of dynamical patterns of just these nonconsensus amino acid positions showed notable differences between sub-families (Figure 2.7 D).
These observations suggest that dynamical differences observed between sequences sharing
distinct functional properties could be linked to the type of residues in non-consensus amino acid
positions, which may influence the functional identity of these sequences.
The use of chimeric constructs such as BtRAHsR3 investigated in this study serve as an important
control system. It is widely discussed that the overall enzyme dynamics (particularly at slow timescales) is determined by the structural fold. Comparison of the conformational exchange profiles
for the chimeric and wild-type RNases (Figure 2.2, 2.4) indicate that for enzymes sharing the
same fold, significant differences could arise from changes in non-conserved or variable regions.
However, it is not sufficient to say that loop regions are the most dynamical regions. The extent
and range of motions depends on the nature and type of residues in the loop regions. Indeed,
characterization of dynamical correlations from molecular dynamics simulations of the BtRAHsR3
chimera shows the long-range effect of loop 1 swapping on loop 4 and residues in the vicinity of
active-site residues His119 and Lys41 (Figure 2.6 B).
Each enzyme could provide a unique set of local dynamical motions depending on the sequence
(such as seen in the case of loop 1 in the two parents and the chimera, Figure 2.4).
Characterization of these differences and its relation to changes in catalytic efficiency requires
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further investigation. Further, it should be noted that even in the conserved regions of fold,
different family members could exhibit distinct dynamics. For example, see Figure 2.2 and related
text for differences in the dynamics of the V2 domain in different sub-families. These observations
open new avenues for probing the effect of conformational exchange associated with loop
swapping between members from the different sub-families. Of notable interest is the effect on
the conformational dynamics and catalytic turnover of swapping loop 4 from BtRA on HsR5, which
is characterized by a truncated loop 4 and a 105-fold lower catalytic efficiency relative to BtRA.
While swapping the loop 4 residues from HsR5 on to BtRA and vice versa have been performed
before, the effect of this swapping on the conformational exchange and the resulting impact on
catalysis have not been characterized 232, 233, 245.
HsR5 exhibits at least 105-fold weaker ribonucleolytic activity than bovine RNase A against
standard RNA substrates

, although this ribonucleolytic activity remains essential for

232

angiogenesis. This low enzyme activity has been structurally and mutationally rationalized by the
obstructive positioning of a C-terminal residue segment of HsR5 (residues 116-123, primarily
Glu117), which is occluding a pyrimidine binding sub-site that is normally solvent exposed in
homologous RNases

. This ‘trademark’ blockage of the active site in HsR5 demonstrates that
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a conformational change of this C-terminal tail is required to alleviate the occluded pocket for
proper RNA substrate recognition and ribonucleolytic activity to occur. Since movement of the Cterminal tail is essential for the ribonucleolytic activity of HsR5, this was not totally unexpected
considering that the catalytic rate of this enzyme occurs on a much slower time-scale than its
RNase homologs. For instance, HsR5 exhibits a kcat/Km = 1.1 M-1s-1 against dinucleotide RNA
substrate UpA, relative to kcat/Km = 4,000,000 M-1s-1 in RNase A 232. Additionally, no less than 19
unique protein partners have been experimentally reported to interact with HsR5 for a wide variety
of biological processes involving cell migration, adhesion, invasion, proliferation, and apoptosis
. This could suggest that the ribonucleolytic activity of HsR5 is carefully programmed in the
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cellular context, perhaps only triggered in the presence of the proper protein binding partner
and/or after translocation to the right cellular compartment. Conformational exchange of the Cterminal tail could thus be closely modulated or allosterically controlled by an uncharacterized
protein partner. Although we did not observe 1H-15N HSQC resonances that could indicate
residues experiencing exchange on a slower time-scale, future chemical exchange saturation
transfer (CEST), ZZ-exchange, and/or H/D exchange experiments could provide additional clues
on slow time-scale motions experienced by HsR5.
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In summary, characterization of dynamical properties of diverse RNases showed their
conservation among sequences that also share similar biological functions. Interestingly,
mutations of sub-family sequences in regions showing large dynamical motions have been shown
to alter their biological function (Table 2.2). The similarity in dynamics for members with common
biological function requires further investigation, especially for sub-families where the connection
between the biological and chemical function is unclear. The present results provide vital clues
that conservation of dynamics as a part of a protein fold may have a broader significance beyond
enzyme catalysis.
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Table 2.2: Amino acid substitutions and their effect on the catalytic and biological activities
of select RNase homologs.

Protein

Mutation

Localization
on structure

Effect on kcat/KM

Loop 7 (V1)

No effect

Other effects

Reduced bactericidal activity against
Gram-positive S. aureus
Reduced bactericidal activity against
Gram-positive S. aureus and reduced
HsR3
W10K
Helix 1
2-fold decrease
membrane-permeating capacity
Reduced bactericidal activity against
HsR3
R75A/F76A Loop 5 (V1) 2-fold decrease
Gram-negative E. coli
R121A/Y122
Reduced bactericidal activity against
HsR3
Loop 7 (V1) 1.25-fold increase
Gram-positive S. aureus
A
Reduced bactericidal activity against
HsR3 W35A/R36A Loop 2 (V2) 1.6-fold increase both E. coli and S. aureus, and reduced
membrane-permeating capacity
Reduced bactericidal activity against
R101A/R104 β-strand 4
Gram-negative E. coli and reduced
HsR3
2-fold increase
A
(V2)
membrane-permeating capacity
(115HsR3
Loop 7 (V1)
No effect
122)EDN
Reduced bactericidal activity against
HsR3
Δ(115-122) Loop 7 (V1) 1.5-fold decrease
Gram-positive S. aureus
Catalytically
Mouse
K35R
No effect on leukocyte chemotaxis
Loop 2 (V2) inactive (catalytic
EAR 11
lysine)
Abolishment of EDN C-mannosylation
HsR2
W7A
Helix 1
(W7 was identified as the Cmannosylation site)
HsR2
W10A
Helix 1
Abolishment of W7 C-mannosylation
Partial rescue of W7 C-mannosylation
HsR2
W10F
Helix 1
abolishment
β-strand 6
HsR2
R132T
12-fold decrease
(V1)
HsR2
S64R
Loop 4 (V1) 74-fold decrease
HsR2 S64R/R132T
V1
12-fold decrease Reduced antiviral activity against RSV
Aotus
β-strand 6
trivirgatus
T132R
1.7-fold decrease
(V1)
EDN
Aotus
trivirgatus
R64S
Loop 4 (V1) 1.5-fold increase
EDN
Aotus
No increase in antiviral activity against
trivirgatus R64S/T132R
V1
15-fold increase RSV (opposite mutation than in HsR2
EDN
S64R/R132T)
Catalytically
HsR2
K38R
Loop 2 (V2) inactive (catalytic
No antiviral activity against RSV
lysine)
Catalytically
HsR2
K38R
Loop 2 (V2) inactive (catalytic
No antiviral activity against RSV
lysine)
HsR3

R121A
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Ref
42

42

42
42

42

42

42
42
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248
248
248
249
249
249
249

249

249

36

36

Table 2.2 continued
Protein
HsR3

Mutation

Localization
Effect on kcat/KM
on structure

R97T (natural
Loop 6 (V2)
variant)

HsR3

R22A

Loop 1 (V2)

HsR3

R34A

Loop 2 (V2)

HsR3

R61A

Loop 4 (V1)

HsR3

H64A

Loop 4 (V1)

HsR3

R77A

Loop 5 (V1)

HsR3

R22A/R34A

V2

HsR3

R22A/R61A

HsR3

R22A/R77A

Other effects

Ref

Reduced cytotoxicity and neurotoxicity

45

Large reduction in cytotoxicity; small
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
1.6-fold decrease
bactericidal activity against Grampositive B. subtilis; large reduction of
antiparasitic activity
Large reduction in cytotoxicity; small
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
1.25-fold decrease
bactericidal activity against Grampositive B. subtilis; large reduction of
antiparasitic activity
Reduction in cytotoxicity; small
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
1.4-fold decrease
bactericidal activity against Grampositive B. subtilis; reduction of
antiparasitic activity
Reduction in cytotoxicity; small
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
1.2-fold increase
bactericidal activity against Grampositive B. subtilis; reduction of
antiparasitic activity
Reduction in cytotoxicity; small
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
1.9-fold increase
bactericidal activity against Grampositive B. subtilis; reduction of
antiparasitic activity
Large reduction in cytotoxicity; large
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
2-fold increase
bactericidal activity against Grampositive B. subtilis; large reduction of
antiparasitic activity
Reduction in cytotoxicity; large
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
2-fold increase
bactericidal activity against Grampositive B. subtilis; reduction of
antiparasitic activity
Reduction in cytotoxicity; abolition of
bactericidal activity against Gramnegative E. coli; large reduction of
4-fold increase
bactericidal activity against Grampositive B. subtilis; reduction of
antiparasitic activity
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111

111

111

111

111

111

111

111

Table 2.2 continued
Protein

Mutation

Localization
Effect on kcat/KM
on structure

HsR3

R22A/H64A

HsR3

R34A/H64A

HsR3

R61A/H64A

V1

HsR3

H64A/R77A

V1

Other effects

No reduction in cytotoxicity; small
reduction in bactericidal activity against
Gram-negative E. coli; no reduction in
5-fold increase
bactericidal activity against Grampositive B. subtilis; reduction of
antiparasitic activity
Large reduction in cytotoxicity; small
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
1.25-fold decrease
bactericidal activity against Grampositive B. subtilis; large reduction of
antiparasitic activity
Large reduction in cytotoxicity; large
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
1.4-fold decrease
bactericidal activity against Grampositive B. subtilis; large reduction of
antiparasitic activity
Reduction in cytotoxicity; large
reduction in bactericidal activity against
Gram-negative E. coli; large reduction in
1.25-fold decrease
bactericidal activity against Grampositive B. subtilis; large reduction in
antiparasitic activity
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Ref

111

111

111

111

2.7 Appendix

Figure 2.9: Conformational exchange rates of selected RNases. Cartoon representation of
Homo sapiens EDN (HsR2), Homo sapiens ECP (HsR3), Pongo pygmaeus ECP (PpR3), Macaca
fascicularis ECP (MfR3), Bos taurus RNase A (BtRA), Homo sapiens angiogenin (HsR5) and
Homo sapiens RNase 4 (HsR4). Structures are colored using a blue-white-red spectrum
corresponding to residues exhibiting exchange rates (kex) ranging from 0 to 1000 s-1. Residues
experiencing enhanced conformational exchange appear in the red end of the spectrum while
residues displaying no conformational exchange are in the blue end of the spectrum. Exchange
rates (kex) were calculated for each individual residue by dual fitting 500 and 800 MHz CPMG data
to the full single quantum relaxation-compensated CPMG equation (Manley and Loria, 2012).
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Figure 2.10: Consensus sequence corresponding to the multiple sequence alignment.
Sequences for 23 RNases shown in Figure 2.1 A are included. The first column and row labels
correspond to sequence identifiers and amino acid positions, respectively.
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Figure 2.11: µs dynamics of all 23 RNase homologs. RMSFs for each protein from each of the
four phylogenetic groups are shown using a tube representation where the thickness of the tube
corresponds to the flexibility of residues in each protein, with thicker tubes corresponding to
flexible regions and thinner tubes representing less flexible regions. The dynamical ranges
represented using the color spectrum is consistent across all sequences with the red and blue
ends of the spectrum corresponding to more and less dynamic regions, respectively. Note that Nterminal residues, which showed larger RMSFs (see left panel), are hidden for clarity.

66

Figure 2.12: Dynamic cross-correlation maps (DCCMs) for the 23 RNase homologs. Values
>0.4 (blue end of the spectrum) represent correlated motions in the protein, while values < -0.4
(red end of the spectrum) represent anti-correlated motions. DCCMs identified using black
outlines are discussed in the section “Microsecond dynamics” of the manuscript. Regions
displaying (anti-)correlations are highlighted in the boxed DCCMs in A and B.
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Nucleotide Substrate Binding Characterization
in Human Pancreatic-type Ribonucleases
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3.1 Abstract
Human genome contains a group of more than a dozen similar genes with diverse biological
functions including antiviral, antibacterial and angiogenesis activities. The characterized gene
products of this group show significant sequence similarity and a common structural fold
associated with binding and cleavage of ribonucleic acid (RNA) substrates. Therefore, these
proteins have been categorized as members of human pancreatic-type ribonucleases (hRNases).
hRNases differ in cell/tissue localization and display distinct substrate binding preferences and a
wide range of ribonucleolytic catalytic efficiencies. Limited information is available about structural
and dynamical properties that influence this diversity among these homologous RNases. Here,
we use computer simulations to characterize substrate interactions, electrostatics and dynamical
properties of hRNases 1-7 associated with binding to two nucleotide substrates (ACAC and
AUAU). Results indicate that even with complete conservation of active-site catalytic triad
associated with ribonucleolytic activity, these enzymes show significant differences in substrate
interactions. Detailed characterization suggests that in addition to binding site electrostatic and
van der Waals interactions, dynamics of distal regions may also play a role in binding. Another
key insight is that a small difference in temperature of 300 K (used in experimental studies) and
310 K (physiological temperature) shows significant changes in enzyme-substrate interactions.

3.2 Introduction
A set of related human genes encoding for enzymes that cleave ribonucleic acid (RNA) substrates
also exhibit diverse biological functions such as angiogenesis, antiviral, antibacterial, and/or
cytotoxic activities. Eight of the encoded enzymes (canonical members) show conservation of two
active-site histidine residues and a lysine associated with the catalytic mechanism of
ribonucleolytic cleavage. An additional five catalytically inactive (non-canonical members)
pseudogenes were also identified in the human genome.5, 231, 250, 251 Collectively, these 13 proteins
exhibit 28% sequence identity (40% among the 8 canonical members). All structurally
characterized members share a common structural fold while displaying a diverse range of
catalytic efficiencies and biological activities.211,

252

These proteins are referred to as human

ribonucleases (hRNases) due to their conserved fold and ribonucleolytic function, which was first
discovered and characterized for bovine ribonuclease A (bRNaseA). As enzymes, hRNases
catalyze the transphosphorylation and hydrolysis of the phosphodiester bond in single-stranded
RNA substrates, although cleavage of double-stranded RNA has also been reported.7, 253 More
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broadly, the hRNases and bRNaseA belong to pancreatic-type ribonucleases (RNases)
superfamily of proteins with about 1500 members, mostly from mammals.
RNase superfamily members bind and catalyze the phosphodiester bond cleavage in a wide
variety of nucleotide substrates of different lengths and sequences. Substrate binding and kinetic
assays for some hRNases have been performed using a number of substrates with varying
nucleotide sequences and lengths, resulting in a wide variety of binding affinities and catalytic
efficiencies being reported.110, 112, 114, 116, 117, 119, 254-266 Structural studies have provided detailed
information for binding sites for the phosphate groups (P0, P1, P2), pyrimidine (B1) and purine (B2)
nucleotide bases in the active-site of bovine RNase A, the archetypal member of this superfamily
(Figure 3.1).7 The past studies have suggested substrate preferences at the B1 pyrimidine binding
site for some of the human RNases: hRNase1 showed a preference for cytosine (C) over uridine
(U), while hRNases 2, 3, 4 and 6 showed a preference for U over C.211, 254 In contrast, the B2
purine binding site was shown to prefer adenosine (A) in these hRNases.9, 211, 254 Substrate
preferences for the other hRNases remains unclear.41 While RNase homologs exhibit specific
nucleotide sub-site preferences in the context of structurally distinct active-site pockets, reports
have illustrated that binding affinities differ over several orders of magnitude between all hRNase
members (KM ranging from about 2 µM to 250 mM and kcat ranging from 0.003 to 2400 s-1), see
Table 1.2 in chapter 1 for details. As hRNases exhibit distinct substrate specificities and bind a
wide range of non-specific RNA sequences with micromolar affinities, the diverging ribonucleolytic
preferences and catalytic activities has created challenges in understanding their chemical and
designated biological functions at the molecular level. Therefore, considerable interest exists in
the characterization of the structure, dynamics and catalytic mechanisms of hRNases, in order to
gain a better understanding of their biological functions in the cell.
One of the most intriguing aspects of hRNases is the wide range of catalytic efficiencies
associated with ribonucleolytic activities observed for these homologs, which differ by as much
as 106-fold.211,

252

Interestingly, the time-scales associated with their intrinsic dynamics

(corresponding to large-scale global conformational exchange) also varies over 5-6 orders of
magnitude.252 The similarity in range of catalytic efficiencies as well as the observed intrinsic
dynamics raises an interesting question regarding the relevance of dynamics in the catalytic
mechanism.252 Recently, structural and dynamical characterization of a group of 23 members of
the RNase superfamily based on nuclear magnetic resonance (NMR) and computational
simulations (of apo proteins) provided unique insights into the conservation of dynamical
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Figure 3.1: RNase-substrate binding sub-sites. Schematic representation based on the
bRNaseA active-site. P0, P1 and P2 represent binding sub-sites for the phosphate groups of the
RNA substrate backbone, while B1 and B2 correspond to nucleotide base sub-sites. The cleaved
phosphodiester bond is indicated by an arrow. The nucleotide bases in pockets B1 (cytosine
drawn, but uracil can also bind) and B2 (adenosine) are rendered based on published information
about nucleotide preference in bRNaseA; for some hRNases, the information about nucleotide
preference is unclear. Figure redrawn based on 7. The substrates investigated in this study are
5’-ACAC-3’ (shown) and 5’-AUAU-3’. In the present work, simplified nucleotides numbering
scheme A(-2)C/U(-1)A(1)C/U(2) is used with negative numbers corresponding to nucleotides
away from cleaved phosphodiester bond decreasing in the 5’ direction and positive numbers for
nucleotides away from cleaved phosphodiester bond increasing in the 3’direction.
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properties within this enzyme family.267 Members within sub-families, identified based on
phylogenetic classification, showed similarity in structure, and more interestingly, similarity in
biological function and intrinsic dynamics. Furthermore, the different sub-families corresponding
to branches of evolution associated with gene duplication followed by functional adaptation show
largely different dynamics. For a direct comparison of the catalytic efficiencies and dynamics of
these hRNases, the use of identical substrates in similar conditions is essential to eliminate effects
caused by inhomogeneous nucleotide sequences and/or experimental variations.
In this study, we use computer modeling to investigate the binding and interactions of 8 canonical
members of the RNase superfamily (hRNases 1-7 and bovine RNase A) in the presence of two
model single-stranded RNA substrates: the tetraribonucleotide sequences ACAC and AUAU. The
selection of these model substrates is based on previous experimental data on nucleotide
preferences in the B1/B2 sub-sites
hRNases from our group.252,

267

as well as structural and dynamical characterization of

Using microsecond time-scale molecular dynamics (MD)

simulations, we characterized the binding stability, hydrogen bonding, van der Waals and
electrostatic interactions between the enzymes in complex with the two model substrates. The
detailed comparative analysis provides new insights into the structural and dynamical properties
that contribute to enzyme-nucleotide substrate interactions in these RNases. The results indicate
that while the 8 enzymes display conservation of the catalytic triad and a number of active-site
residues involved in substrate interactions and stability, their substrate preference and binding
affinities differ significantly. These results further indicate that, in addition to the conserved
catalytic triad, other active-site residues play important roles in enzyme-substrate interaction and
stability, and therefore, could have important consequences for differences in the biological
function between functional and structural enzyme homologs. Somewhat surprisingly, a
temperature difference from 300 K to 310 K shows significant differences in substrate stability
behavior in these enzymes. This is intriguing because the vast majority of prior experimental
enzyme characterization were performed at room temperature (~300 K), while the relevant
physiological temperature for these enzymes is closer to the average human (~310 K) and bovine
(~312 K) body temperatures. These observations highlight the effect of subtle changes in
temperature on the structural and dynamical properties of enzymes and further illustrate the
importance of the selection of temperature in experimental and computational studies that are
representative of physiological conditions.
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3.3 Materials and methods
Atomic coordinates: Seven human ribonuclease substrate complexes were prepared based on
X-ray/NMR structures with the following PDB codes: 2K11 (hRNase1),268 1GQV (hRNase2),269
1QMT (hRNase3),270 1RNF (hRNase4),271 1ANG (hRNase5),272 2HKY (hRNase7)273 and 7RSA
(bRNaseA),274 while hRNase6 was crystallized in our group.138 The sequence alignment of these
8 proteins is provided in Figure 1.2 of Chapter 1. hRNase8 was not investigated in this study as
structural information about this enzyme is not yet available. Each of these proteins were
investigated complexed with two model substrates AUAU and ACAC, under explicit water
conditions based on the procedure described below.
Computational systems preparation: Computational system preparation and all-atom MD
simulations were performed using the AMBER simulation package.275 For preparation of the
nucleotide substrate, the coordinates for the phosphate and ribose sugar backbone were adopted
from the DNA ligand (ATAA) in PDB structure 1RCN

. The nucleotide bases of the substrate

276

template were modified to create the desired nucleotide (ACAC or AUAU), using AMBER’s tleap
modeling preparation module. AMBER’s ff14SB force-field were used for modeling both protein
residues and RNA substrates. The protein-ligand complex was neutralized with the addition of
chloride (Cl-) counterions and solvated by immersing in a rectangular box (SPC/E277 water model)
with periodic boundary conditions. The prepared system was equilibrated using the protocols
developed in our group and described previously.278, 279 These protocols were effective in fully
resolving the steric clashes caused by the introduction of modeled substrate in the active site.
AMBER’s pmemd simulation engine was used for equilibration and production runs, with PMEmethod for long range electrostatics280. All hydrogen bonds were constrained using SHAKE281.
Histidine protonation states: There are two conserved histidine residues in the active-site of all
RNases that participate in the phosphodiester bond cleavage mechanism. The protonation states
for these residues were determined based on the past pH profiles for bRNaseA as well as
structural interaction with modeled substrate and other residues;85, 282 the two histidine residues
His12 and His119 (bRNaseA numbering), were modeled in single (proton on Nẟ1) and double
protonated states respectively. All the other histidine residues were modeled in single protonated
state for all 8 RNases.
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MD simulations: Equilibration runs were performed under constant volume and temperature
(NVT) conditions with a thermostat to bring the system to target temperature of 300 K or 310 K
for production run (see below). Production runs of 0.5 µs (microsecond) were performed under
constant volume and energy (NVE) simulation conditions using a 2 femtoseconds (fs) time-step.
Production runs under NVE ensemble were performed as this ensemble offers better
computational stability and performance for longer MD simulations.283 All simulations were
performed using NVIDIA graphics cards with CUDA-enabled version of AMBER’s pmemd MD
simulation engine. The default precision in the pmemd.cuda_SPFP binary was used from AMBER
v14 package.
Two independent sets of simulations were performed at 300 K and 310 K (no thermostat was
applied during production runs). Furthermore, to ensure the reproducibility of the results from this
study, two independent trajectories were computed at each temperature (labeled as 300 K 1, 300
K 2, 310 K 1, and 310 K 2 in the remaining text and Table 3.1). For the set 2, after equilibration
the system was minimized (100,000 steps) followed by MD (1000 ps) to slowly readjust the
temperature before the production runs were performed. At each temperature, for each of the
unique RNase-substrate complex, 2,000 structures (1,000 from each trajectory, 500 picoseconds
apart) were stored and analyzed for structural, electrostatic and dynamical analysis, as described
below. A subset of stored structures was used for hRNase5 (1,400 structures) and hRNase7
(1,360 structures) analysis as the substrates were ejected mid-way during the simulations;
therefore, only the structures where the substrate stays bound in the sub-sites were used for
analysis. Specifically, only the first 400 structures from hRNase5-AUAU 300 K 2 trajectory and
first 360 structures from hRNase7-AUAU 300 K 1 trajectory were used for structural (H-bonding)
and interaction energy analyses as described below. For the two systems where the substrate
was ejected (hRNase5-AUAU at 300 K and hRNase7-AUAU at 300 K), addition MD simulations
were performed to ensure the reproducibility of the behavior. To generate the starting coordinate
for this third set of trajectories for these two systems, the equilibrated structures were heated for
1000 ps to 305 K (for simulation set for 300 K) and 315 K (for simulation set for 310 K) to generate
conformational diversity. The ending structures were minimized for 100,000 steps and heated to
final temperature before production runs were performed similar to the other two sets
Structural analysis using H-bonding patterns: H-bonding interactions between the substrate
and RNases were analyzed using ptraj, with the following criteria: less than 3.3 Å for donor to

acceptor heavy atom distance at an angle between 135° and 180° for the donor-hydrogen75

acceptor. The percentage occupancies of H-bonds, defined as fraction (percentage) of total
number of structures (as described in last paragraph) where the interaction meets the H-bonding
criterion mentioned above, were also calculated.
Enzyme-substrate interaction: The energy for the enzyme-substrate interactions (Eenz-subs) were
calculated as a sum of electrostatic (Eel) and van der Waals energy (Evdw) between atom pairs,
based on an approach developed in our group.278, 284

E enz − subs = ∑ ( E el + E vdw )

(3.1)

Eel is the electrostatic contribution, Evdw is the van der Waals term and the summation runs over
all atom pairs for the enzyme and nucleotide substrate. The Eel and Evdw terms were computed as
follows

Eel =

qi q j

ε(r)rij

and

Evdw =

Aij
12
ij

r

−

Bij
rij6

(3.2)

where qi , qj are partial charges, and Aij, Bij are Lennard-Jones parameters. These parameters
were obtained from AMBER ff14SB force field. A distance-dependent dielectric function was used:

ε (rij ) = A +

B
1 + k exp(−λBrij )

(3.3)

B=εo-A; εo=78.4 for water; A= -8.5525; 𝜆𝜆=0.003627 and k=7.7839.

All enzyme and substrate (ACAC/AUAU) atom pairs were included in the calculations and
resulting interaction energies were summed for each residue-nucleotide pair. For each system,
the reported interaction energies are an average over total number of structures (as described
above). This method has successfully been used to predict the experimentally obtained binding
preference/affinities of substrates for a number of proteins including human cyclophilin A,
xylanases, and maltose binding proteins similar to the substrate preference of hRNases described
in this study.278, 284, 285
Electrostatic surface calculations: The enzyme electrostatic surface was computed using the
Adaptive Poisson-Boltzmann Solver (APBS) software.286 APBS requires a protein conformation.
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The ideal case of using averaged enzyme structure for the entire MD simulation was not feasible
as the averaged structure shows artificial bonds and angles, particularly to the sampling of
different conformations over the 0.5 µs simulations. Therefore, a conformation from the MD
ensemble closest to the averaged structure (with least RMSD to the average) was used to
generate the electrostatic surface.
RMSF10 calculations: For dynamical analysis, backbone (Cα) and all-atom flexibility of simulation
trajectories was determined from the root mean square fluctuation (RMSF), computed by
aggregating the magnitude of displacement eigenmodes computed using the quasi-harmonic
analysis (QHA) in the ptraj analysis module in AMBER. As described previously,228, 287 only the
top 10 QHA modes (RMSF10) were used in the analysis to focus on the principal dynamics or long
time-scale functionally relevant fluctuations in the proteins. For comparison, the results for apo
systems were obtained from our previous study.267

3.4 Results
3.4.A Stability of the substrate-bound RNase complexes
Table 3.1 summarizes the interactions of hRNases 1-7 in complex with model tetranucleotide
substrates ACAC and AUAU. Starting from the enzyme conformation with substrate-bound in the
active-site, 0.5 µs MD simulations were used to characterize the stability of interactions between
the enzyme and nucleotide substrates. Note, the starting coordinates for the substrate phosphate
and ribose sugar backbone were adopted from a bRNaseA-substrate complex published
previously (PDB code 1RCN), and the nucleotide bases were added computationally. Two
independent MD simulation trajectories for each complex were performed, labeled 1 and 2 in
Table 3.1, to ensure reproducibility of the results reported. The characterization of enzymesubstrate complex stability is based on interaction analysis between the two central nucleotides
and enzyme residues. Only the two central nucleotides were considered for stability analysis as
these nucleotides are adjacent to the phosphodiester bond cleaved by RNases and have well
defined interactions with active-site residues forming the P1/B1 and P2/B2 binding sites (see Figure
3.1). The other/terminal two nucleotides in the model substrates do not have well defined
interactions and show significantly lower stability over the course of the MD simulations. In Table
3.1, simulation trajectories where the two central nucleotides show stable binding in their
respective sub-sites (for entire 0.5 µs) are represented with a green box, while trajectories where
one of the two central nucleotides is ejected from the sub-site are shown using a yellow box. The
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stable nucleotide in the binding sub-site is identified in the yellow boxes of Table 3.1. The cases
where both the central nucleotides lose all contacts with the sub-site residues and are considered
to be ejected out of the binding pocket are marked in red boxes. Ejection out of the binding pocket
is defined as no direct hydrogen bond or van der Waals contact between the enzyme residues
and the two central nucleotides (any water or ion-mediated indirect interactions were excluded
from this analysis).
The interaction analysis shows that the majority of RNases show stable nucleotide binding
throughout the simulations for the two alternate temperatures at 300 K and 310 K, reproduced in
both the alternative MD trajectories. Notable exceptions include hRNase5 and hRNase7, where
the substrate AUAU is completely ejected out of the active-site. In the case of hRNase3, the
enzyme displays interactions with only one of the two central nucleotides, while the second central
nucleotide is ejected out of the binding pocket (Table 3.1). There are marked differences
associated with the two temperatures as well as two independent trajectories at each
temperature, but overall the results are qualitatively similar. Note that these are human proteins
and 310 K is close to the physiological temperature, while a number of experimental enzyme
kinetics parameters are reported for these systems at temperature close to 300 K.54, 110, 112, 114, 116,
117, 254, 255, 264, 265

For hRNase5 and hRNase7, additional data was collected to confirm the

observations of the ejection of substrate from the active-site. The third MD set (data only collected
for these two systems) indicated that for hRNase7-AUAU at 300 K, the behavior was reproduced,
as the substrate was completely ejected from the active-site at 370 ns. For hRNase5-AUAU the
behavior was partially reproduced, as 3 out of the 4 nucleotides broke all contacts, with only
central U maintaining contact with the protein.
Characterization of the relative substrate positions and interactions with enzymes over the course
of MD simulations revealed significant variations among the different RNases. The results are
depicted in Figure 3.2 for simulations at 300 K and Figure 3.3 for simulations at 310 K (the
trajectory labeled 1 in Table 3.1 is shown). These figures depict three substrate conformations
(relative positions); at the start (0 µs, green sticks for carbon), half-way (0.25 µs, yellow sticks for
carbon) and endpoint (0.5 µs, magenta sticks for carbon) of the simulations. In cases where the
substrate is completely ejected from the active-site, the mid-way and ending frames have been
adjusted according to the time of ejection (listed in Table 3.1).
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In the cases of bRNaseA, hRNase1, and hRNase6, both model substrates (ACAC and AUAU)
stay bound in the active-site for the entire 0.5 µs simulations (300 K as well as 310 K), close to
the original orientation, suggesting equal stability of these substrates in these enzymes. Note that
the central nucleotides remain close to their initial orientation in the active-site (in P1/B1 and P2/B2
sites), while the two peripheral nucleotides show considerable variation from their initial
orientation. In the case of hRNase2, both substrates stay in their initial orientation at 300 K, with
the central adenosine base showing minor movement out of the B2 pocket while phosphate stays
bound in the P2 pocket. For simulations at 310 K, substrate ACAC is partially displaced from its
initial orientation, with the central cytosine in trajectory 1 (adenine in trajectory 2) moving
completely out of the P1/B1 (P2/B2) pockets (Figure 3.3). In the case of hRNase4, substrate ACAC
at 300 K stays localized in the active-site while at 310 K adenine leaves the binding pocket; for
substrate AUAU at both temperature adenosine moves out of its binding pocket. In hRNase5, the
substrates show considerable movements in simulations at 300 K, particularly in the case of
AUAU, where the substrate completely leaves the active-site in one of the MD trajectories (labeled
as trajectory 2 in Table 3.1). For hRNase3 and hRNase7, at least one of the nucleotide binding
to B1 or B2 site (for both ACAC and AUAU) show significant movement away from the binding
pocket over the course of MD simulations at both temperatures investigated.

3.4.B Structural interactions
To quantitatively characterize the substrate interactions with each of the 8 proteins in this study,
hydrogen bonding interactions were calculated for the ensemble of conformations sampled during
the MD simulations. The average distance between heavy atoms of the enzyme and substrate
nucleotide, and percentage occupancy of the hydrogen bonding interactions over the course of
aggregate 1 µs MD sampling (by combining two simulations labeled as 1 and 2 in Table 3.1) were
calculated; the results are summarized in Table 3.2 for 300 K and Table 3.3 for 310 K, for the two
substrates. The results indicate that the conserved catalytic triad (His12, Lys41 and His119,
bRNaseA numbering) does not form stable hydrogen bonds, and any definite patterns in the Hbonding interactions between these residues (across all 8 enzymes investigated) and substrates
were not observed. Among the non-catalytic active-site residues, the equivalent of bRNaseA
residues Thr45 and Asn71 showed most stable H-bond interactions with the substrates in several
human RNases. These residues were previously shown to be part of the B1 and B2 binding sites,
respectively.288 Unsurprisingly, Thr45 and Asn71 are fully conserved in all 8 RNases investigated
in this study, possibly illustrating their role in active-site substrate stabilization.
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Table 3.1: Stability of nucleotide substrates ACAC and AUAU in the active-site of RNases.
Stable substrates in the active-site for entire 0.5 µs (500 ns) are colored as green boxes; cases
where one nucleotide is ejected are colored yellow and the stable nucleotide base is labeled (A –
adenine, U – uracil, C – cytosine); and cases where both nucleotides are ejected are indicated as
red boxes (time in nanoseconds when the substrate is fully ejected is specified). Note that only
the two central nucleotides were considered for this analysis (in red, underlined). a = additional
(3rd) trajectory indicates that only central U remained in active-site, b = additional (3rd) trajectory
indicates that the substrate was ejected from active-site at 370 ns.

ACAC
Enzyme

PDB ID

300 K
1

bRNaseA

7RSA

hRNase1

2K11

hRNase2

1GQV

hRNase3

1QMT

hRNase4

1RNF

hRNase5

1ANG

hRNase6

*

hRNase7

2HKY

AUAU

C

310 K
2

A

300 K

1

2

A

C

A

A

C
C

C

C

80

1

310 K
1

2

U

U

A

U

U

A

180 ns
b

2

200 ns
a

U

U

U

U

Figure 3.2: Substrate behavior over the course of 0.5 µs MD simulations. The enzymes are
shown as gray cartoons and the 3 orientations of the substrate at start (0 µs, green), mid-way
(0.25 µs, yellow) and end (0.5 µs, magenta) of the simulations are shown as sticks. The results
for the two substrates ACAC and AUAU are shown separately. The central two nucleotides of the
substrate that interact with two binding sub-sites (B1/P1 or B2/P2) are shown in dark colors, while
the two terminal nucleotides (one on each side) are depicted with faded color. The results depicted
are from the 300 K simulation trajectories and represent the MD simulations set 1. The results
from trajectory 2 at 300 K are qualitatively similar (Table 3.1). * indicates simulations where the
substrate is ejected and leaves the active-site; the end and mid-way frames for these cases are
adjusted accordingly. a indicates that the substrate was stable in depicted trajectory (300 K 1);
however, it was ejected out from the pocket in second trajectory (300 K 2).
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Figure 3.3: Substrate behavior over the course of 0.5 µs MD simulations at 310 K. The
enzymes are shown as gray cartoons and the 3 relative positions of the substrate at start (0 µs,
green), mid-way (0.25 µs, yellow) and end (0.5 µs, magenta) of the simulations are shown as
sticks. The results for the two substrates ACAC and AUAU are shown separately. The central two
nucleotides of the substrate that interact with two binding sub-sites (B1/P1 or B2/P2) are shown in
dark colors, while the two terminal nucleotides (one on each side) are depicted with faded color.
The results depicted are from the 310 K simulation trajectories and represent the MD simulations
set 1. The results from trajectory 2 at 310 K are qualitatively similar (Table 3.1).
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For enzymes bRNaseA, hRNase1, hRNase4 and hRNase6, strong H-bonding interactions are
observed with both substrates at 300 K (Figure 3.4 and Table 3.2). In this study, strong H-bonds
are defined as H-bonds with bond length less than 3 Å between the heavy atoms; and H-bond
occupancies greater than 80% is considered significant. hRNase2 forms at least one H-bond
interaction with relatively higher occupancy (79.4%) with substrate ACAC while it forms H-bonds
with AUAU that have lower occupancies. On the other hand, hRNase3 and hRNase7 form Hbonds with both substrates that have lower occupancies (≤ 70%). It was also observed that
hRNase5 shows no H-bonding interactions with the substrate AUAU. This might be due to the
complete ejection of substrate from the binding site of hRNase5 after ~200 ns (0.2 µs) of
simulation (Table 3.1).
A number of differences were observed when comparing the enzyme-substrate H-bonding
interactions at experimental (300 K) and physiological (310 K, see Figure 3.5 and Table 3.3)
temperatures with the most obvious difference in H-bonding pattern appears in hRNase3,
hRNase5 and hRNase7. Interestingly, hRNases 2 and 3 show lower occupancies with both
ligands relative to bRNaseA at both temperatures. For hRNase2, strong H-bonding interactions
with substrate ACAC that were observed at 300 K simulations exhibit lower occupancies at 310
K. Simulations indicated that hRNase3 does not form any H-bonds with ACAC at 310 K. A
comparison of the interactions at 310 K suggest significantly more interactions for hRNases 3 and
4 with the AUAU ligand. Note when compared to lower temperature, hRNase3 forms H-bonding
interactions with AUAU that have lower occupancies. On the other hand, it is observed that
hRNase7 does not show any H-bonding interactions with the substrate AUAU at 310 K, although
stronger H-bonds are observed with ACAC at 310 K, suggesting a potential preference for cytidine
(C) in the B1 sub-site. hRNase5, which did not show any H-bonding interactions with substrate
AUAU at 300 K, exhibits H-bonds with substrate AUAU at 310 K through the conserved Asn43
and Thr44 residues. The time evolution behavior of H-bonds for various complexes is shown in
Figures 3.12 – 3.19 (Appendix 3.7).
Overall, results suggest that even though all the 8 enzymes have conserved catalytic triad and
several other conserved residues in the active-site,267 the model substrates show significant
differences in their interactions with the enzymes, with some of them showing weak interactions
and/or lower occupancies. An interesting observation is that even for substrates which stay bound
to the enzymes, the conserved catalytic triad residues do not exhibit strong H-bonding
interactions, while other residues show stronger interactions, including residues reported to be
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Figure 3.4: Hydrogen-bonding interactions between RNases and model substrates at 300
K. H-bonds (with >45% occupancy) are indicated with black dotted line and averaged bond length
(Å) and percentage occupancy are shown in red colored text. Enzyme and nucleotide atoms
participating in the H-bonds are labeled, with enzyme residues shown in blue and substrate
nucleotides shown in green for carbon atoms, blue for nitrogen, red for oxygen, and orange for
phosphorus. Enzyme residue numbers correspond to enzyme sequence, while substrate
nucleotides are numbered as A(-2)C/U(-1)A(1)C/U(2), as described in the legend of Figure 3.1.
hRNase5-AUAU did not show any H-bonds meeting the criteria and is only shown for comparison.
Note that the substrates orientation (marked by 3’ and 5’ for bRNaseA) appear opposite to the
depiction in Figure 3.1, as enzymes are shown from view used commonly in literature. The
percentage occupancies have been rounded off to the nearest whole number.
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Figure 3.5: Hydrogen-bonding interactions between RNases and model substrates at 310
K. H-bonds (with >45% occupancy) are indicated with black dotted line and averaged bond length
(Å) and percentage occupancy are shown in red colored text. Enzyme and nucleotide atoms
participating in the H-bonds are labeled, with enzyme residues shown in blue and substrate
nucleotides shown in green for carbon atoms, blue for nitrogen, red for oxygen, and orange for
phosphorus. Enzyme residue numbers correspond to enzyme sequence, while substrate
nucleotides are numbered as A(-2)C/U(-1)A(1)C/U(2), as described in the legend of Figure 3.1. Note
that the substrates orientation (marked by 3’ and 5’ for bRNaseA) appear opposite to the depiction
in Figure 3.1, as enzymes are shown from view used commonly in literature. The percentage
occupancies are rounded off to the nearest whole number.
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Table 3.2: H-bonding properties of bovine and human pancreatic-type RNases at 300 K.
The H-bonds that meet the criteria of 3.3 Å, angle between 135 - 180° and more than 45%
occupancy are listed. Results are based on analysis of both the alternate MD trajectories for each
system (see methods for details).
ACAC

AUAU

Substrate

Residue

bond length
(% occupancy)

Substrate

Residue

bond length
(% occupancy)

bRNaseA

C(-1) (N3)
C(-1) (O2)
A(1) (N1)
C(-1) (O2')
A(1) (N6)

Thr45 (Oϒ1)
Thr45 (N)
Asn71 (Nδ2)
Phe120 (O)
Asn71 (Oδ1)

2.87 (95.7%)
2.87 (88.5%)
3.01 (65.0%)
2.74 (47.2%)
3.00 (46.4%)

U(-1) (O2)
U(-1) (N3)
A(1) (OP2)
A(1) (N6)
A(1) (N1)
A(1) (OP1)

Thr45 (N)
Thr45 (Oϒ1)
Gln11 (Nε2)
Asn71 (Oδ1)
Asn71 (Nδ2)
Phe120 (N)

2.88 (95.4%)
2.97 (85.8%)
2.84 (73.2%)
2.95 (69.2%)
3.02 (68.8%)
2.93 (58.6%)

hRNase1

C(-1) (N3)
C(-1) (O2)
C(-1) (O2')

Thr45 (Oϒ1)
Thr45 (N)
Phe120 (O)

2.89 (93.6%)
2.89 (72.2%)
2.75 (49.2%)

U(-1) (N3)
A(1) (N1)
U(-1) (O2')
A(1) (N6)

Thr45 (Oϒ1)
Asn71 (Nδ2)
Phe120 (O)
Asn71 (Oδ1)

2.91 (98.4%)
2.98 (94.2%)
2.73 (87.0%)
2.98 (85.6%)

hRNase2

C(-1) (N3)
A(1) (OP2)

Thr43 (Oϒ1)
Gln15 (Nε2)

2.88 (79.4%)
2.87 (65.6%)

U(-1) (N3)
A(1) (OP2)
U(-1) (O4)

Thr43 (Oϒ1)
Gln15 (Nε2)
Ile134 (N)

2.95 (66.1%)
2.88 (55.8%)
2.98 (47.7%)

hRNase3

A(1) (N6)
A(1) (N1)

Asn71 (Oδ1)
Asn71 (Nδ2)

2.95 (51.6%)
3.01 (50.8%)

A(1) (N6)
A(1) (N1)
5’A(-2) (N6)

Asn71 (Oδ1)
Asn71 (Nδ2)
Thr133 (O)

2.96 (67.4%)
3.01 (67.0%)
2.89 (60.0%)

hRNase4

A(1) (OP1)
A(1) (OP1)
C(-1) (N4)
A(1) (N1)
A(1) (N6)
A(1) (O5')

Phe118 (N)
His117 (Nδ1)
Thr45 (Oϒ1)
Asn71 (Nδ2)
Asn71 (Oδ1)
His117 (Nδ1)

2.91 (92.9%)
2.80 (66.3%)
2.91 (63.1%)
3.00 (61.0%)
2.94 (59.9%)
2.96 (54.2%)

U(-1) (N3)
U(-1) (O2)
A(1) (OP1)

Thr45 (Oϒ1)
Thr45 (N)
Phe118 (N)

2.95 (93.8%)
2.93 (86.2%)
2.89 (59.0%)

hRNase5

C(-1) (N4)
A(1) (OP1)

Thr44 (Oϒ1)
His114 (Nδ1)

2.95 (63.0%)
2.77 (58.6%)

hRNase6

A(1) (OP1)
A(1) (N1)
A(1) (N6)
A(1) (OP1)
A(1) (N6)
C(-1) (O2')

Gln15 (Nε2)
Asn69 (Nδ2)
Asn69 (Oδ1)
Trp11 (Nε1)
Asn65 (Oδ1)
Leu124 (N)

2.92 (85.8%)
3.02 (84.8%)
2.98 (84.4%)
2.91 (79.7%)
2.98 (50.6%)
3.00 (46.9%)

A(1) (N6)
A(1) (N1)
3’U(2) (O4)
A(1) (N6)
A(1) (OP2)

Asn69 (Oδ1)
Asn69 (Nδ2)
Arg67 (Nη1)
Asn65 (Oδ1)
His123(Nε2)

2.93 (96.2%)
3.05 (88.0%)
2.93 (83.1%)
2.94 (70.7%)
2.94 (52.0%)

hRNase7

C(-1) (N3)

Thr43 (Oϒ1)

2.85 (53.2%)

U(-1) (O2')
5’A(-2) (N6)

Leu125 (O)
Thr43 (Oϒ1)

2.67 (70.51%)
2.95 (48.01%)
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Table 3.3: H-bonding properties of bovine and human pancreatic-type RNases at 310 K.
The H-bonds that meet the criteria of 3.3 Å, angle between 135 - 180° and more than 45%
occupancy are listed. Note that the results are based on analysis of both MD alternate trajectories
for each system (see methods for details).

ACAC

AUAU

Substrate

Residue

bond length
(% occupancy)

Substrate

Residue

bond length
(% occupancy)

bRNaseA

C(-1) (N3)
C(-1) (O2)
A(1) (N1)
C(-1) (O2')
A(1) (N6)

Thr45 (Oϒ1)
Thr45 (N)
Asn71 (Nδ2)
Phe120 (O)
Asn71 (Oδ1)

2.88 (91.4%)
2.88 (86.4%)
3.02 (58.7%)
2.74 (48.7%)
2.99 (46.3%)

A(1) (N1)
U(-1) (O2)
A(1) (N6)
U(-1) (N3)

Asn71 (Nδ2)
Thr45 (N)
Asn71 (Oδ1)
Thr45 (Oϒ1)

3.02 (79.2%)
2.91 (78.8%)
2.96 (76.8%)
2.93 (74.9%)

hRNase1

C(-1) (N3)
C(-1) (O2)
A(1) (N1)
A(1) (N6)
C(-1)(O2')

Thr45 (Oϒ1)
Thr45 (N)
Asn71 (Nδ2)
Asn71 (Oδ1)
Phe120 (O)

2.87 (93.6%)
2.88 (84.4%)
3.02 (70.1%)
2.98 (61.2%)
2.74 (45.4%)

U(-1) (N3)
A(1) (N1)
U(-1) (O2)
A(1) (N6)
U(-1) (O2')

Thr45 (Oϒ1)
Asn71 (Nδ2)
Thr45 (N)
Asn71 (Oδ1)
Phe120 (O)

2.92 (93.9%)
3.00 (80.0%)
2.91 (76.9%)
2.97 (73.3%)
2.73 (52.0%)

hRNase2

A(1) (OP2)
C(-1) (N3)

Gln15 (Nε2)
Thr43 (Oϒ1)

2.92 (56.4%)
2.84 (49.6%)

A(1) (OP2)
U(-1) (O2)

Gln15 (Nε2)
Thr43 (Oϒ1)

2.94 (57.2%)
2.81 (56.8%)

hRNase3

A(1) (N1)
A(1) (O)
A(1) (OP2)
A(1) (N6)

Asn71 (Nδ2)
His129 (Nδ1)
Gln15 (Nε2)
Asn71 (Oδ1)

2.98 (47.9%)
2.83 (47.4%)
2.89 (46.8%)
2.97 (45.1%)

hRNase4

C(-1) (N4)
A(1) (O)
A(1) (OP1)

Thr45 (Oϒ1)
Phe118 (N)
His117 (Nδ1)

2.90 (86.0%)
2.92 (58.0%)
2.78 (49.4%)

U(-1) (N3)
U(-1) (O2)
A(1) (O)
A(1) (N1)
A(1) (N6)
A(1) (O)

Thr45 (Oϒ1)
Thr45 (N)
Phe118 (N)
Asn71 (Nδ2)
Asn71 (Oδ1)
His117 (Nδ1)

2.94 (92.6%)
2.92 (88.1%)
2.88 (69.8%)
3.02 (48.7%)
2.96 (48.5%)
2.79 (47.4%)

hRNase5

C(-1) (N3)
C(-1) (O2)

Thr44 (Oϒ1)
Thr44 (N)

2.85 (76.3%)
2.90 (70.7%)

U(-1) (O4)
U(-1) (N3)

Thr44 (N)
Asn43 (Oδ1)

2.91 (56.9%)
2.92 (54.2%)

hRNase6

A(1) (N6)
A(1) (N1)
A(1) (O)
A(1) (O)
C(-1) (N4)
A(1) (N6)

Asn69 (Oδ1)
Asn69 (Nδ2)
Trp11 (Nε1)
Gln15 (Nε2)
Thr43 (Oϒ1)
Asn65 (Oδ1)

2.97 (93.6%)
3.03 (90.4%)
2.87 (87.2%)
2.97 (70.6%)
2.95 (48.2%)
2.97 (47.2%)

A(1) (N6)
A(1) (N1)
A(1) (N6)
A(1) (O)

Asn69 (Oδ1)
Asn69 (Nδ2)
Asn65 (Oδ1)
Gln15 (Nε2)

2.95 (95.6%)
3.05 (85.0%)
2.95 (59.2%)
2.90 (46.7%)

hRNase7

C(-1) (N3)
C(-1) (O2)
C(-1) (O2')
C(-1) (N4)

Thr43 (Oϒ1)
Thr43 (N)
Leu125 (O)
Thr43 (Oϒ1)

2.83 (81.3%)
2.94 (74.8%)
2.71 (60.2%)
3.04 (50.6%)
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involved in substrate recognition and stabilization. This suggests that while other conserved
residues may hold the substrate in place, the catalytic triad shows a large degree of flexibility
which is possibly required for the catalytical cleavage step. This behavior is different than other
enzyme systems where it is shown that the catalytic active-site residues are fairly rigid and make
strong interactions with the substrates.138, 210, 216 Note that the structural analysis based on Hbonds does not provide information about complete set of interactions between substrate and
hRNases. It helps in identification of the most important direct hydrophilic interactions; however,
long range electrostatic and hydrophobic interactions are not captured by H-bonding analysis. In
RNases particularly the strongly charged phosphate backbone and the hydrophobic interactions
of the nucleotide base in the binding pocket provide important contributions. Therefore, a detailed
and quantitative analysis based on full electrostatic and van der Waals interaction energy was
also performed as described below.

3.4.C Electrostatic interactions
ssRNA substrates are highly negatively charged molecules, particularly due to the presence of a
phosphate backbone. It has been documented that long-range electrostatic interactions play an
important role in the binding of negatively-charged RNA substrates to the highly cationic surface
of this RNase superfamily.289, 290 For characterizing and comparing the charge distribution on the
surface of these homologs, the averaged electrostatic surface for each enzyme over the course
of MD trajectories was calculated (Figure 3.6 for results obtained from simulations at 300 K and
Figure 3.7 for results from simulations at 310 K). hRNases have been reported to bind to similar
substrates and share the same overall shape, but the electrostatic surface shows variations due
to the difference in protein sequence. In addition, the charge distribution also showed differences
based on the type of bound substrate, possibly indicating changes in orientation of enzyme
residues on the surface due to the nature of the substrate. The most prominent feature is that all
RNases in this study have highly positively charged surfaces (blue regions in Figures 3.6 & 3.7).
This is not surprising as the RNA substrates are negatively charged, and the positively charged
surface is expected to guide the substrate into the active-site pocket. An interesting observation
is that the electrostatic surfaces for human enzymes are similar when bound to the two substrates
ACAC and AUAU, but different in the case of bRNaseA. Note that bRNaseA is catalytically the
most efficient enzyme (for ribonucleolytic cleavage activity) of 8 enzymes investigated in this
study. Further studies could investigate the correlation between these enzymes to adapt
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conformations for optimal electrostatic based on bound substrate and efficiency of ribonucleolytic
cleavage.

3.4.D Quantitative characterization of interaction energies
Figure 3.8 depicts an overview of the interaction energy between the enzyme and the model
substrates, based on the 300 K simulations. The results for 310 K are shown in Figure 3.9. The
total interaction energy was computed as a sum of van der Waals and electrostatic interaction
energies between each enzyme residue and each nucleotide of the substrate molecules. Tables
3.5 and 3.6 (Appendix 3.7) provide the quantitative values, using a cut-off value of < -3 kcal/mol
per residue-nucleotide pair being considered as significant. Overall, these results from this
analysis indicate that both model substrates show favorable interactions (blue to yellow regions
in the figure panels) with the enzyme. Note that H-bonding based structural analysis presented
above, describes only a sub-set of key interactions but interaction energy analysis provides a
complete picture. More specifically, favorable interactions with the catalytic His119 (bRNaseA
numbering) were observed for both the substrates with all RNases. Most RNases also showed
favorable interactions with Thr45 (bRNaseA numbering) in the β1 strand, a residue shown to bind
to the pyrimidine nucleotide.9 bRNaseA residue Lys7 further showed favorable interactions with
both the substrates and Lys66 (from loop L4) with substrate ACAC. Similar interactions were
observed for hRNase1, which showed additional favorable interactions by Asn71 and Lys7 with
AUAU. In case of hRNase2 residues Arg133 and Trp8 show additional interactions in case of
substrate AUAU; the latter residue is previously reported to interact with the ribose group.9 In
contrast to hRNase2 where a significant number of interactions are present in the region 39-43,
hRNase3 showed significantly fewer interactions with the two substrates. The interaction energy
profile of hRNase4 was similar to that observed for bRNaseA for the two substrates. The Cterminal region of hRNase5 displayed favorable interactions with the nucleotide substrates in
addition to the catalytic Lys40, however, significantly fewer interactions of hRNase5 were
observed with AUAU. In contrast to other RNases, hRNase6 showed favorable interactions with
several residues of loop L4, suggesting a potential effect on the dynamical properties of this loop
upon substrate binding. hRNase7 showed very few favorable interactions localized to the catalytic
His124 with substrate AUAU while substrate ACAC showed additional interactions with the Lys39
and residues of β1 strand. Similar results were observed for all RNases at 310 K except hRNase5
and hRNase7, which showed more favorable interactions with substrate AUAU. See text in
supporting information for more details of substrate interactions with each RNase.
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Figure 3.6: Electrostatic surface of RNases with the two model substrates at 300 K. Enzyme
conformation from the MD ensemble closest to the averaged structure for the entire trajectory
(conformation with smallest RMSD with averaged structure) was used to calculate the
representative electrostatic potential (+5kT/e in blue and –5kT/e per electron in red).

90

Figure 3.7: Electrostatic surface of RNases with the two model substrates at 310 K. Enzyme
conformation from the MD ensemble closest to the averaged structure for the entire trajectory
(conformation with smallest RMSD with averaged structure) was used to calculate the
representative electrostatic potential (+5kT/e in blue and –5kT/e per electron in red).
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A comparison of the total van der Waals (Evdw) and electrostatic (Eel) energies summed up for the
enzyme-substrate complexes provide a number of interesting observations (Table 3.4). Even
though the nucleotide substrates are highly charged molecules (particularly the backbone
phosphate), the largest contribution to the favorable interactions comes from van der Waals
interactions, indicating that the active-site residues have preferential interactions with the bases.
These quantitative estimates provide additional insights, indicating that bRNaseA possibly has a
slight preference for substrate AUAU relative to ACAC, as Etotal is lower by 3-5 kcal/mol. In the
case of human enzymes, hRNase1 has a better interaction with ACAC at higher temperature
(Etotal is lower by ~ 9 kcal/mol); hRNase4, RNase5, RNase6 and RNase7 show a preference for
ACAC substrate at 300 K, with Etotal lower more than 10 kcal/mol; hRNase3 prefers AUAU at 310
K (Etotal is lower by almost 9 kcal/mol); while hRNase2 has similar interactions with both
substrates. An interesting observation is that hRNase5 and hRNase7, particularly for substrate
AUAU, show very weak interactions compared to all the other enzymes in this study. The reason
appears to be weak (and even repulsive for hRNase7) electrostatic interactions seen for the
AUAU model substrate at 300 K. These quantitative estimates are consistent with the
observations that the substrate is ejected midway during the simulations (note the energies were
calculated, and averaged, only for conformations where substrates were bound to the enzymes).
In the cases of hRNase5 and hRNase7, this observation possibly indicates that active-site
residues other than the conserved catalytic triad may not be optimal for the enzyme-substrate
interactions (see Figure 3.8 and 3.9, and discussion above). However, as indicated by the H-bond
analysis with bound substrate, the non-catalytic residues appear to make modest interactions in
these two enzyme systems, a different behavior from other enzymes investigated in this study.
Therefore, the binding preference and stable interactions in these two systems may be related to
non-catalytic residues. This behavior is very different than other enzyme systems such as human
cyclophilin A, E. coli dihydrofolate reductase and horse liver alcohol dehydrogenase where the
catalytic residues make the strongest interactions with the substrate.291-293
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Figure 3.8: Enzyme-substrate interaction energy at 300 K. Total interaction energy was
computed as a summation of electrostatic and van der Waals interaction energy between atom
pairs of enzyme residue and substrate nucleotide (ACAC and AUAU, respectively). The areas of
largest negative energy (blue) represent favorable interactions, while positive energy (red)
represents less favorable or unfavorable interactions. For ease of comparison, sequence of the
model substrate has been adjusted to match the orientation depicted in Figure 3.2 and Figure 3.4
(CACA and UAUA). Enzyme residues showing total interaction energy (Etotal) contributions < -3
kcal/mol were considered significant and are marked with ellipses. (See Table 3.5 in Appendix
3.7 for individual Etotal of selected residues)
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Figure 3.9: Enzyme-substrate interaction energy at 310 K Total interaction energy was
computed as a summation of electrostatic and van der Waals interaction energy between atom
pairs of enzyme residue and substrate nucleotide (ACAC and AUAU, respectively). The areas of
largest negative energy (blue) represent favorable interactions, while positive energy (red)
represents less favorable or unfavorable interactions. For ease of comparison, sequence of the
model substrate has been adjusted to match the orientation depicted in Figure 3.3 and Figure 3.5
(CACA and UAUA). Enzyme residues showing total interaction energy (Etotal) contributions < -3
kcal/mol were considered significant and are marked with ellipses. (See Table 3.6 in Appendix
3.8 for individual Etotal of selected residues)
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Table 3.4: Averaged total interaction energy between nucleotide substrates and RNases.
The total interaction energy (Etotal) was computed as a sum of van der Waals (Evdw) and
electrostatics (Eel) energy, averaged over 2,000 snapshots (see Methods for details). Difference
>5 kcal/mol in Etotal is considered significant for preference of substrate ACAC and AUAU binding
to the same RNase; such cases are underlined. Note that the case of bRNaseA-ACAC at 300 K
is close to this criterion (5.1 kcal/mol) but is not marked. The repulsive Evdw observed in case of
hRNase7-AUAU at 310 K is marked in bold.
ACAC

bRNaseA
hRNase1
hRNase2
hRNase3
hRNase4
hRNase5
hRNase6
hRNase7

Evdw

300 K
Eel
Etotal

Evdw

310 K
Eel
Etotal

-62.7

-34.4

-97.1

-59.1

-30.0

-89.1

-64.8

-36.2

-101.0

-69.0

-39.5

-64.1
-60.5

-44.0

-108.1

-59.4

-51.9

-112.3

-51.9

-70.4

-45.6

-116.0

-63.7

-36.6

-77.0
-59.3

AUAU

Evdw

300 K
Eel
Etotal

Evdw

310 K
Eel
Etotal

-66.6

-35.5

-102.2

-61.4

-30.7

-92.1

-108.5

-65.5

-35.9

-101.4

-64.1

-35.3

-99.4

-45.6

-105.0

-69.0

-36.3

-105.2

-69.9

-36.2

-106.1

-50.3

-102.2

-68.9

-43.1

-111.9

-56.7

-55.1

-111.8

-66.9

-41.1

-108.1

-68.5

-34.4

-102.9

-69.9

-37.2

-107.1

-100.3

-55.9

-32.8

-88.7

-39.9

-8.4

-48.3

-51.9

-30.0

-81.8

-39.8

-116.8

-79.4

-41.5

-120.9

-66.2

-38.1

-104.3

-74.8

-38.9

-113.7

-41.9

-101.2

-66.7

-47.8

-114.5

-31.2

11.3

-19.9

-67.9

-42.7

-110.5
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3.4.E Dynamical characterization of the enzyme-substrate complexes
The conformational flexibility (or intrinsic dynamics) of the RNases in presence of the two model
substrates was quantified using quasi-harmonic analysis (QHA) of the snapshots sampled during
the MD simulations. The aggregated root means square fluctuation of top 10 slowest QHA modes
(RMSF10) provides a good measure of a protein’s conformational flexibility. Such an analysis has
been successfully used for relating dynamics to function for a number of other proteins.284, 294
Figure 3.10 depicts the RMSF10 for the 8 enzymes when bound to the two model substrates, as
well as enzymes without substrate (apo) at 300 K. The corresponding results from 310 K
simulations are shown in Figure 3.11. Results indicate that the most significant differences occur
in the loop regions, similar to apo enzyme systems, as recently reported.267 For RNases, and
other enzymes, it is widely reported that motions of surface loops play important roles in function
through various steps in the catalytic cycle.138, 210
The dynamical characterization at 300 K indicates distinct differences in RNases flexibility upon
ligand binding. The intrinsic dynamics of bRNaseA is very similar for the substrate-bound and the
apo forms with the largest fluctuations observed for residues of loop L1 (residues 13-21). Note
that bRNaseA has the highest catalytic activity among these 8 enzymes, and the long-range
dynamics of loop L1 was previously shown to play a functional role in enzyme activity.

138, 252

hRNase1 showed overall reduction in fluctuations upon binding of the two substrates with
additional reduction in fluctuations of loop L1 (residues 13-21) observed in the AUAU-bound state.
The truncated loop L1 in hRNase2, hRNase3, hRNase6 and hRNase7 displayed diminished
dynamics in these enzymes relative to bRNaseA. The large fluctuations in L4 (residues 58-71 for
both enzymes) observed in the apo forms of hRNase2 and hRNase3 were diminished upon
binding of the two substrates. Further, hRNase3 showed reduced conformational motions of L2
(residues 35-40) and L4 upon binding of the two substrates while loop 6 (residues 85-94)
displayed enhanced motions upon binding of AUAU. hRNase4 showed significant reduction in
the dynamical profile throughout the protein upon binding of the two substrates, consistent with
similar changes in the conformational exchange patterns observed experimentally (data not
shown). hRNase5 showed modest changes near L6 (residue 85-94) upon substrate binding. In
the case of hRNase6, large fluctuations observed in L4 (residues 58-68) in the apo state were
diminished upon binding of the two substrates. Further, the dynamics observed in loop L7
(residues 109-119) in the apo and AUAU-bound states was diminished in the ACAC-bound state.
hRNase7 showed larger fluctuations upon binding of the two substrates in L7 (residues 109-119)
while the reduced dynamics upon substrates binding was observed in L4 (residues 58-68). In
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comparison to fluctuations observed at 300 K, the dynamical profiles at 310 K (Figure 3.11)
displayed minor differences in the fluctuations of loops of hRNase2, hRNase3 and hRNase4 for
the two substrates. However, in the case of hRNase7, about a 2-fold increase in fluctuations are
observed in loop L4 when bound to substrate ACAC, while the fluctuations in loop L7 are
decreased for substrate AUAU at the higher temperature.
In a joint NMR-computational study of the RNase superfamily, we recently reported that the
intrinsic dynamics of apo proteins is similar for members within phylogenetic sub-families that
share common biological activities and different between sub-families.267 Comparison of intrinsic
dynamics when the two different substrates are bound also provides some unique insights.
Comparison of members within phylogenetic sub-families showed different dynamical properties
upon binding of the two substrates. For example, AUAU binding led to reduced flexibility of L1 in
hRNase1 relative to the apo state, while this change was not observed in bRNase1 at both 300
K and 310 K. Similarly, a comparison of hRNase2 and hRNase3, which belong to the same
phylogenetic sub-family, suggests that while regions displaying large fluctuations are similar,
there are notable differences in the changes in the dynamical profiles upon substrate binding
between the two enzymes. These observations are consistent with recent studies which showed
distinctly different effects of ligand binding for members within phylogenetic sub-families.295
However, further investigations are required, as the current work cannot fully rule out whether the
observed changes in loop motions help in differentiating binding of substrates or are simply a
result of substrate binding.
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Figure 3.10: Dynamical behavior of RNases bound to model substrates at 300 K. In the left
panel, for each enzyme-substrate [ACAC (red), AUAU (blue), and apo (black)], the flexibility of Cα
atoms of each residue calculated from the slowest 10 quasi-harmonic modes (RMSF10) is shown
as a function of enzyme residue numbering. Secondary structures [alpha-helix (α), beta sheets
(β) and loops (L)] are identified (top); the important loop regions are highlighted in gray. On the
right side, RMSF10 are projected on cartoon representations of each enzyme, with flexible loop
regions identified. The thickness of the cartoon tube corresponds to the amplitude of RMSF10,
and the color corresponds to the dynamic range observed: least dynamic (0 Å, blue) to most
dynamic (5 Å, red). These fluctuations are on the same scale, allowing direct comparison between
different enzymes and substrates. For clarity, fluctuations in the terminal regions are removed
(bRNase 1-2; hRNase1 1-2 and 126-127; hRNase2 134-135; hRNase3 1-3; hRNase4 1-3;
hRNase5 1-3 and 121-123; hRNase6 1-4; hRNase7 1-4) from the cartoon representation.
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Figure 3.11: Dynamical behavior of RNases bound to model substrates at 310 K. In the left
panel, for each enzyme-substrate [ACAC (red), and AUAU (blue), the flexibility of Cα atoms of
each residue calculated from the slowest 10 quasi-harmonic modes (RMSF10) is shown as a
function of enzyme residue numbering. Secondary structures [alpha-helix (α), beta sheets (β) and
loops (L)] are identified (top); the important loop regions are highlighted in gray. On the right side,
RMSF10 are projected on cartoon representations of each enzyme, with flexible loop regions
identified. The thickness of the cartoon tube corresponds to the amplitude of RMSF10, and the
color corresponds to the dynamic range observed: least dynamic (0 Å, blue) to most dynamic (5
Å, red). These fluctuations are on the same scale, allowing direct comparison between different
enzymes and substrates. For clarity, fluctuations in the terminal regions are removed (bRNase 12; hRNase1 1-2 and 125-127; hRNase4 1-3 and 119-120; hRNase5 1-2 and 121-123; hRNase6
1-3 ; hRNase7 1-3) from the cartoon representation.
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3.5 Discussion
Ribonucleases are a superfamily of enzymes that catalyze the endonucleolytic cleavage of RNA
substrates. The eight canonical human pancreatic-type RNases, identified in the initial
sequencing of the human genome, perform distinct biological functions such as antipathogenicity, angiogenesis and host defense, among others.16, 211, 252 In addition, they also share
the common chemical function of ribonucleolytic activity of RNA substrates of non-specific
nucleotide sequences. The human RNases investigated so far also display a diverse range of
substrate specificities and catalytic efficiencies.252 While numerous studies have characterized
the nucleotide substrate binding properties, rate kinetics and efficiencies of human RNases, these
studies were performed by different research groups with diverse substrates under various
experimental conditions. Other studies also attempted to characterize the nucleotide preference
based on available crystal structures.9 Unfortunately, these comparisons also suffer the same
limitations due to different substrates and varying conditions. These differences prevent a direct
comparison of the nucleotide specificities across hRNases, which in turn limits our current
understanding of the underlying mechanism for the observed nucleotide specificities as well as
the detailed mechanism of biological and chemical function of these enzymes.
Characterizing the nucleotide binding properties of RNases with the same substrate(s) under
identical conditions would provide a benchmark for comparison of members of this superfamily.
This in turn would provide a framework for the systematic identification of structural and energetic
contributions in the enzyme function. In this study, computer simulations and detailed analysis
were used for characterization of human RNases 1-7 and bovine RNase A to probe the nucleotide
binding properties in the presence of two model substrates – ACAC and AUAU. Differences in
structural stability and hydrogen bonding interactions were characterized (Figure 3.2-3.5, and
Tables 3.2, 3.3). Further, the interaction energies between enzyme residues and substrate
nucleotide pairs were calculated (as sum of van der Waals and electrostatics energy, see Figure
3.8, 3.9 and Table 3.4). The results indicate that both AUAU and ACAC substrates stay either in
or close to the binding pocket for most enzymes on the microsecond time-scale (Table 3.1).
hRNase5 and hRNase7, however, show the weakest interactions with substrate AUAU. In one of
the two alternate trajectories, the substrate was ejected from the binding pockets of these two
enzymes, consistent with weaker binding affinities

. Note that we consider the set of two

146

alternative trajectories as a representation of the expected behavior. A large set of
alternate/longer trajectories (for each enzyme-substrate complex) will provide better quantitative
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estimates of how often the substrate is ejected out of the pocket; however, we expect the results
presented here will be qualitatively similar to the results from the bigger set of trajectories.
Detailed description of model substrates ACAC and AUAU interactions with bRNaseA and
hRNase1-7 are provided in supporting information text. Our results indicate that while all RNases
used in this work share the conserved active-site catalytic triad (two histidine residues and one
lysine), subtle changes in the binding site result in distinct binding interactions for the two
substrates. Interestingly, the non-catalytic active-site residues show the strongest H-bonding
interactions with the substrates. However, when the detailed interaction energies are calculated,
some of these residues do not show the most favorable interactions; instead, the catalytic triad
shows the most favorable interaction energy. One possible interpretation of these results is that
rigid interactions are required between the enzymes and the substrates for stability. However, the
interactions with the catalytic triad may need to be flexible for mechanistic aspects. In other words,
strong H-bonds between the substrate nucleotides and non-catalytic active-site residues holds
the substrate in place, while the catalytic residues with most favorable interactions need to be
non-rigid. This is consistent with a number of previous reports, whereby dynamics of several
conserved catalytic residues play an important role in the mechanism of bovine RNase A.138, 216,
252

The results reported here require further comparison with experiments to confirm these

observations.
Substrate preferences of bRNaseA and several human RNases were reported previously using
a variety of RNA substrates.9, 211, 254 A comparison of the H-bonding properties of the different
RNases with the two model substrates AUAU and ACAC in this work suggest that bRNaseA and
hRNase1 show similar H-bonding interactions with the two substrates. Interestingly, the Hbonding occupancy for hRNase2 and hRNase3 is significantly lower, consistent with the lower
binding affinities and catalytic rates of these enzymes relative to bRNaseA at 300 K and 310 K.
Interestingly, hRNase3 shows no interactions with the substrate ACAC at 310 K, suggesting a
lower preference for this substrate. Similar results are observed for hRNase4 at 310 K, which
shows a significant increase in H-bonding occupancy for AUAU while a reduction in the
occupancy is observed for ACAC-bound state. These observations for hRNase3 and hRNase4 at
310 K are consistent with the substrate preference reported for these enzymes.211, 254 Our results
further highlight the significant differences in the observed substrate binding properties of the
different RNases between 300 K and 310 K. These observations suggest the importance of
selecting temperatures for experimental and computational characterization of conformational
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properties and enzyme-substrate interactions that are representative of physiological conditions.
As summarized in Table 1.2 in Chapter 1, the majority of previous studies have been conducted
at room temperature (298 K).
Overall, the results of this study show that all the 8 investigated RNase family members have
conserved active-sites residues; however, there is not a uniform preference of a substrate across
all of these enzymes. The difference in substrate preferences observed in this study are broadly
consistent with previous observations using a variety of RNase substrates. While our results
provide structural and energy-based insights that form the basis for this preference for the
different pyrimidine bases, it is not clear how this relates to the diverse biological functions of
these RNases. Further investigations are required to gain insights into sequence dependence on
designated biological functions of host-defense (antibacterial and antiviral), angiogenesis and
RNA cleavage.

3.6 Summary of observations for each RNases investigated in this
study
bRNaseA: Both the substrates ACAC and AUAU show stable binding in the active-site on the
microsecond time-scale. The substrates show strong H-bond interactions with residues Thr45,
Asp71, and Phe120. In addition, Gln11 shows H-bond interaction with substrate AUAU. The
dynamical motions of the enzyme are similar in the case of two substrates, exhibiting highest
flexibility in loops L1 and L6. The electrostatic surface of the bRNaseA is mostly positively charged
but shows slight differences in the case of ACAC and AUAU, which appear to be an anomaly for
the set of proteins investigated in this study. The residue Lys7, Val43, Thr45, Lys66, His119, and
Phe120 show large favorable van der Waals and electrostatic interactions with these substrates.
While the dynamical behavior at the temperatures 300 K and 310 K are qualitatively similar for
both substrates, the overall strength of the favorable enzyme-substrate interactions increase at
higher temperature (corresponding to more negative energy in Table 3.4); however, the number
of H-bond interactions with substrate AUAU are reduced at 310 K.
hRNase1: Similar to the case on bRNaseA, the two substrates ACAC and AUAU show stable
binding in the active-site of hRNase1 on the microsecond time-scale. However, the substrate
ACAC forms strong H-bond interactions only with Thr45, while AUAU is observed to form strong
H-bonds with Thr45, Asn71 and Phe120. The electrostatic surface of hRNase1 is mostly positively
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charged and very similar in the case of both substrates. Residues Arg4, Val43, Thr45, Lys66,
His119 and Phe120 show the most favorable van der Waals and electrostatic interactions with
both substrates. The dynamical motions of the enzyme are very similar in the case of two
substrates, with large flexibility in loop L1; however, this loop shows higher flexibility when bound
to ACAC than AUAU. An increase in number of H-bonds and their occupancies is observed at
higher temperature (310 K) for both substrates investigated. The electrostatic and van der Waals
interactions are more favorable for substrate ACAC and less favorable for substrate AUAU at the
higher temperature investigated. The dynamical behavior at the temperatures 300 K and 310 K
are similar in presence of both substrates.
hRNase2: Substrate AUAU shows stable binding in the hRNase2 active site at both
temperatures, while the substrate ACAC shows stable binding only at 300 K. However, strong
hydrogen bonds are observed with residues Gln15 and Thr43 in both cases. hRNase2 has mostly
positively electrostatic surface when bound to both substrates as well. The van der Waals and
electrostatic interactions show that residues Lys39, Gln41, Thr43 and His130 make the largest
favorable contributions to interaction energy with both substrates. The dynamical motions of the
enzyme are observed to be very similar for the two substrates, with high flexibility in loops L4, L6
and L7. The dynamical behavior is mostly similar at the two temperatures, except for loop L7
where increased fluctuations are observed with substrate AUAU at 310 K. The H-bond
occupancies with substrate ACAC is reduced at 310 K as compared to simulations at 300 K. The
interactions for substrate ACAC are weakened at higher temperature while it remains the same
for AUAU at both temperatures.
hRNase3: Both the substrates ACAC and AUAU show significantly less stability in the active-site
of hRNase3 on the microsecond time-scale as compared to the other members of the family
investigated in this study. Only residue Asn71 (and Thr133 for AUAU) shows hydrogen bonding
interactions with the substrates. Much like other RNases, the electrostatic surface of the hRNase3
shows the presence of mostly positively charged residues and is also similar in the case of both
substrates investigated. Residues Lys39 and His129 make the largest contribution to van der
Waals and electrostatic interaction energy. The protein dynamics is very similar for the two
substrates, with largest flexibility in loops L2, L4 and L6; however, loop L6 has higher fluctuation
when bound to AUAU than ACAC. At 310 K, no strong H-bonds are observed with substrate
ACAC and the interactions become less favorable; however, the H-bond occupancies for
substrate AUAU are considerably reduced, and the overall interaction energy remains the same.
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Dynamics of the enzyme remains the same for most regions at the two temperatures for both
substrates.
hRNase4: On the microsecond time-scale, both substrates are mostly stable in the active-site of
hRNase4. Substrate ACAC forms strong hydrogen bonds with residues Thr45, Asn71, His117
and Phe118; while substrate AUAU forms hydrogen bonds only with Thr45 and Phe118. The
electrostatic surface of hRNase4 is also mostly positively charged and similar in the case of both
substrates. His117 and Phe118 are the largest contributors to van der Waals and electrostatic
interaction energy with the two substrates. Lys8, Lys41 and Thr45 also make large contributions
towards electrostatic and van der Waals interaction energy for both substrates. The dynamical
motions are observed to be very similar for the two substrates. While the dynamical behavior is
similar at the two temperatures, considerable difference is observed in H-bond occupancies. At
higher temperature, the number of H-bonds with substrate ACAC is reduced significantly,
whereas an increase is observed in the H-bonds and their occupancies with substrate AUAU,
consistent with decrease in the interaction energy (less negative value in Table 3.4) in case of
ACAC but increase in the case of AUAU. Further, these observations are consistent with the
preference of the uridine nucleotide in the B1 sub-site reported previously for hRNase4 9.
hRNase5: For hRNase5, substrate ACAC is more stable in the active-site than the substrate
AUAU on the microsecond time-scale. In one of the trajectories investigated, the substrate AUAU
is completely ejected out of the active-site. This behavior is different than other hRNases (except
for hRNase7, as discussed below), where either both or one central nucleotide of the substrate
stays bound in the active-site. This is also indicated by the observation that substrate ACAC forms
strong hydrogen bonds with Thr44 and His114, while no hydrogen bonds are observed between
substrate AUAU and the enzyme. Much like other RNases in this study, the electrostatic surface
of hRNase5 is also mostly positively charged. Residues Lys40 and His140 make the largest
contribution to van der Waals and electrostatic interaction energy. The dynamical motions are
observed to be very similar for the two substrates with flexibility in loops L1, L2 and L6 when
bound to both substrates. The dynamical behavior at two temperatures 300 K and 310 K is similar.
At the higher temperature, H-bonds are formed with substrate AUAU, contrary to the observations
at 300 K. Additionally, an increase in the favorable interaction is observed, while in the case of
substrate ACAC, diminished interactions are observed.

108

hRNase6: Both the substrates ACAC and AUAU are stable in the hRNase6 active-site on the
microsecond time-scale. Residue Gln15, Asn69 and Trp11 form strong hydrogen bonds with
substrate ACAC, while substrate AUAU shows strong hydrogen bonding with Asn65, Arg67 and
Asn69. The electrostatic surface of hRNase6 is mostly positively charged and similar in the case
of both substrates. The van der Waals and electrostatic interactions show that His123 and Leu124
make the largest favorable contributions to interaction energy in case of both substrates.
Additionally, large contributions are also observed form residues Asn65, Arg67 and Asn69 in
presence of both substrates. The dynamical motions are very similar for the two substrates,
except for loop L7 that shows higher fluctuations when bound to AUAU than ACAC. The
dynamical behavior and hydrogen bond occupancies are alike at the two temperatures, while the
favorable interactions become more pronounced at higher temperature for both substrates.
hRNase7: The substrates ACAC and AUAU are less stable in interacting with the active-site of
hRNase7, forming only one strong hydrogen bond with Thr43 and Leu125, respectively. Similar
to the case of hRNase7, in one of the trajectories investigated, substrate AUAU is completely
ejected out of the active-site. The electrostatic surface of hRNase7 appears more positively
charged when substrate ACAC is bound when compared to AUAU. Residues Lys39 and His124
make the largest contribution to van der Waals and electrostatic interaction energy. The enzyme
dynamics is observed to be different for the two substrates with hRNase7: loop L2 and L7 show
higher fluctuations when bound to ACAC; while loop L6 shows higher fluctuations when bound to
AUAU. The overall dynamics of hRNase7 at two temperatures 300 K and 310 K is observed to
be similar, except for loop L4 that shows higher fluctuation when substrate ACAC is bound.
However, considerable change is observed in H-bond patterns at the two temperatures
investigated. At higher temperature, more H-bonds with higher occupancies are formed with
substrate ACAC, while no strong H-bonds are formed with substrate AUAU. Also, considerable
increase in the favorable interaction energy is observed for both substrates at 310 K.
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3.7 Appendix
Table 3.5: Residues showing significant favorable interactions with the substrates at 300
K. An interaction is considered as significant if the enzyme-nucleotide pair with interaction energy
< -3 kcal/mol of Etotal. Results for central two nucleotides and terminal nucleotides are shown
separately. The enzyme residues are listed in the order of decreasing energy of interaction with
the nucleotide making the favorable interaction is listed after value.
center
nucleotides
(ACAC)
His119 (-10.9, A;
-4.0, C)
Thr45 (-4.6, C)
Phe120 (-4.5, C)
Val43 (-4.4, C)
Lys7 (-4.1, A)
Lys66 (-4.1, C)
Asn44 (-3.4, C)
His119 (-11.3, A;
-3.7, C)
Arg4 (-4.6, A)
Lys66 (-4.5, C)
Thr45 (-4.5, C)
Val43 (-4.1, C)
Phe120 (-4.1, C)

terminal
nucleotides
(ACAC)
Pro42 (-4.3, A)
Val43 (-3.0, A)
Lys7 (-3.3, C)

center
nucleotides
(AUAU)
His119 (-14.5, A)
Phe120 (-5.1, U)
Val43 (-4.7, U)
Lys7 (-3.5, A)
Lys41 (-3.4,U)
Thr45 (-3.3, U)

terminal
nucleotides
(AUAU)
Pro42 (-3.9, A)
Val43 (-3.3, A)

Pro42 (-4.4, A)
Val43 (-3.2, A)

Pro42 (-4.5, A)
Val43 (-3.2, A)
Lys7 (-3.6 ,U)

hRNase2

His130 (-11.5, A)
Lys39 (-7.5, C;
-4.3, A)
Gln41 (-5.3, C)
Thr43 (-4.3, C)
Asn42 (-3.7, C)
Arg69 (-3.0, A)

Arg133 (-4.3, A)

hRNase3

His129 (-11.0, A;
-3.2, C)
Lys39 (-5.2, C;
-4.1, A)

Arg2 (-7.8, C)
Met1 (-6.7, C)
Gln41 (-3.2, A)
Arg35 (-3.2, C)

His119 (-11.6, A;
-3.5, U)
Lys66 (-4.8, U)
Phe120 (-4.5,U)
Arg4 (-3.9, A)
Val43 (-3.9, U)
Lys7 (-3.7, A)
Asn71 (-3.7, A)
Thr45 (-3.4, U)
Asn44 (-3.0, U)
His130 (-10.0, A)
Lys39 (-5.9, U; 4.7 A)
Gln41 (-4.9, U)
Leu131 (-3.8, U)
Trp8 (-3.4, A)
Arg133 (-3.1, U)
Thr43 (-3.1, U)
His129 (-11.8, A;
-3.8, U)
Leu130 (-5.4, U)
Lys39 (-4.7,U)

hRNase4

His117 (-15.4, A;
-7.0, C)
Phe118 (-6.0, C)
Lys41 (-5.7, C)
Arg8 (-3.9, A)
Lys66 (-3.4, C)
Thr45 (-3.1, C)

Phe43 (-5.6, A)

bRNaseA

hRNase1
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His117 (-12.3, A; 3.6, U)
Phe118 (-6.2, U)
Phe43 (-4.4, U)
Lys41 (-3.9, U)
Arg8 (-3.8, A)
Thr45 (-3.6, U)

Arg133 (-3.8, A)
Arg37 (-3.2, U)
Gln41 (-3.0, A)

Met1 (-6.5, U)
Thr133 (-3.7, A)
Gln41 (-3.7, A)
Arg2 (-3.1, U)
Phe43 (-6.3, A)
Arg8 (-4.4, U)
Arg42 (-3.5, A)

Table 3.5 continued

hRNase5

hRNase6

hRNase7

center
nucleotides
(ACAC)
His114 (-14.4, A;
-4.6, C)
Lys40 (-5.8, C)
Gln117 (-5.2, C)
Leu115 (-4.0, C)
Thr44 (-3.8, C)
Arg121 (-3.2, C)
His123 (-9.8, A;
-5.4, C)
Lys8 (-6.2, A)
Lys39 (-5.5, C)
Leu124 (-5.3, C)
Trp11 (-4.0, A)
Asn69 (-3.4, A)
His16 (-3.2, C)
Arg67 (-3.2, A)
Asn65 (-3.0, A)
Gln15 (-3.0, C)
His124 (-7.9, A)
Thr43 (-4.2, C)
Lys39 (-4.0, C)
Asn42 (-3.8, C)
Leu41 (-3.8, C)

terminal
nucleotides
(ACAC)
Arg5 (-6.6, C)
His8 (-3.4, C)

center
nucleotides
(AUAU)
His114 (-11.7, A; 3.2, U)
Lys40 (-5.3, U)

terminal
nucleotides
(AUAU)
Arg5 (-7.2, U)

Arg5 (-4.8, C)
Lys8 (-4.6, C)
Gln41 (-4.1, A)

His123 (-11.5, A;
-5.2, U)
Lys64 (-5.0, U)
Lue124 (-4.6, U)
Asn69 (-3.7, A)
Asn65 (-3.6, A)
Arg67 (-3.3, A)

Arg67 (-3.9, U)
Lys8 (-3.5, U)
Gln41 (-3.5, A)

Leu41 (-5.7, A)
Arg37 (-3.9, C)
Met1 (-3.4, C)

His124 (-4.2, A)

Met1 (-3.2, U)
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Table 3.6: Residues showing significant favorable interactions with the substrates at 310
K. An interaction is considered as significant if the enzyme-nucleotide pair with interaction energy
< -3 kcal/mol of Etotal. Results for central two nucleotides and terminal nucleotides are shown
separately. The enzyme residues are listed in the order of decreasing energy of interaction with
the nucleotide making the favorable interaction is listed after value.

bRNaseA

hRNase1

hRNase2

hRNase3

hRNase4

center
nucleotides
(ACAC)
His119 (-10.2, A;
-4.0, C)
Thr45 (-4.4, C)
Phe120 (-4.2, C)
Lys66 (-4.1, C)
Val43 (-4.0, C)
Lys7 (-3.9, A)
Asn44 (-3.1, C)
His119 (-11.5, A;
-4.2, C)
Lys66 (-5.1, C)
Thr45 (-4.5, C)
Phe120 (-4.4, C)
Val43 (-4.4, C)
Arg4 (-4.3, A)

terminal
nucleotides
(ACAC)
Pro42 (-3.3, A)

center
nucleotides
(AUAU)
His119 (-11.1, A;
-4.0, U)
Phe120 (-5.2, U)
Lys66 (-4.5, U)
Val43 (-3.8, U)
Thr45 (-3.3, U)
Asn71 (-3.1, A)

terminal
nucleotides
(AUAU)

Pro42 (-4.4, A)
Val43 (-3.3, A)

Pro42 (-4.5, A)
Lys7 (-3.1, U)
Val43 (-3.1, A)

His130 (-8.3, A;
-5.7, C)
Lys39 (-6.1, C;
-4.1, A)
Met1 (-3.3, A)
Gln41 (-3.1, C)
His129 (-9.8, A)
Arg35 (-6.6, C)
Arg8 (-5.4, A)
Lys39 (-4.8, C)
Met1 (-4.4, A;
-4.1, C)
Arg2 (-4.0, A)
His117 (-10.0, A;
-4.9, C)
Lys41 (-6.2; C;
-3.5, A)
Phe118 (-5.7, C)
Arg8 (-5.6, A)
Thr45 (-3.2, C)
Lys66 (-3.2, C)

Asn40 (-3.02, C)

His119 (-11.6, A;
-3.5, U)
Lys66 (-5.3, U)
Val43 (-4.0, U)
Phe120 (-3.9, U)
Lys41 (-3.4, U)
Thr45 (-3.4, U)
Arg4 (-3.4, A)
Asn71 (-3.1, A)
His130 (-11.9, A)
Lys39 (-5.5, U;
-4.4, A)
Arg133 (-4.8, U)
Gln41 (-4.4, U)

Arg69 (-4.1, U)
Arg133 (-4.4, A)
Gln41 (-3.2, A)

Met1 (-4.78, C)

His129 (-9.3, A;
-3.7, U)
Lys39 (-4.9, U;
-3.6, A)
Met1 (-3.9, U;
-3.3, A)

Arg2 (-4.4, U)
Arg35 (-3.5, U)

Phe43 (-6.8, A)
Arg8 (-4.4, C)

His117 (-11.8, A;
-4.4, U)
Phe118 (-6.5, U)
Arg8 (-4.3, A)
Lys41 (-4.2, U;
-3.7, A)
Phe43 (-4.2, U)
Thr45 (-3.5, U)

Phe43 (-5.9, A)
Arg8 (-3.9, U)
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Table 3.6 continued

hRNase5

hRNase6

hRNase7

center
nucleotides
(ACAC)
His114 (-7.0, A;
-4.2, C)
Lys40 (-6.6, C)
Thr44 (-4.3, C)
Ile42 (-4.0, C)
Leu115 (-3.6, C)
Phe120 (-3.8, C)
Asn43 (-3.5, C)
His123 (-9.2, A; 4.5, C)
Lys39 (-6.6, C)
Lys8 (-6.6, A)
Leu124 (-4.5, C)
Trp11 (-4.1, A)
Thr43 (-3.8, C)
Asn69 (-3.6, A)
Arg67 (-3.4, A)
Gln15 (-3.3, C)
Asn65 (-3.1, A)
His124 (-9.2, A;
-4.0, C)
Lys39 (-5.5, C)
Thr43 (-4.4, C)
Leu125 (-4.2, C)
Leu 41 (-3.5, C)
Asn 42 (-3.2, C)

terminal
nucleotides
(ACAC)
Arg5 (-4.5, C)

Arg5 (-6.4, C)
Gln41 (-3.5, A)
Lys8 (-3.4, C)

Met1 (-4.6, C)
Leu41 (-4.7, A)
Arg37 (-3.6, C)
Lys2 (-3.9, C)
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center
nucleotides
(AUAU)
Gln117 (-6.8, U)
His114 (-6.7, A;
-6.5, U)
Arg5 (-4.8, A)
Leu115 (-4.2, U)
Lys40 (-3.6, U)
His13 (-3.5, U)
Asn43 (-3.2, U)
His123 (-10.9, A;
-5.3, U)
Leu124 (-5.3, U)
Lys8 (-4.1, A)
Lys64 (-4.0, U)
Asn69 (-3.7, A)
Asn65 (-3.4, A)
Arg67 (-3.4, A)
Thr43 (-3.0, U)

terminal
nucleotides
(AUAU)
Arg121 (-3.1, A)

His124 (-7.3, A;
-3.8, U)
Met1 (-4.7, A)
Lys64 (-3.9, U)
Lys39 (-3.7, U)
Leu125 (-3.2, U)

Trp11 (-4.0,U)
Met1 (-4.0, U)
Leu41 (-3.5, A)

Gln41 (-3.9, A)

Figure 3.12: Important H-bond behavior over time for bRNaseA-substrate complexes.
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the
distance range used for defining H-bonds.
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Figure 3.13: Important H-bond behavior over time for hRNase1-substrate complexes.
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the
distance range used for defining H-bonds.

115

Figure 3.14: Important H-bond behavior over time for hRNase2-substrate complexes.
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the
distance range used for defining H-bonds.
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Figure 3.15: Important H-bond behavior over time for hRNase3-substrate complexes.
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the
distance range used for defining H-bonds.
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Figure 3.16: Important H-bond behavior over time for hRNase4-substrate complexes.
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the
distance range used for defining H-bonds.
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Figure 3.17: Important H-bond behavior over time for hRNase5-substrate complexes.
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the
distance range used for defining H-bonds.
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Figure 3.18: Important H-bond behavior over time for hRNase6-substrate complexes.
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the
distance range used for defining H-bonds.
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Figure 3.19: Important H-bond behavior over time for hRNase7-substrate complexes.
Results from ACAC are shown on top, and from AUAC complex on the bottom. The two alternate
trajectories are marked as (1) and (2) for two temperatures 300 K and 310 K. Red lines mark the
distance range used for defining H-bonds.
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Conformational Sub-states Associated with
Product Release in Ribonucleases
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4.1 Abstract
Conformational fluctuations between different sub-states with unique configurations allow
enzymes to efficiently catalyze reactions with high turnover. However, establishing a direct link
between protein motions and enzymatic function remains challenging. The structural basis of RNA
hydrolysis has been extensively studied in bovine ribonuclease A (bRNaseA), and product release
is the suggested rate-limited step. However, conformational motions that affect the turnover rate
have received relatively little attention for bovine, as well as human ribonucleases
(hRNases). This work identifies conformational sub-states and conformational fluctuations that
play a role in product release step in hRNases and bRNaseA. Conformations collected from
molecular dynamics simulations with umbrella sampling were analyzed using higher order
statistical clustering method; this method, quasi anharmonic analysis, allows identification of
conformational sub-states. The results revealed the existence of functionally relevant
conformational sub-sates in product release step of these closely related enzymes. Enzyme
residues that interact with cleaved RNA products were also identified. Conformational fluctuations
were observed in distal regions away from the reactive center of the enzymes. Residues in these
regions have previously been reported to experience perturbations during

N-CPMG relaxation

15

dispersion experiments, which correspond to the time-scale of RNase function.

4.2 Introduction
Members of the ribonuclease (RNase) superfamily catalyze the hydrolysis of ribonucleic acid
(RNA). Bovine ribonuclease A (bRNaseA), which is the prototype of the family, is one of the most
widely studied enzyme. In recent years, interest in human members of the RNase superfamily
has increased due to their reported clinical importance and increasing therapeutic applications.15
A number of studies have focused on the intracellular localization, tissue distribution and
biological role of human RNases (hRNases).4, 8, 26, 52 Studies have also focused on the structurefunction relationship in these enzymes.72, 296 However, the wide range of catalytic efficiencies
found in hRNases cannot be explained in terms of structure alone.8 Enzymes are intrinsically
dynamic, and conformational motions in enzymes are known to play an essential role in their
function.297-299 The role of dynamics in the catalytic cycle of hRNases has not yet been explored
in detail. Understanding functionally relevant dynamics in hRNases is will open new avenues for
therapeutic interventions in these enzymes.
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Enzymes undergo a wide range of motion in terms of space and time. The time-scales of motion
in enzymes range from picoseconds to seconds (ps - s).300 The faster atomic fluctuations occur
on the ps time-scales. Motions in enzyme backbone and amino acid side chains are observed in
the picoseconds to nanoseconds (ps - ns) time-scales. Conformational rearrangements of loops
and domains occur on the milliseconds to seconds (ms - s) time-scale.128, 301 Any of these motions
can be functionally significant and directly related to catalysis.299,

300

These motions promote

catalysis by allowing the enzymes to overcome the activation barrier and reach its active form.
The time-scale of catalytically important motion is dependent on the enzyme. Correlation between
the time-scale of conformational fluctuation and catalytic turnover has been established for a
number of enzyme systems including bRNaseA.128, 136, 137, 140, 302, 303
The rate of conformational exchange has been shown to correlate with the rate limiting step,
product release, in bRNaseA.136,

140

The structure of bRNaseA is well-studied by both

homonuclear solution NMR and X-ray crystallography7. The mechanism of RNA cleavage by
RNases has been extensively studied by both experimental and theoretical approaches,7, 85 which
suggest that microsecond to millisecond (µs - ms) motions occur throughout the bRNaseA
enzyme, including fluctuations in the active site residues.136, 267 The rate of conformational kinetics
measured in NMR spin relaxation experiments (average kex = 1600 s-1) is similar to the enzyme
turnover rate (kcat = 1900 ± 130 s-1).136 Note, that the NMR experiments were performed in the apo
state. Additionally, NMR line shape analysis of titrations of product analogue (3′-CMP) into
bRNaseA yields a dissociation constant (koff) of ∼1200 s−1 suggesting that product release (koff) is

the rate-limiting step in bRNaseA .138 It was further implicated that the motion of loop 1 enables

efficient release of product, and disrupting these motions results in 10-fold decrease in the product
release rate.138,
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These evidences presents a clear connection between enzyme motions,

catalytic turnover and product release in bRNaseA.
Dynamical fluctuations occurring over a wide range of time-scales allow enzymes to sample a
wide variety of distinct conformations (also called as conformational sub-states).129, 304 These
conformational sub states are sometimes rarely populated, high energy states that can contain
functionally important features.122 Conformational transitions between low energy ground states
to higher energy sub-states are vital for the events occurring in an enzyme’s reaction pathway;
substrate recognition and binding, the chemical step and product release.204, 305 Conformational
fluctuations that govern the catalytic mechanism in enzyme systems like DHFR,306 CypA,204 HIVprotease,302 and DNA polymerase307 have been identified. Interestingly in these systems,
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conformational fluctuations in distal regions (sometimes more than 10 Å away from the active site)
modulate the rate-limiting step. Note that the rate-limiting step is not same for all enzymes, for
example the rate limiting-step in CypA is the catalytic step, while in DHFR product release is ratelimiting.
Conformational fluctuations are essential for enzyme function, and therefore characterizing the
conformational sub-states in the rate limiting step is of paramount importance to understanding
of the role dynamics in enzyme function. A deeper understanding the conformational motions in
each step of reaction process of hydrolysis of RNA by these enzymes is essential for the rational
design of novel therapies toward diseases associated with RNase action. Chapter 3 demonstrates
the occurrence of conformational motions in the substrate bound form of RNases. Nevertheless,
detailed characterization of conformational change coupled to the product release in these
enzymes remains unknown. Very few studies have focused on the release of nucleotide products
in bRNaseA, and to the best our knowledge none for human RNases. Note, that the rate-limiting
step in hRNases is still unknown. Therefore, this study is focused on understanding how the
protein conformations and dynamical properties evolve during product release; what are the key
residues involved; and whether these motions and residues involved in product release are
conserved in members of this diverse superfamily.
Studies from chapter 2 report that members of the RNase superfamily can be classified into subfamilies based on their primary sequence and intrinsic dynamics, and the biological function of
the members within a sub-family is same308. To characterize the role of dynamics in function of
individual sub-family, it is required to determine the conformational sub-states in at least one
representative member in each family. Comparative analysis of conformational dynamics
associated with product release in each sub-family will aid in understanding the role of dynamics
in the function of the entire RNases superfamily. The select RNases in this study include hRNase3
from the EAR-like sub-family, hRNase5 from the Angiogenin sub-family and bRNaseA from the
RNase A-like sub-family. Conformational sub-sates in these enzymes occurring during product
release are characterized using quasi anharmonic analysis (QAA)129, a higher order statistical
method, with conformations obtained from umbrella sampling molecular dynamics simulations.
Conformational transitions associated with product release provide insights into the existence of
separate sub-states sampled by these closely related enzymes.
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4.3 Materials and methods
Modeling enzyme-product(s) complexes: The cleaved nucleotide products (Figure 4.1) were
modeled into the active site of two human ribonucleases, hRNase3 (PDB ID: 1QMT270) and
hRNase5 (PDB ID: 1ANG309), as well as the active site of bRNaseA (PDB ID: 7RSA274). The
coordinates for the phosphate and ribose sugar backbone for the products were adopted from the
DNA ligand in the crystal structure of bRNaseA (PDB id 1RCN).276 The nucleotide bases of the
substrate were modified to match the desired nucleotide using AMBER’s310 xleap modeling and
preparation module. The parameters for both protein residues and RNA products were obtained
from AMBER’s ff14SB force-field.311
Histidine protonation states: The two catalytic histidine residues, His12 and His119 (bRNaseA
numbering), were modeled in single and double protonated states respectively in all three
RNases. The protonation states for these residues were determined based on pH profiles for
bRNaseA,282 as well as structural interaction with the modeled substrates and products.85 All the
other histidine residues were modeled in the single protonated state for all three RNases.
Umbrella sampling simulations: All modeled complexes were neutralized with the addition of
chloride (Cl-) counterions and subsequently solvated in a SPC/E 277 water box with 15 Å distance
between the edges on all sides of the protein and the water box. Periodic boundary conditions
were applied, and the solvated complexes were equilibrated using a previously described
protocol.312, 313 To monitor the release of product from the active site of RNases, the distance
between the geometric center of mass (COM) of the side chain of three catalytic residues (two
histidine residues and one lysine residue) and COM of each of the products were increased from
4 Å up to 18 Å (Figure 4.2 & 4.3). Ten ns of distance restrained simulations were performed to
increase the distance between the two COMs in 1 Å increments and generate starting points for
15 windows. This increase in the distance between the two COMs is referred to as the reaction
coordinate of the product release pathway. Conformations in each window along the reaction
coordinate were sampled for a total of 70 ns with an appropriate biasing harmonic potential to
ensure a reasonable overlap for all windows. Distance restraints were applied between the two
COMs and a 2 femtoseconds (fs) time-step was used. All hydrogen atoms involved in bonds were
constrained with the SHAKE
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algorithm. All simulations were performed at 300 K using

AMBER’s pmemd.sander simulation engine.314 Time-averaged distance restraints between the
two COMs were saved after every 10 steps. In each window, for each of the unique RNase-
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product(s) complex, 3500 structures (20 picoseconds apart) were saved and analyzed for
structural effects and conformational dynamics as described below.
Analysis: To obtain an accurate description of the conformational dynamics associated with the
product release process, continuous sampling along the reaction coordinate is required. To
ensure a reasonable overlap for all windows along the reaction coordinate, the distribution
probability of all the time-averaged distance restraints values between the two COMs were binned
into histograms. Using xmgrace315 plotting too histograms were binned from 3 – 20 Å into 1000
bins. Additionally, to ensure that the enzyme samples reasonable conformations in all windows
along the reaction coordinate, the root mean square deviation (RMSD), referenced to the first
structure of first window (4 Å) in the reaction coordinate, were computed for all trajectories.
RMSDs were computed from the simulation trajectories using AMBER’s cpptraj program.
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Simulation trajectories where the RMSD was beyond 4 Å were repeated until the sampled
conformations had RMSD below the cutoff. Hydrogen atoms were excluded in the RMSD
calculations.
Hydrogen bond interactions: Hydrogen bond (H-bond) interactions between the RNases and
the product nucleotides were computed using AMBER’s cpptraj program. H-bonds with bond
length less than 3.3 Å for the donor to acceptor heavy atom distance at an angle between 135°
and 180° between the donor-hydrogen-acceptor were considered for analysis. The percentage
occupancies of H-bonds, defined as a fraction (percentage) of the total number of structures
where the interaction meets the H-bond criterion mentioned above, were also calculated.
Hydrophobic interactions: Hydrophobic interactions between the substrate and backbone
atoms of hydrophobic residues glycine, alanine, valine, leucine, isoleucine, proline,
phenylalanine, methionine, tryptophan, and tyrosine were computed using AMBER’s cpptraj
program. A distance cutoff of 4.5 Å was used. Hydrophobic interactions that were present in more
than 50% of all simulation snapshots were considered for analysis.
Potential of mean force along the reaction coordinate: To remove the biasing due to harmonic
restraints in the umbrella sampling, the potential of mean force (PMF) was computed using the
weighted histogram analysis method (WHAM). The weighted histogram calculation was
performed from 4 - 20 Å with 1000 bins. All calculation were performed at 300 K. WHAM version
2.0.9 was used for the analysis.317
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Figure 4.1: Schematic representation of ribonuclease reaction. Tetranucleotide RNA
substrate (AUAU) is shown on right and cleaved products are shown on left. A- Adenine, U –
Uracil, 5’ A - 5’ Adenine, 3’ U - 3’ Uracil, U-p - Uracil with phosphate group.
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Figure 4.2: Representation of geometric center of mass (COM) of catalytic residues and
products. Enzyme ribonuclease is shown as a gray ribbon, while the catalytic triad residues are
shown as sticks; COM of catalytic residues are represented in cyan sphere. The two products
obtained after cleavage of tetranucleotide substrate are shown as sticks, and their respective
COMs are shown as cyan spheres. 5’ A - 5’ Adenine, 3’ U - 3’ Uracil, U-p - Uracil with phosphate
group.
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Figure 4.3: Schematics of product release umbrella sampling simulations. Enzyme
ribonuclease (RNase) is represent as a pink sphere, the catalytic triad is represented as a green
sphere, the cleaved products are represented as blue rectangles and the center of mass (COM)
of catalytic triad and products are represented as cyan spheres. Dotted arrows represent the
distance between the COM of product(s) and catalytic triad, and the corresponding distance is
labelled.
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Intrinsic dynamics along the reaction coordinate: The simulation trajectories from 15 windows
along the reaction coordinate were group into three categories; the first includes simulation
trajectories from windows 4 Å to 8 Å, i.e. when the products are in the near vicinity of the
catalytic triad residues. The second includes simulation trajectories from windows 9 Å to 13 Å,
when the products are on the surface of the protein, but not in direct contact with the catalytic
triad residues. And third is when the products are in the bulk solvent (14 – 18 Å), making no
direct contact with the enzyme. The fluctuations of Cα atoms for all residues were computed to
analyze the intrinsic dynamics profile for each of the three categories. An aggregate of root mean
square fluctuation (RMSF) of the top 10 (RMSF10) quasi-harmonic analysis (QHA) modes were
used in the analysis to focus on the principal dynamics. The magnitude of displacement
eigenmodes of QHA were computed using AMBER’s cpptraj program.
Conformational sub-states using quasi-anharmonic analysis (QAA): The 52,500
conformational snapshots obtained from the umbrella sampling simulations were used for QAA.129
The original 3N dimensional space for the Cα atoms was projected onto 100 - dimensional space
using QHA modes and then analyzed using QAA. This method provides an exploration of a nonequilibrium process as compared to the equilibrium state that is explored in free MD. Using a
mixture of gaussian modes three clusters representing various regions of the reaction coordinate
were identified. The three QAA-independent component vectors were analyzed in detail to
characterize the conformational sub-states associated with the release of products in each of the
three RNases studies. Note that the protein Cα atom positions were used for this analysis.

4.4 Results
4.4.A Evaluating the conformational coverage of umbrella sampling simulations
Umbrella sampling simulations along the reaction coordinate pertaining to product release were
performed for hRNase3, hRNase5 and bRNaseA. Conformations obtained from the simulation
trajectories were binned into histograms to ensure continuous sampling along the reaction
coordinate. Histogram binning was based on the distance between the COMs of the catalytic triad
and the nucleotide bases of the product(s). In general, all binned histograms followed a gaussian
distribution for both products of all three enzymes (Figure 4.4). For hRNase3 and bRNaseA, the
histogram binning show overlap in adjacent windows, indicating continuous and ample sampling
of the reaction coordinate. In hRNase5, for product 1 there is a gap between the histograms
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around 8 Å, indicating that additional sampling is required. The sampling for other areas of the
hRNase5 reaction coordinate falls within the acceptable limits.
To ensure that the force constants and restraints applied in the umbrella sampling simulations do
not render the enzyme structure unphysical, RMSD with reference to the first structure of the first
window (4 Å) were computed for individual trajectories (Figure 4.5) of all the windows along the
reaction coordinate. For all three RNases the maximum RMSD for the conformations sampled in
the trajectory was less than 4 Å. A visual inspection of equally space conformations from the
simulation trajectories ensured that each of the three enzymes adopts its near-native structure.
The cysteine residues continued to form disulfide bonds during all simulations maintaining the
signature kidney shape fold of these enzymes.

4.4.B Computational Analysis of enzyme-product interactions
To quantitatively characterize the non-bonded interactions of product nucleotides with the enzyme
residues along the reaction coordinate, H-bond and hydrophobic interactions were calculated for
all conformations of the umbrella sampling simulations. The average distance between heavy
atoms of the enzyme and product nucleotide, and the percentage occupancy of the H-bonds along
the reaction coordinate were calculated (Table 4.1). Weak interactions of the product nucleotides
with hydrophobic amino acids are reported in Table 4.2. These H-bond and hydrophobic
interactions have been reported to increase the binding between protein and ligands, be essential
for full activity of enzymes and be an important aspect of rational design of potential drugs.318-322
Thus, product nucleotides must overcome these interactions to completely release themselves
from the enzyme after catalysis.
The results indicate occurrence of more H-bonds in all three enzymes when the products are in
the near vicinity of the catalytic triad (4 - 8 Å). Most of the residues listed in Table 4.1 in the 4 - 8
Å trajectories were reported to strongly interact with the substrate nucleotides (Chapter 3, Table
3.2). As seen in Chapter 3, the substrate nucleotides strongly interacted with the residues of their
respective sub-sites (B1 and B2) for all three enzymes. These interactions remain conserved until
the products are in the near vicinity of the catalytic triad. In other words, same interactions are
present for the substrate and products, until the products leave the near vicinity of the catalytic
triad. The B1 sub-site residues Thr44 (for hRNase5) and Thr45 (for bRNaseA) and the B2 sub-site
residue Asn71 (for hRNase3 and bRNaseA) strongly interact with over 50% occupancy with the
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Figure 4.4: Overlap of histograms between umbrella sampling windows. To ensure a
reasonable overlap for all windows along the reaction coordinate (4 -18 Å of COM spacing), the
distribution probability of all the time-averaged distance restraints values between the two COMs
were binned into histograms. Using xmgrace plotting tool histograms were binned from 3 – 20 Å
into 1000 bins. The histograms follow a gaussian distribution.
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Figure 4.5: Root men square deviation of protein structures along the reaction coordinate.
The RMSD of the protein atoms (excluding hydrogens) with respect to the first structure of the
first window (4 Å). Plots are shown for hRNase3 (red), hRNase5 (blue) and bRNaseA (black).

products residues. The catalytic residue His129 (hRNase3), His114(hRNase5) and His119
(bRNaseA) form strong H-bonds when the product nucleotides are close to the active site. Note
that this observation is contradictory to our observation of the substrate bound state where the
catalytic triad residues do not form strong H-bonds with the substrate nucleotide. Therefore, upon
hydrolysis of the phosphodiester bond, the catalytic histidine residue interacts with the newly
formed product.
When the product nucleotides move along the reaction coordinate, 9 - 13 Å away from the COM
of the catalytic triad, they interact with the surface of the enzyme. At this point along the reaction
coordinate, H-bonds between the products and most residues of the active site and the binding
sub-sites (B1 and B2) are lost for all three RNases. In hRNase3, product nucleotides form new
interactions with resides Arg2, Arg8 (N terminal helix) and Arg35. In hRnase5, one of the
nucleotide products interacts with C-terminal residues Phe120 and Arg121. These residues are
away from the catalytic triad, on the surface of enzyme, suggesting possible interaction of the
product nucleotide with other regions of the enzyme before they are completely dissociated and
released in the bulk solvent. Such interactions are not observed for bRNaseA. Table 4.2 reports
a number of hydrophobic interactions for hRNase3 and bRNaseA when the products are in near
vicinity of the catalytic triad and on the surface of the enzyme further along the reaction
134

coordination. Comparatively, the extent of hydrophobic interactions is lesser for hRNase5. Finally,
when the product nucleotides are more than 13 Å away on the reaction coordinate they do not
form any H-bonds or hydrophobic contacts with the enzyme residues suggesting that they are
completely released from the enzyme into the bulk solvent.

4.4.C Conformational dynamics associated product release
The conformational dynamics of RNases during the product release were quantified by QHA of
the conformations obtained from the umbrella sampling simulations along the reaction coordinate.
RMSF10 , the aggregate root means square fluctuation of the top 10 slowest QHA modes, provides
a good measure of a protein’s conformational flexibility.284, 294 RMSF10 was computed for all the
three categories of the reaction coordinate; when the products are in near vicinity of the catalytic
triad (4 - 8 Å), when the products are on/near the surface of the enzyme (9 -13 Å), and when the
products are in bulk solvent making no contact with the enzyme (14 -18 Å). The RMSF10 profiles
of the product release simulations indicate that the most significant differences in dynamics occur
in the loop regions of RNases (Figure 4.6), similar to the apo and substrate bound studies
(Chapters 2 and 3).
The dynamical characterization along the reaction coordinate indicates distinct differences in
flexibility of the three RNases during product release. Difference in flexibility along the reaction
coordinate is also observed for hRNase3, hRNase5 and bRNaseA. Specifically, in hRNase3, loop
L4 (residues 58-71) has higher fluctuations when the products are in the near vicinity (4 - 8 Å), of
the catalytic triad. As the products move away (9Å and beyond) from the catalytic triad along the
reaction coordinate, dynamics in L4 decrease considerably. Dynamical fluctuations in L4 is
considerably lower in hRNase5 and bRNaseA for all three categories of the reaction coordinate.
In hRNase5, loops L1, L4 and L6 show fluctuations of equal magnitude throughout the reaction
coordinate. In bRNaseA, loop L1 (residues 13-21) exhibits considerably higher fluctuations when
the products are in the near vicinity of the catalytic triad. Motions in L1 subside when the products
move away from the catalytic triad. Loop L1 of bRNaseA has been shown to affect product
dissociation, and thereby modulate the catalytic efficiency.138 Loop L1 displays considerably lower
fluctuations in hRNase5 while it is truncated in hRNase3. For all the three enzymes, fluctuations
in the other loop regions remain constant while the product is moving along the reaction
coordinate.
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Table 4.1: H-bonding interaction of pancreatic-type RNases with product nucleotides. The H-bonds that meet the criteria of 3.3
Å, angle between 135 - 180° and more than 45% occupancy are listed. P1 - product 1; P2 - product 2; A5’ - 5’ adenine nucleotide; U3’
- 3’ uracil nucleotide; U-p - Uracil nucleotide with the cleaved phosphate group (refer to Figure 4.2)
hRNase3

hRNase5

RC
(Å)

Residue

Product
Nucleotide

Bond Length
(%
occupancy)

4

Gln15 (Nε2)

U3’ (OP1) (P2)

2.82 (59.83)

5

6

7

8
9
10

Val128 (O)
Arg2 (N)

His129 (Nδ1)
Asn71 (Oδ1)
Leu130 (O)

A5’ (O5') (P2)
U3’ (OP1) (P2)

A5’ (O5') (P2)
A5’ (N6) (P2)
U-p (N3) (P1)

2.69 (72.14)
2.84 (55.51)

bRNaseA

Residue

Product
Nucleotide

Gln117 (Nε2)
His114 (N)
His114 (Nδ1)

U-p (OP1) (P1)
U3’ (OP2) (P2)
U3’ (OP2) (P2)

Bond Length
(%
occupancy)
2.82 (72.06)
2.82 (63.86)
2.76 (60.51)

Thr44 (N)

U-p (O2) (P1)

2.85 (63.71)

Thr44 (N)

U-p (O2) (P1)

Residue

Product
Nucleotide

Bond Length
(%
occupancy)

Asn71 (Oδ1)

A5’ (N6) (P2)

2.88 (52.17)

2.86 (59.34)

Gln11 (Nε2)
Thr45 (Oγ1)
His119 (Nδ1)
Asn71 (Nδ2)
Asn71 (Oδ1)

U-p (ON3)
(P1)
U-p (N3) (P1)
U-p (ON2)
(P1)
A5’ (N1) (P2)
A5’ (N6) (P2)
U-p (O2) (P1)
U-p (ON2)
(P1)
A5’ (O5') (P2)
U-p (ON3)
(P1)
U-p (N3) (P1)
A5’ (N6) (P2)

2.80 (85.60)
2.87 (60.51)
2.78 (57.31)
2.90 (54.23)
2.87 (52.17)

2.86 (55.77)
2.85 (55.37)
2.85 (50.29)

Gln117 (Nε2)

U-p (OP2) (P1)

2.83 (55.06)

Thr45 (N)
His119 (Nδ1)
Val118 (O)
Gln11 (Nε2)
Thr45 (Oγ1)
Asn71 (Oδ1)

Leu115 (N)
Thr44 (N)
Leu115 (O)
Gln117 (Nε2)

U-p (O4) (P1)
U-p (O2) (P1)
A5’ (N6) (P2)
U-p (OP2) (P1)

2.82 (86.40)
2.84 (79.91)
2.85 (71.00)
2.84 (65.46)

Asn71 (Oδ1)

A5’ (N6) (P2)

2.87 (54.43)

His114 (Nε2)

U3’ (OP1) (P2)

2.78 (56.51)
Asn71 (Nδ2)

A5’ (N1) (P2)

2.90 (57.86)

Asn71 (Oδ1)

A5’ (N6) (P2)

2.86 (59.66)

Arg35 (Nε)
Arg35 (NH2)
Arg2 (Nε)
Arg2 (NH2)
Arg8 (Nε)

U-p (ON3) (P1)
U-p (ON1) (P1)
U3’ (OP2) (P2)
U3’ (OP1) (P2)
U3’ (OP1) (P2)

2.81 (70.89)
2.80 (67.77)
2.79 (80.31)
2.82 (74.17)
2.84 (63.66)

RC: Reaction Coordinate
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2.85 (51.66)
2.76 (70.14)
2.68 (62.89)
2.83 (61.91)
2.86 (59.83)
2.86 (56.14)

Table 4.1 continued
RC
(Å)

11

12

13
14 18

hRNase3
Residue

Product
Nucleotide

Arg2 (Nε)
Arg8 (Nε)
Arg2 (NH2)
Arg35 (NH2)
Arg35 (NH1)
Asn40 (N)
Arg2 (Nε)
Arg2 (NH2)
Arg8 (Nε)
Arg35 (NH2)
Arg35 (NH1)
Arg2 (NH2)
Arg2 (Nε)

U3’ (OP2) (P2)
U3’ (OP1) (P2)
U3’ (OP1) (P2)
U-p (ON2) (P1)
U-p (OP2) (P1)
U-p (OP1) (P1)
U3’ (OP2) (P2)
U3’ (OP1) (P2)
U3’ (OP1) (P2)
U-p (ON3) (P1)
U-p (O2) (P1)
U3’ (OP1) (P2)
U3’ (OP1) (P2)

hRNase5
Bond Length
(%
occupancy)
2.79 (87.91)
2.82 (81.60)
2.81 (77.23)
2.75 (69.23)
2.79 (61.57)
2.85 (51.71)
2.80 (78.43)
2.80 (78.00)
2.83 (57.94)
2.78 (85.46)
2.82 (77.26)
2.79 (53.63)
2.81 (53.31)

bRNaseA

Residue

Product
Nucleotide

Bond Length
(%
occupancy)

Leu115 (N)

U-p (O4) (P1)

2.87 (58.20)

Phe120 (O)
Arg121 (Nε)

U-p (N3) (P1)
U-p (ON2) (P1)

2.84 (60.34)
2.81 (52.97)

No Bonds

RC: Reaction Coordinate
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Residue

Product
Nucleotide

Bond Length
(%
occupancy)

Asn71 (Nδ2)

A5’ (N1) (P2)

2.89 (57.57)

Table 4.2: Interaction of product nucleotides with hydrophobic amino acids. Contacts less
than 4.5 Å with hydrophobic residues are listed. P1 - product 1; P2 - product 2; A5’ - 5’ adenine
nucleotide; U3’ - 3’ uracil nucleotide; U-p - Uracil nucleotide with the cleaved phosphate group
(see Figure 4.2)
Reaction
Coordinate
(Å)

hRNase3
Residue

Products

Trp11
Phe12
Leu130
Met1
Trp11

U3’ (P2)
A5’ (P2)
A5’ (P2)
U3’ (P2)
U3’ (P2)

6

Met1
Trp11
Phe12
Val128

7

8

4
5

hRNase5
Residue

Products

Residue

Products

Ile42
Leu115

U-p (P1)
U-p (P1)/ A5’(P2)

Ile42
Leu115

U-p (P1)
U-p (P1)

Val43
Val118
Phe120

U-p (P1)
A5’ (P2)
U-p (P1)

Phe8

A5’ (P2)

U3’ (P2)
A5’ (P2)/U3’(P2)
A5’ (P2)
A5’ (P2)

Ile42

U-p (P1)

Met1
Val128

U3’(P2)/U-p(P1)
A5’ (P2)

Ile42
Leu115
Phe120

U-p (P1)
U-p (P1)
U-p (P1)

Met1
Leu69
Val128

U-p(P1)/U3’(P2)
A5’ (P2)
A5’ (P2)

Ile42
Leu69
Ala106
Leu115

U-p (P1)
A5’ (P2)
A5’ (P2)
U-p (P1)

Met1
Leu69
Met1
Leu69

U-p (P1)
A5’ (P2)
U3’ (P2)
A5’ (P2)

Ile42
Leu115

U-p (P1)
U-p (P1)

Met1

U3’ (P2)

Ala4
Pro42
Val118
Phe120
Ala122
Ala4
Val43
Phe120
Ala122
Ala4
Pro42
Ala109
Val118
Pro42
Ala109
Val118
Ala109
Val118
Ala109
Val118
Ala4
Ala109
Val118
Val118

A5’ (P2)
A5’ (P1)
A5’ (P2)
U-p (P1)
U-p (P1)
U3’ (P2)
A5’ (P1)
U-p (P1)
U-p (P1)
U3’ (P2)
U-p (P1)
A5’ (P2)
A5’ (P2)
U-p (P1)
A5’ (P2)
A5’ (P2)
A5’ (P2)
A5’ (P2)
A5’ (P2)
A5’ (P2)
A5’ (P2)
A5’ (P2)
A5’ (P2)
A5’ (P2)

9
10
11
12
13
14 - 18

bRNaseA

No Bonds
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Figure 4.6: Conformational dynamics along the reaction coordinate. The conformational
flexibility of the Cα atoms of each residue is obtained from the aggregate root mean square
fluctuations from the top 10 modes (RMSF10). The 2D plots represent the RMSF10 as a function
of enzyme residues. The important loop regions are highlighted in pink. RMSF10 are also projected
on cartoon representations of each enzyme, with flexible loop regions identified. The thickness of
the cartoon tube corresponds to the amplitude of RMSF10, and the color corresponds to the
dynamic range observed: least dynamic (blue) to most dynamic (red).
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4.4.D Conformational sub-states associated with product release
QAA was employed to obtain insights into the conformational sub-states associated with the
release of products in the members of RNase superfamily. The original 3N-dimensional space for
the Cα atoms of 52,500 conformations obtained from the umbrella sampling simulations along the
reaction coordinate were projected onto 100-dimensional space using QHA modes for QAA.
Using a mixture of gaussian modes, three clusters representing the three categories of reaction
coordinate (mentioned above) were identified from QAA (Figure 4.7). Interestingly, these clusters
identified using QAA contain homogenous populations of conformational sub-states. Motion
involved in product release along the reaction coordinate are illustrated in wireframe, showing
only the Cα trace of the enzyme residues, and colored according to their respective sub-states.
QAA applied to umbrella sampling simulations along the reaction coordinate of product release
for the three RNases reveal the existence of distinct sub-states for these closely related enzymes.
Moreover, the conformational sub-states also differ among the reaction coordinate for the three
RNases studied here. In the modes, when the products are in near vicinity of the catalytic triad
(blue conformations in Fig 4.7), large dynamical fluctuations are observed in loop L4 of hRNase3
and in loop L1 of bRNaseA. However, motions in these loops subside in other modes along the
reaction coordinate for both hRNase3 and bRNaseA. There were no particular region showing
motions with large change in amplitude in hRNase5.

4.4.E Potential of Mean Force (PMF)
The free energy profile of product(s) release along the reaction coordinate was calculated using
WHAM and is represented in Figure 4.8. For all three enzymes studied here the free energy profile
is different for both products. Energy difference between the release of two products is 2 folds for
hRNase3 and 3 folds for hRNase5 and bRNaseA. Also, there is a difference of ~ 4 kcal/mol in the
release of product 1 (Figures 4.1 and 4.2) from bRNaseA and hRNase5. The free energy for
release of product 1 increases along the reaction coordinate (7 Å - 18 Å) for hRNase5, suggesting
that additional energy is required to drive release of product 1 and the process is less likely to be
spontaneous. On the other hand, there is a decrease in the free energy for release product 1 in
bRNaseA, suggesting that product 1 suggesting that release of this product is more spontaneous
in bRNaseA as compared to hRNase5. The free energy for release of product 2 decreases for
both hRnase3 and hRNase5. However, this observation also contrary for bRNaseA where the
free energy for release of product 2 increases (7 Å - 18 Å). These observations suggest that the
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Figure 4.7: Conformational sub-states associated with release of products in
ribonucleases. Higher order statistical clustering of conformations sampled in the molecular
dynamics trajectories is shown in the box plots above. Each dot corresponds to a single
conformation and is colored according to the reaction coordinate (see color bar). The ellipses
represent conformational sub-states identified along the reaction coordinate. The black arrows
indicate transitions from heterogenous population to a well-defined homogenous sub-state. 𝛾𝛾
represents anharmonic modes identified by QAA and the subscripts denotes the rank of the QAA

vector. Motions along the anharmonic mode (𝛾𝛾) are illustrated in the panels below in a wire frame
representation, showing only the C⍺ trace of the protein and color coded according to the reaction
coordinate.
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Figure 4.8: Free energy profile of product release. The potential for mean force along the
reaction coordinate was constructed using WHAM. The free energy profile for product 1 is shown
in solid lines and for product 2 is shown in dotted lines. Results are shown for hRNase3 (red),
hRNase5 (blue) and bRNaseA (black).

energetics of product(s) release is different for hRNases when compared to bRNaseA. Note,
when the product(s) are in the bulk solvent (> 14 Å) away from the catalytic residues, they are
free to diffuse in the simulation box. However due to limited size of the simulation box the product
nucleotides stay close to the enzyme surface. This can certainly affect the shape of the PMF.
It is reported that a decrease of 1.37 kcal/mol in activation energy results in 10 fold improvement
in the rate constant.323 The free energy of product release for hRNase5 is 4.5 kcal/mol more than
bRNaseA (Figure 4.8). Suggesting a ~104 folds difference in the activation energy between these
two enzymes. This observation corresponds with the 105 folds difference in catalytic efficiency
between bRNaseA and hRNase5, with bRNaseA being the faster enzyme. However, whether this
difference in the catalytic efficiency is due to difference in activation energy required for product
release step needs further experimental validation
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4.5 Discussion
Enzymes are not rigid structures but sample an ensemble of conformations driven by internal
motions occurring over a wide range of length and time-scales. The role of these conformational
fluctuations in enzyme catalysis has been recognized, and in some cases even considered vital
for the designated function.324, 325 Experimental characterization of conformations sampled by
enzymes provide information only on a narrow time-scale window, with low a probability of finding
functionally relevant conformational sub-states.326 Computer simulations, enhanced sampling
techniques and higher order statistical methods have enabled the identification of functionally
important conformational fluctuations and sub-states over a wide range of time-scales.129
In this study, we observed that there were strong non-bonded interactions between the products
and the residues lining the active site. When the product nucleotides are in the near vicinity of the
catalytic triad (4 - 8 Å), the enzyme residues of all three RNases (Tables 4.1 and 4.2) strongly
interacts with the cleaved products. As the product nucleotides move 9 - 13 Å away from the
catalytic triad, the number of residues interacting with the product nucleotides decrease
substantially. Further down the reaction coordinate (beyond 13 Å), the product nucleotide
overcomes these strong interactions to completely release themselves into the bulk solvent. Many
of these residues have been previously identified as part of networks of amino acid residues that
show conformational exchange upon binding of single nucleotides in these RNases.146,

327

However, mutagenesis studies and further experiments are necessary to gain insights into the
individual contribution of these residues to the catalytic turnover of select RNases.
In hRNase3, the product nucleotides interact with the residues on the surface of enzyme, away
from the catalytic triad, suggesting possible interaction of the product nucleotide with other regions
of the enzyme before they are completely dissociated and released in the bulk solvent. However,
such interactions in distal regions are not observed for bRNaseA, suggesting that distal residues
on the surface of this faster enzymes do not interact with the cleaved products post catalysis.
This study characterizes the internal dynamics in the product release step of three RNases. The
RMSF10 profiles indicate that the most significant differences in dynamics occur in the loop regions
for these RNases (Figure 4.6). This further implies that loop regions, which are energetically more
favorable to movements within a protein structure, play a major role in catalysis.328 However, for
each RNases studied here different loops show fluctuations with higher amplitude, indicating a
143

marked difference in the conformational dynamics of product release in RNases. Long range
effects in RNases have also been identified to modulate ligand binding, and these effects were
also distinct for individual RNases.139, 146, 327 As seen in chapter 2, the three RNases studied here
belong to different phylogenetic sub-family with unique function, distinctness in their
conformational motions suggests that the even closely related RNases are uniquely adapted to
their respective functions. These observations are also consistent with previous studies which
show that enzymes/proteins sharing common fold can also have diverse functions and
dynamics.285, 329
This study further characterizes the conformational sub-states and motions associated with the
product release step in RNase family members, using atomistic umbrella sampling molecular
dynamics simulations and QAA. QAA has been used to study the conformational sub-states and
conformational fluctuation for a number of protein systems 129, 284, 330 and the motions identified by
QAA are intrinsic property of each protein studied. The results from this study indicate the
presence of separate conformational sub-states in the three RNases studies here (Figure 4.7). In
these sub-states, loops L4 of hRNase3 and L1 of bRNaseA, show fluctuations with high
amplitude, suggesting a potential role of these loops in product release. It is also interesting to
note that the conformational dynamics in product release are significantly different for members
of the individual phylogenetic sub-family. Further, conformational exchange probed by 15N-CPMG
relaxation dispersion experiments on the micro-millisecond time-scale were compared to the
conformational fluctuations observed in the product release step from QAA (Figure 4.9). The
residues of the functionally important loops, L4 in hRNase3 and L1 in bRNaseA, that show
conformational fluctuations in product release simulations also undergo conformational exchange
in

N-CPMG experiments of apo protein. This observation supports the suggestion that free
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protein can samples conformations that resemble the ligand bound conformations.285, 331
Overall this study identified structural and dynamical features important product release in RNase
family members. Modulating the dynamical fluctuations identified here, can help fine-tuning the
conformational landscape of these enzymes to favor efficient catalysis. Subsequent experimental
effort will be required to bring home the points raised by this computational study and to prove
that modulating internal dynamics in these enzymes can greatly enhance their catalytic
efficiencies. Apart from modulating enzyme function, insights gained form this work will have
implications in the design of novel inhibitors and modulators of RNase function in the context of
neurotoxicity, angiogenesis and anti-pathogenicity.332 This study further demonstrated that the
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umbrella sampling simulations combined with QAA technique can generate reliable results for the
study of product release in proteins at the atomistic level and can therefore be applied to study
other enzymatic systems.
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Figure 4.9: Comparison of computational conformational sub-states and NMR
conformational exchange. Conformations sampled along reaction coordinate allowed
identification of conformational sub-states (top panel) and transitions into these states (wire
frames) as products move from active sites into bulk solvent. Residues that experience ms
conformational exchange in NMR

15

N-CPMG experiments are shown as spheres. Results are

shown for hRNase3, hRNase5 in comparison with bRNaseA.
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Specialized Techniques to Identify
Conformational Fluctuations Associated with
Enzyme Catalysis
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5.1 Abstract
It is now widely accepted that enzymes are dynamic entities and conformational fluctuations in
enzymes is essential for efficient catalysis. Whether these conformational fluctuations affect
one/all step of the enzymes’ catalytic cycle is still a point of debate. By combining NMR chemical
shift titration experiments with the chemical shift projection analysis (CHESPA) this study
characterizes the dynamics in ribonucleases (RNases) during ligand binding. Results indicate that
members of the hRNase family display discrete chemical shift perturbations upon ligand binding.
The amino acid networks exhibiting long range dynamics upon ligand binding are unique to each
of the RNases analyzed. In addition, steady-state kinetic parameters for RNases was obtained.
The results reveal that catalytic efficiency in the human homologs differs by a more than 105 folds.
Further using hybrid quantum classical simulations (QM/MM) and QAA, conformational sub-states
and dynamics associated with the chemical (RNA cleavage) step of RNase function are identified.
Interestingly the dynamics in bRNaseA during the chemical step were considerably reduced and
the conformational sub-states did not show high amplitude motions even for functionally important
loops. These observations suggest that high amplitude motions in RNase function facilitate the
formation of transition state species while the actual chemical step is a result of reaction-ready
active site configuration.

5.2 Introduction
Enzymes are biological macromolecules that enhance the rate of reaction in a cell by >1020
folds.333 Catalytic cycle of enzymes involves several steps, including substrate recognition and
binding to the active-site, chemical step involving the conversion of substrate to product(s), and
product(s) release. Any of these steps could be the rate-limiting step affecting the overall rate of
catalytic turnover in enzyme function.297, 334 An enzyme progresses through these steps in its
catalytic cycle by the virtue of conformational fluctuation occurring over a wide range of timescales.128 These conformational fluctuations affect structural rearrangement of the ligand binding
site allowing the reactive partners to orient themselves for the catalytic process.335 Evidence from
computational and experimental approaches have revealed the existence of correlation between
rate of catalytic turnover and time-scale of conformational flexibility in a number of enzyme
systems including bovine ribonuclease A (bRNaseA).137, 204, 297, 302, 303
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Members of the RNase enzymes family cleave 3’- 5’ phosphodiester bond in ribonucleic acid
(RNA) substrates.7 In humans, eight functionally important RNases (hRNases 1-8) have been
identified.5, 8 All RNases have a conserved kidney shaped fold, catalytic residues (2 histidine and
one lysine) and possess two-nucleotide base binding sub-sites that interact with the substrate
molecules. A pyrimidine base binds in the B1 sub-site and a purine base binds in the B2 sub-site
of RNases.7, 270 However, they display a wide range of substrate specificities and the catalytic
efficiency in these enzymes differ by a million fold.9, 57, 58, 69, 105, 107, 112, 114, 117 In addition, recent
studies report the existence of diverse biological function in the human members. In humans,
RNases have evolved to perform other biological functions such as host defense,
immunosuppressivity, angiogenesis, and antipathogenic activity.8, 72 The detailed understanding
of factors that contribute to the divergence of function in these structurally related enzymes
remains limited. The existence of distinct dynamic behavior within hRNases (Chapter 2, 3 and 4)
suggest a significant role of dynamics in facilitating their diverse catalytic efficiencies and
biological functions.
Efforts have been made to relate dynamics with ribonucleolytic function in bRNaseA. NMR
experiments reveal the existence of ms time-scale conformational motions in RNases which also
corresponds to the time-scale of catalytic turnover reported for bRNaseA.136 It was further
uncovered that conformational motions in bRNaseA corresponds to the product release step.
Conformational exchange during product release was observed in residues of distal loop.25
Mutating these distal residues not only reduced the global motions in bRNaseA but also
decreased the rate of product release by 10 folds.138, 216 These evidences suggest a possible role
of conformational fluctuations in function of bRNaseA, particularly the product release step.
Whether the motions in distal regions also affect the chemical step of bRNaseA needs to be
examined. Moreover, the effect of dynamics in ligand binding and chemical step of hRNases has
not been characterized in such details. Therefore, several areas where dynamics could potentially
play a promoting role in the function of hRNases and bRNaseA remain unexplored. This study
aims to compare and characterize the structural and conformational changes associated with
ligand binding for select hRNases. Further, this study seeks to address if RNases have specific
motions corresponding to the chemical step in their enzymatic cycle and identify whether these
motions are localized around the active site or occur in the distal regions of the enzyme. And
finally, establish whether motions in ligand binding or catalytic step affect catalytic turnover
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The rate of catalytic turnover in these structurally related RNases varies by a million-fold.9, 57, 58, 69,
105, 107, 112, 114, 117

However, these studies were performed by different groups under different

experimental conditions using a wide variety of substrates ranging from dinucleotide RNA
substrates to tRNA of unknown sequence and lengths. The diversity in the previously used
method for characterizing kinetic rates for RNases rather makes it difficult to comparatively
analyze the difference in the efficiency of these enzyme. For quantitative and relevant
comparisons, it is essential to remove the errors and variations that could be imparted due to
differences in experimental conditions. And therefore, this study systematically characterizes the
kinetic rates in hRNases and bRNaseA under same experimental conditions and with same
dinucleotide substrate (UpA).
In this study, three aspects of RNase function were investigated: Kinetic parameters for various
hRNases were obtained using steady-state kinetics with same substrate (UpA) under identical
conditions; Conformational dynamics induced by ligand binding in the members of the RNase
family were probed by NMR titrations and chemical shift projection analysis (CHESPA);
Conformational dynamics and sub-states associated with phosphor-diester bond cleavage (the
chemical step) were identified using hybrid QM/MM modeling of the reaction pathway and quasi
anharmonic analysis (QAA).

5.3 Materials and methods
Michaelis-Menten steady-state kinetics: The rate of enzymatic reaction is measures over a
range of substrate concentration ([S]). The initial rate V0 increases with the increase in [S].
However, as [S] gets higher, the enzyme becomes saturated with substrate and the initial rate
reaches Vmax, the enzyme's maximum rate. At Vmax, increase in substrate concentration does not
cause any increase in reaction rate as there is no more enzyme (E) available for reacting with
substrate (S). Using the steady-state method kinetic parameters are obtained from the MichaelisMenten equation described below (Eq 5.1). However, the Michaelis-Menten equation is based on
two assumptions; first, the concentration of the substrate-bound enzyme changes much more
slowly than those of the product and substrate and thus the change over time of the complex can
be set to zero. And second, the total enzyme concentration does not change over time.
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Michaelis-Menten equation:

v=

Where

𝑉𝑉𝑚𝑚𝑚𝑚𝑚𝑚 [S]

5.1

𝐾𝐾𝑀𝑀 +[S]

5.2

𝑉𝑉𝑚𝑚𝑚𝑚𝑚𝑚 = 𝑘𝑘𝑐𝑐𝑐𝑐𝑐𝑐 [E]

KM is the Michaelis constant, experimentally defined as the concentration at which the rate of the
enzyme reaction is half Vmax. kcat denotes the maximum number of enzymatic reactions catalyzed
per second also called turnover number.
Steady-state kinetic parameters (kcat and KM) were obtained on a Perkin Elmer Lambda 35 UVvis spectrophotometer. Activity of RNases was measured in 50 mM sodium acetate, 1 mM EDTA
at pH 5.5 and 25°C. Dinucleotide substrate UpA was obtained from Dharmacon at GE Healthcare.
The concentration of UpA was measured using the extinction coefficient 24600 M-1cm-1 supplied
from Dharmacon. Change in UpA absorbance was measured in 1 or 2 mm path length cuvettes
at 286 nm for 10 mins. Enzyme and substrate concentrations used for the study are indicated in
Table 5.1, and all measurements were performed in duplicate. Water was incubated with 1%
DEPC for 1 hr and autoclaved. All equipments were cleaned with DEPC-treated water before
starting the experiment to inhibit the environmental contaminant RNases from interfering with the
kinetic assay. Buffer was made with DEPC treated water as well. The data were fitted to MichaelisMenten equation using sigma plot.

Table 5.1: Enzyme concentrations and range of substrate (UpA) concentrations used in
steady-state kinetics experiments.
Enzyme
bRNaseA
hRNase2
hRNase3
hRNase4
hRNase5
hRNase6

Enzyme
concentration
(µM)
0.002
0.05
1.0
0.05
9.0
0.1
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Range of UpA
concentration
(mM)
0.1 – 1.5
0.0 – 3.0
0.5 – 4.2
0.3 – 2.1
0.8 – 4.0
0.1 – 1.6

NMR chemical shift titrations: NMR chemical shifts of atoms are sensitive to changes in their
chemical environment and are therefore used to detect structural and conformational changes
associated with ligand binding. In this study, NMR chemical shift titration experiments were
performed to compare and characterize the effect ligand binding (two ligands, 3′-UMP and 5′AMP) on the conformational properties of the five RNases, hRNase2, hRNase3, hRNase4,
hRNase5 and bRNaseA. All RNases were expressed and purified in our collaborator Dr. Nicolas
Doucet’s group using the protocols described in

.

138, 142, 146, 327

N-carr-purcell-meiboom-gill
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(CPMG) NMR relaxation experiments and NMR titration experiments were also performed in Dr.
Nicolas Doucet’s group as described in 327.
Chemical shift perturbations (Δδobs): were calculated as the difference in the weighted average
chemical shift of the ligand-bound (5′-AMP and 3′-UMP) and apo states, using the equation below.

(∆δH )2 +(0.2∆δN )2

∆δobs = �

2

5.3

Chemical shift projection analysis (CHESPA): CHESPA was performed based on the protocol
described by Selvaratnam et al.336 The chemical shift perturbations (Δδobs) of the ligand-bound
state relative to the apo state corresponds to the shifts for the highest enzyme: ligand molar ratios
for each enzyme. For all enzymes studied, residues with a chemical shift variation Δδobs > 0.05
ppm were selected for further analysis. The two CHESPA parameters, projection angle (cos(θ))
and fractional shift (X), were calculated according to the equations (5.4 and 5.5 respectively)
below using the 1H and 15N peak coordinates in their free (apo) form and upon binding to the two
mononucleotide ligands, 3′-UMP (vector A) and 5′-AMP (vector B) at saturation conditions (Figure
5.1).
cos(θ) =

Α∙Β
|Α|∙|Β|

5.4

Α∙Β
|Β|2

5.5

X=

The projection angle (θ) is defined as the angle between the chemical shift peak displacements
(for residues with Δδobs > 0.05 ppm at the highest ligand concentration) upon binding 3′-UMP (A
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vector) and 5′-AMP (B vector) relative to the apo state. The fractional shift (X) corresponds to the
magnitude of displacement of A relative to B.
Residues that show a gain (or loss) of millisecond exchanges in both the 3′-UMP- and 5′-AMPbound states relative to the apo state are defined as displaying coordinated changes in motions
(Figure 5.2 A). Residues displaying a gain (or loss) of dynamics in only one of the two (5′-AMP or
3′-UMP) ligand-bound states relative to the apo state are defined as displaying uncoordinated
changes (Figure 5.2 B).
Reaction pathway sampling using Hybrid quantum mechanics/molecular mechanics
(QM/MM) and nudged elastic band (NEB) method: RNA cleavage step for bRNaseA was
modeled using hybrid QM/MM and NEB method in AMBER.310 In NEB method, the pathway for
conformational change between two end points is calculated using a series of images (called as
nodes) of the molecule/system. Each image between the end points is connected to the previous
and next image by springs that force each node to remain at an average separation between its
partner images along the current path preventing the nodes from sliding onto each other.
Minimization of the nodes between the end points provides a minimum energy pathway. Further
optimization using simulated annealing estimates the global minimum energy pathway. The result
is a minimum potential energy path that represents the conformational change between the two
endpoint structures, independent of time-scale. The NEB337 method requires the users to define
the start and end points of the reaction pathways to be studied. Also, the pathway endpoints are
fixed during the NEB simulation in AMBER. Therefore, the reactant state (RS) and product state
(PS) were modeled and extensively simulated to obtain a desirable start and end points for the
QM/MM-NEB simulations.
Structure preparation of RS and PS: The catalytic mechanism of phosphodiester cleavage has
been well studied for bRNaseA.85 Based on these studies, the reactant and product states for
bRNaseA were modeled (Figure 5.3). Since there are no published X-ray structures of bRNaseA
with substrate, tetranucleotide substrate was modeled in the active site of bRNaseA as mention
in chapter 3. The bRNaseA enzyme with cleaved product(s) was modeled as mention in chapter
4. The RS and PS complexes were solvated in a SPC/E277 water box with periodic boundary
conditions and neutralized with the addition of chloride (Cl-) counterions. The systems were
equilibrated using the previously described protocol.338 PME-method339 was implemented for long
range electrostatics. All hydrogen bonds were constrained using SHAKE.281
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Figure 5.1:Illustration of the CHESPA approach. The 1H-15N peak is represented for apo
(gray), and bound forms 5’-AMP (blue) and 3’-UMP (orange), respectively. Arrows indicate the
movement of the 1H-15N chemical shift for each peak from its apo (in red) to its saturated position
(blue and orange). The compounded chemical shift upon ligand binding is calculated as the
magnitude of vectors A and B, respectively (see text for details). θ represents the angle between
vector A and B. Figure adapted from 340

Figure 5.2: The NMR chemical shift projection analysis (CHESPA). Graphical representation
of scenarios representing (A) coordinated and (B) uncoordinated displacements of the chemical
shifts upon ligand binding. Figure adapted from 340
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Figure 5.3: Starting structures for enzyme-substrate and enzyme-products complexes. The
computationally modeled structures for QM/MM-NEB simulation are shown; bRNaseA (gray
ribbon), substrate (green sticks), products (yellow and light green sticks) and water molecules
considered for reaction (red spheres). The cleaved bond is shown as black dash.

Production runs of 0.5 µs (microsecond) were performed under constant volume and energy
(NVE) conditions using a 2 femtoseconds (fs) time-step. Simulations to obtain starting
conformation of RS and PS systems were performed using NVIDIA graphics cards with CUDAenabled version of AMBER’s pmemd MD simulation engine. The default precision in the
pmemd.cuda_SPFP binary was used from AMBER v14 package.310 The final structures of the
production trajectories were used as input for QM/MM optimization.
Structure preparation of RS and PS for QM/MM optimization: A QM region and a MM region
were identified for RS and PS. The QM region includes 47 atoms selected from the side chains
of three catalytic residues (two histidine and one lysine residues), ribose sugar rings of the two
nucleotides next to the cleaved phosphate group, and three water molecules (Figure 5.4). The
remaining parts of the tetra-nucleotide substrate, enzyme, counterions and the water box were
modeled as classical region and treated by molecular mechanics (AMBER’s ff14SB311 force field).
A total of 38162 atoms constitute the MM region. QM/MM optimization of RS and PS was
performed for 2000 steps using SCC-DFTB341 level of theory for QM atoms. The SCC-DFTB level
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of calculation was chosen because of its manageable computational complexity. QM compatible
PME approach was used for calculating the long-range QM-MM electrostatic and forces. The
optimized QM/MM structures of the RS and PS were used as endpoints for reaction pathway
sampling using QM/MM-NEB method.
Reaction pathway sampling using QM/MM - NEB method: NEB methods attempts to find the
lowest pathway on the potential energy surface between the two endpoints provided. The NEB
protocol created six additional replicates (making a total of 8 nodes including the two endpoints
provided) that will stretch along our pathway and be joined by springs. First all eight nodes were
heated from 0 – 300 K in 20,000 steps with a 0.1 fs timestep. During the heating process hydrogen
atoms were not constrained by SHAKE. Relatively small spring constant of 10 kcal/mol/Å2 was
used. Next simulated annealing was performed with the temperature profile increasing from 300
K to 500 K and back to 300 K. A total of 150 ps MD was performed in this step with a time-step
of 0.25 fs. In the next step the system was cooled down, so that that images freeze out along
the low energy pathway. The nodes were cooled in 2 stages. At first stage the nodes were
gradually cooled from 300 K to 0 K step over 6 ps. Finally, a long cooling was performed at 0 K
for 10 ps with a time-step of 0.1 fs. Conformations were saved after every 10 steps per NEB node.
Final QM/MM - NEB production run was performed for 200,000 steps at the time step of 1 fs for
all 8 NEB nodes. Coordinates were saved after every 2 ps.
Intrinsic dynamics: The intrinsic dynamics in bRNaseA during the chemical step was deduced
from the root mean square fluctuations of the Cα atoms of the top 10 QHA modes (RMSF10).
287

228,

Fluctuations were computed using the ptraj analysis module in AMBER.342 Conformations form

only the final production trajectory of all 8 NEB nodes were used for RMSF10 calculations. For
comparison RMSF10 results for apo, substrate bound and product release simulations from
chapters 2, 3 and 4 respectively were used.
Conformational sub-states using quasi anharmonic analysis (QAA): The 80000
conformations (10000 conformations per NEB node) obtained from the hybrid QM/MM and NEB
simulations were used for QAA.129 The original 3N dimensional space for the Cα atoms was
projected onto 60 - dimensional space using QHA modes and then analyzed using QAA. Using a
mixture of gaussian modes three clusters representing distinct NEB nodes were identified. The
three QAA independent component vectors were analyzed in detail to characterize the
conformational sub-states associated with the chemical step in bRNaseA.
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Figure 5.4: Reactive center for reactant and product states. The side chain of catalytic
residues and the sugar-phosphate backbone that form the reactive center for the RS and PS are
shown. Atoms included in the QM region (blue) and MM region (black) are identified. Note that
water molecules that form the part of the QM region are not shown to increase the clarity of the
Figure (See Figure 5.3 to identify the water molecules (red spheres)).
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5.4 Results
5.4.A Elucidating the differences in kinetics parameters for human ribonucleases
Kinetic parameters (kcat and KM) for cleavage of dinucleotide substrate UpA by hRNases and
bRNaseA were obtained using Michaelis-Menten steady-state kinetics at pH 5.5 and 25 °C. To
facilitate comparison between the different enzymes the enzymatic activity of the hRNases was
quantified using the same substrate UpA. The kinetic parameters of bRNaseA was quantified for
reference. The results indicate that all RNases were able to cleave UpA, as expected for the
canonical members of this superfamily.8 Most RNases exhibited KMs above 1 mM, with bRNaseA,
hRNase2, hRNase4, hRNase6 showing better affinities (Table 5.2). hRNase2 showed the highest
kcat (~88 s-1) among hRNases and a catalytic turnover ~ 6 times lower than bRNaseA. The catalytic
efficiency (kcat/KM) of hRNase3 was three to four orders of magnitude lower than that of the
bRNaseA. Approximately 104-fold difference was observed in the kcat values, between the fastest
(bRNaseA) and the slowest (hRNase5) enzyme. Together, these results indicate a nearly 105fold difference in catalytic efficiency (kcat/KM) between hRNases, further exemplifying the distinct
roles of the ribonucleolytic activity in their unique and varied biological functions.

Table 5.2: Comparing the steady-state kinetic parameters for RNases. The parameters were
obtained at pH 5.5, 25 °C substrate concentration was varied, and the data were fitted to
Michaelis-Menten equation.
Enzyme

KM (µM)

bRNaseA
120 ± 40
hRNase2
520 ± 50
hRNase3*
hRNase4
440 ±160
hRNase5
2500 ± 880
hRNase6
140 ± 10
* saturation was not obtained

kcat(s-1)

kcat/KM (M-1s-1)

450 ± 30
88 + 3

3.8 ± 0.7 x 106
1.7 ± 0.2 x 105
6.7 ± 1.6 x 102
3.7 ± 0.6 x 104
12 ± 2
4.1 ± 1.3 x 104

16 ± 2
0.031 ± 0.006
5.7 ± 0.1
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5.4.B Ligand-induced variations in structural and dynamical properties of RNases
The effect of binding of two mononucleotide ligands 3’-UMP and 5’-AMP (also product analogs),
on conformational properties of RNases was probed using NMR shift titrations. The compounded
chemical shift changes Δδobs (at the highest ligand concentration) upon binding of 3’-UMP and 5’AMP for the five RNases studied (hRNase2, hRNase3, hRNase4, hRNase5, bRNaseA) are
shown in Figure 5.5. Residues displaying Δδobs > 0.1 ppm for all RNases are reported in Table
5.3. Notable differences were observed in the number of residues affected upon binding of 3’UMP to the functionally distinct RNases. In bRNaseA, 21 residues displayed Δδobs > 0.1 ppm and
largest chemical shift perturbations were observed near the residues Thr45, His119 and Lys41
primarily the B1 pyrimidine binding sub-site. Additional large perturbations (Δδobs > 0.1 ppm) were
observed for some residues far from the active site, suggesting long-range conformational
changes or motions in these regions upon 3’-UMP binding. Similar to bRNaseA, in hRNase2 large
perturbations were observed in residues near the B1 sub-site, as well as residues of distal loops
(Ser64 and Lys66 of L4 and Cys37 of L2). However, the total number of residues that displayed
Δδobs > 0.1 ppm were less when compared to bRNaseA. Further, in hRNase4 only few residues,
primarily localized to the pyrimidine binding B1 sub-site, displayed chemical shift perturbations
upon ligand binding. This observation is significantly different from its behavior in apo state, where
most residues undergo conformational exchange.267 On the contrary, in hRNase3 perturbations
were dispersed throughout the protein with large chemical shift variations in loops L4 (positions
67–76) and L5 (positions 80–83). These loops however were minimally perturbed in the other
RNases upon binding of 3’-UMP. In contrast to bRNaseA, the catalytic residues of hRNase3
(Lys39 and His128) did not display significant perturbations upon 3’-UMP binding. Similarly, in
hRNase5, residues in the B1 sub-site did show perturbations while residues far from the active
site were affected.
Titration of ligand 5′-AMP resulted in perturbations of residues near the purine binding sub-site
(B2) in all RNases, except hRNase5. In, bRNaseA, hRNase2 and hRNase4 residues of loop L4
displayed significant perturbations. Loop L4 has previously been reported to interact with the
purine base. Additional perturbations are observed in N-terminal alpha helix in hRNase2 and Cterminal regions of hRNase4. In contrast perturbations in L4 were diminished in hRNase3 upon
binding of 5’-AMP and even fewer residues displayed perturbations relative to 3’-UMP binding. In
hRNase5, no changes were observed in loop L4 and overall very few residues displayed large
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Figure 5.5: Effect of ligand binding on functionally distinct RNases. Compounded chemical
shift perturbations (Δδobs) relative to the apo form upon binding of two mononucleotides 3’-UMP
and 5’-AMP are plotted as function of consensus sequence. Chemical shift perturbations were
calculated by comparing the shifts at the largest enzyme:ligand molar ratios relative to the apo
state for each enzyme. Δδobs are depicted on the 3D structures using the putty representation to
the right of the plots, the width of the tube corresponds to larger Δδobs. The 3’-UMP and 5’-AMP
ligands are shown in the structures of bRNaseA only, they bind at same site in other RNases.
Catalytic residues (His12, Lys41, His119, bRNaseA numbering) are highlighted using gray lines.
Secondary structure of bRNaseA is shown on top of the graphs. The consensus sequence
(obtained including gaps in the multiple sequence alignment) is used for easier comparison of
proteins.
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Table 5.3: Chemical shift perturbations upon ligand binding. Residues displaying ∆δobs ≥ 0.1
ppm upon 3’-UMP and 5’-AMP binding to RNases is reported.
Residues displaying Δδobs ≥ 0.1 ppm upon 3’-UMP binding
bRNaseA
hRNase2
hRNase3
hRNase4
hRNase5
Residue Δδobs Residue Δδobs Residue Δδobs Residue Δδobs Residue Δδobs
11
0.145
7
0.147
4
0.281
5
0.105
11
0.125
12
0.137
11
0.241
11
0.134
20
0.125
42
0.172
17
0.149
15
0.195
14
0.194
42
0.349
50
0.113
41
0.223
16
0.102
16
0.162
44
0.310
51
0.157
44
0.490
37
0.229
31
0.129
103
0.114
53
0.120
45
1.197
42
0.213
40
0.335
116
0.127
56
0.124
46
0.258
43
0.247
48
0.118
117
0.261
61
0.107
47
0.110
64
0.145
55
0.109
118
0.121
65
0.125
51
0.180
66
0.101
57
0.105
72
0.106
66
0.152
82
0.162
62
0.123
84
0.159
82
0.163
83
0.209
64
0.302
103
0.137
96
0.149
103
0.108
66
0.238
97
0.108
129
0.249
69
0.113
99
0.101
130
0.477
75
0.279
100
0.130
131
0.361
77
0.189
101
0.187
84
0.346
105
0.107
129
0.568
119
0.225
130
0.136
120
0.403
122
0.206
Residues displaying Δδobs ≥ 0.1 ppm upon 5’-AMP binding
bRNaseA
hRNase2
hRNase3
hRNase4
hRNase5
Residue Δδobs Residue Δδobs Residue Δδobs Residue Δδobs Residue Δδobs
11
0.166
7
0.101
10
0.279
5
0.183
12
0.122
43
0.107
8
0.208
41
0.112
11
0.100
14
0.179
45
0.227
11
0.244
64
0.118
20
0.118
25
0.158
46
0.133
14
0.250
110
0.132
44
0.125
106
0.106
51
0.239
15
0.164
128
0.235
50
0.158
117
0.112
58
0.249
39
0.109
129
0.169
66
0.178
64
0.134
64
0.211
130
0.194
68
0.228
65
0.450
66
0.101
70
0.201
66
0.193
82
0.100
71
0.157
68
0.139
83
0.105
115
0.110
69
0.145
95
0.190
116
0.137
71
0.190
128
0.236
117
0.625
72
0.194
129
0.460
118
0.152
101
0.116
130
0.332
119
0.208
112
0.104
131
0.464
118
0.149
119
0.259
120
0.325
121
0.107
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chemical shift perturbations, suggesting few interactions with 5’-AMP. Overall, these observations
indicate that closely related RNases display distinctly different conformational rearrangements of
local chemical environment upon binding of the two single-nucleotide RNA product mimics. These
observations further confirm the difference in affinity of these RNase for a common ligand as seen
in Chapter 2. Additional dynamics in distal regions is different for these enzymes even though
they share the same fold, consistent with our observation of distinct conformational sub-states in
product release (Chapter4).
The structural rearrangements and local/global conformational motions in proteins that occur
upon ligand binding can be identified by probing the changes in chemical shift perturbations. In
this study, the chemical shift projection analysis (CHESPA) is employed to delineate the changes
associated with 3’-UMP and 5’-AMP binding to RNases. The schematic representation of the
CHESPA approach is shown in Figure 5.1. The projection angle and fractional shift determined
for each of the five RNases is shown in Figure 5.6. The projection angle (θ) is the angle between
the chemical shift peak displacements (for residues with Δδobs > 0.05 ppm at the highest ligand
concentration) upon binding of 3’-UMP and 5’-AMP (represented by A vector B vector respectively
in Figure 5.1) relative to the apo state. The fractional shift (X) corresponds to the magnitude of
displacement of A vector relative to B vector. Chemical shift changes are defined as coordinated
when cos(θ) ≥ 0.9 and the chemical shift perturbations upon binding of the two ligands is similar,
and uncoordinated when cos(θ) < 0.9. Residues that display coordinated chemical shift
displacements also showed fractional shift (X) ≥ 1, suggesting similar or larger changes in
magnitude upon binding of 3′-UMP relative to 5′-AMP in all RNases.
Most residues of bRNaseA were involved in both 3’-UMP and 5’-AMP ligand binding. Lys66 (P0),
Thr45 (B1) and the catalytic His12, showed coordinated displacements (Figure 5.6). While, the
residues His119 and Lys41 (of active-site), Lys7 (P1) binding site, Thr17 (loop 1) and residues of
the C-terminal 𝛽𝛽 strand showed uncoordinated displacements of the chemical shifts, indicating

the different effects upon binding of the two ligands (Figure 5.6). In hRNase2, residues in the
ligand binding sites displayed both coordinated and uncoordinated displacements, with residues

of loop L4 displaying uncoordinated displacements. Uncoordinated displacements were observed
throughout hRNase3, with the exception of residues Gln4 and His15 that displayed coordinated
behavior. The effect of ligand binding on hRNase3 was markedly different from hRNase2 and
bRNaseA. The active site residues of hRNase4 showed coordinated chemical shift
displacements, while uncoordinated displacements were observed in the C-terminal 𝛽𝛽7 strand.
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Figure 5.6: Chemical shift projection analysis of ligand binding to RNases. The projection
angle (cos(θ), left) and the fractional shift (X, right), calculated for residues with Δδobs > 0.05 ppm
at the highest ligand concentration are shown. Coordinated (cos(θ) ~ 0.9, green) and
uncoordinated (cos(θ) < 0.9, red) residues are identified on the three-dimensional structures of
individual RNases using tube representations. Residues displaying positive and negative
fractional shifts are displayed using black and white bars, respectively. Catalytic residues (His12,
Lys41, His119, bRNaseA numbering) are highlighted using gray lines. Secondary structure of
bRNaseA is shown on top of the graphs. The consensus sequence (obtained including gaps in
the multiple sequence alignment) is used for easier comparison of proteins.
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Effect of ligand binding in hRNase4 was quite similar to bRNaseA. Coordinated chemical shift
displacements were predominant in the V1 domain of hRNase5, consistent with previous
observations146 while uncoordinated displacements were observed for residues His8, Ser28 and
His84 (Figure 5.6). Overall, these results suggest that subtle variations in the ligand binding
pocket or the active-site environment in these closely related RNases can lead to significantly
different long-range effects throughout the structures upon ligand binding.

5.4.C Conformational dynamics in the chemical step of bRNaseA
The conformational flexibility (or intrinsic dynamics) of bRNaseA during the chemical (RNA
cleavage) step was quantified using the aggregated root means square fluctuation of top 10
slowest QHA modes (RMSF10) sampled in the hybrid QM/MM - NEB simulations. QM/MM
simulations have been previously used to identify conformational fluctuations in enzymatic
systems.343 The conformational fluctuations in the chemical step of bRNaseA is shown in Figure
5.7. The dynamics of bRNaseA in the chemical step is further compared to fluctuations observed
in the apo state, substrate bound and product release simulations (Figure 5.7 B). Higher
fluctuations are observed in the loop regions particularly loops L1 and L4, as compared to other
secondary structure elements (Figure 5.7 A). Loop L1 is previously reported to play a role in
bRNaseA function.138 Residues of Loop L4 (particularly Asn71) are reported to interact with purine
residue of RNA substrate (Chapter 3). These loops are therefore functionally important in
bRNaseA catalytic cycle and continue to be dynamic in the chemical step. However, fluctuations
in these loops is considerably reduced for the chemical step when compared to other steps of the
bRNaseA catalytic cycle (Figure 5.7 B). This variation in the fluctuations could be due to the
difference in simulation methods used for each step. Dynamics for apo, and substrate bound
systems were computed using long time-scale classical MD simulations, product release
simulations were performed with umbrella sampling simulation, while the dynamics in chemical
step is computed using hybrid QM/MM method which are relatively of shorter. Further, the amount
of sampling varies in the computed trajectory of each step. Therefore, in order to firmly conclude
that the reduced dynamics in chemical step is not by chance but a feature of bRNaseA function
more sampling is required for the QM/MM - NEB simulations.
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A

B

Figure 5.7: Dynamical behaviour of bRNaseA in the chemical step. Root mean square
fluctuations corresponding to the Cα displacements in the top 10 quasi-harmonic modes (RMSF10)
for bRNaseA (A) RMSF10 is projected on cartoon representations of the enzyme (B) Comparison
of conformational dynamics in each step of the bRNaseA catalytic cycle; apo enzyme (red),
substrate bound (orange), chemical step (turquoise) and product release (green). Flexible loop
regions of bRNaseA are identified.
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5.4.D Conformational sub-states in the chemical step of bRNaseA function
The RNA cleavage step in bRNaseA was modelled using hybrid QM/MM and NEB simulations in
AMBER simulation package. Eight nodes were computed along the pathway from reactant to
product states (Figures 5.3 and 5.4). QAA was used to determine the conformational sub-states
in the chemical step of bRNaseA. Coordinates of 80800 conformations obtained along reaction
pathway were projected on to 60-dimensional space using QHA for QAA. Using a mixture of
gaussian modes, three clusters representing three nodes of the NEB pathway were identified
(Figure 5.8). Conformational sub-states in bRNaseA during the cleavage of RNA molecule are
illustrated in wireframe, showing only the Cα trace of the enzyme residues, and colored according
to their respective sub-states. Detailed analysis of the conformational fluctuations reveals that no
particular region in the enzyme show motions with large amplitude in the conformational substates identified along the chemical step pathway from reactant to product states. Whereas the
conformational sub-states associated with the product release step revealed the existence of high
amplitude fluctuation in loop L1 of bRNaseA (Figure 4.7). This variation in conformational motions
associated with chemical step in bRNaseA could be characteristic of intrinsic dynamics in the
catalytic pathway. Suggesting that functionally relevant conformational sub-states with high
amplitude of fluctuations are present in product release rather than the chemical step. However,
it is quite possible that reduced motions in the chemical step are a result of scarce sampling in
the QM/MM - NEB method. Therefor to validate the preliminary findings of this study, profound
sampling of the NEB nodes in the chemical step pathway is required.

5.5 Discussion
The rate of enzymatic reactions is traditionally measured during the steady-state period. During
this time the reaction rate changes relatively slowly and therefore steady-state kinetics methods
provide a good approximation of the catalytic efficiency. To facilitate comparison between the
different hRNases the enzymatic activity of these enzymes was quantified using the same
substrate and the kinetic parameters of bRNaseA was quantified for reference (Table 5.3). The
results indicate that the catalytic efficiency in hRNases vary by ~105 fold with hRNase5 being the
slowest enzyme. While hRNase2 is fastest among all hRNases compared in this study, it is
however ~20 times slower than bRNaseA. And hRNase5 is ~ 106 folds slower than bRNaseA.
These observations correlate to the previously identified kinetic parameters (Table 1.2) for these
enzymes indicating that variation in substrate only slightly affects catalytic efficiency in these
enzymes.
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Figure 5.8: Conformational sub-states in the chemical step of bRNaseA function. Quasi
anharmonic analysis was used for higher order statistical clustering of conformations sampled in
the QM/MM-NEB simulations is shown in the box plots above Each dot corresponds to a single
conformation and is colored according to the NEB node it belongs to (see color bar). The ellipses
represent identified conformational sub-states. The black arrows indicate transitions from
heterogenous population to a well-defined homogenous sub-state. Motions along the anharmonic
mode (𝛾𝛾) are illustrated in the panels below in a wire frame representation, showing only the C⍺

trace of the protein and color coded according to their respective NEB node.
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Characterizing conformational motions that affect enzyme catalysis is essential to understand
enzyme function.344, 345 These motions are known to occur in each step of the enzymes’ catalytic
cycle; apo, ligand binding, ground-state, product release and the chemical event itself.346 Ligand
binding perturbs the energy landscape of the enzymes resulting in conformational changes that
affect enzyme catalysis. The structural and dynamical changes induced as a result of ligand
binding have been identified for a few enzymatic systems.235, 331, 347 However how motions in
RNases facilitate ligand recognition and catalysis remains unknown. It will be interesting to identify
conformational motion induced by ligand binding in the members of the RNase family, where
different members have distinct ligand specificities. Comparison of motion in ligand binding would
further provide information on the role of dynamics in the wide range of specificities and catalytic
efficiencies in this enzyme family.
In this study, NMR chemical shift titration experiments were combined with the chemical shift
projection analysis (CHESPA) to characterize conformational motions induced upon binding of
two mononucleotides (3’-UMP and 5’-AMP) to gain insights into the mechanism and function of
RNases with different biological functions. Long-range conformational rearrangements are
observed in hRNase3 upon binding of 3’-UMP consistent with previous studies.142 While, in
hRNase4 perturbations were confined only to the pyrimidine binding site consistent with the low
binding affinity observed in this enzyme.327 The results indicate the occurrence of distinct longrange and local conformational rearrangement in each of the enzyme studied. Further using
CHESPA, amino acid residues that exhibit long-range coordinated chemical shift perturbations
upon ligand binding were identified. Interestingly not all RNases displayed the same coordinated
amino acid perturbations previously shown in hRNase5.146 Difference in the amino acid displaying
concerted motions was observed even for closely related enzymes, hRNase2 and hRNase3.
These observations suggest that dynamical pattern in RNases is not conserved and might be
adapted to the biological function of each enzyme. To confirm if these long-range motions affect
the function of individual enzyme, further mutagenesis experiments and development of allosteric
modulators that can directly affect the ribonucleolytic activity or biological function is required.
Evidence suggest millisecond motions affect catalysis by bRNaseA.136 Whether these functionally
relevant motions occur in one/all steps of the enzymes’ catalytic cycle remains unknown. The
conformational sub-states that modulate enzyme function are not yet identified for RNases. To
obtain insights into the conformational dynamics associated with the chemical step the pathway
for RNA hydrolysis by bRNaseA was modelled using hybrid QM/MM and NEB simulations. Higher
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order QAA is further employed to identify the conformational sub-states associated with the
conversion of substrate to products. This type of analysis has not been previously employed for
other enzyme systems. The conformational sub-states/motions identified from QAA in the
chemical step show reduced dynamics as compared to apo, substrate bound and product release
steps (chapters 2, 3, and 4). These observations suggest that motions in RNases might not affect
the chemical step directly, consistent with the proposition that efficient enzymes minimize dynamic
coupling in their transition states.348 Previous studies suggest that conformational fluctuations in
enzymes facilitate the formation of transition state species while the actual chemical step is a
result of reaction-ready active site configuration.348-350 This argument could stand true for
bRNaseA, where conformational motions in ground state or product releases effect catalysis,
while the dynamics is considerably reduced in the chemical step. However, this observation would
have been more obvious if the time-scales QM/MM simulations and the chemical events were
same. Therefore, correlations between the identified conformational sub-states/motion and
chemical step must be interpreted with caution. To identify the direct effect of dynamics on the
chemical step, the kinetic isotope effect in the chemical step of a ‘dynamic knockout’ (mutations
that result in loss of flexibility) of bRNaseA could be measured.350

170

Conclusions and Future Directions
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6.1 Conclusions
The motivation of the work described in this thesis was to characterize the role of internal motions
in the function of closely related RNases family, including human RNases. Dynamical features
that allow the progress of enzymes’ catalytic cycle through various stages were identified for
several hRNases and bRNaseA, using a combination of computational and experimental
methods. The major contributions of the work are summarized below.
In chapter 2, sequence base phylogenetic analysis classifies 23 RNases from the vertebrate
family into four sub-families. Members of each sub-family incidentally also shared similar
biological functions. The millisecond time-scale motions of representative members from each
sub-family were characterized using

N-CPMG relaxation dispersion experiments. The
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dynamical profile of all 23 RNases, on the µs time-scale, were probed using computer simulations.
Results indicate, members within a sub-family not only perform similar biological functions but
also exhibit remarkably similar dynamics. Hence, in this enzyme superfamily, dynamics is
conserved in association to biological function. Characterization of dynamical properties of
diverse RNases showed higher fluctuations in the loop regions as compared to other secondary
structural elements in all RNases. However, distinct variations in the dynamical pattern of each
sub-family arise from higher fluctuations of different loops in each sub-family. Loop L1 exhibits
motions with highest amplitude in the members of the RNase A-like sub-family. On the other hand,
L1 is truncated in members of EAR-like sub-family and residues of loop L4 have fluctuations
higher than other regions. Further it is noted that the difference in dynamics between different
sub-families arise from non-conserved residues, which may influence the functional identity of
these sequences.
Large protein families found in humans and other organisms are an outcome of gene duplication
events. It is unlikely that two genes with same function are stably maintained in the genome unless
that extra amount of gene product is advantageous.351 Therefore, the paralogous genes either
adopts a new/related functions (neofunctionalization) or specializes in performing one of the
function of the parent genes (sub-functionalization).352 For instance in the RNase A superfamily,
a novel antibacterial activity emerged in hRNase3 of the EAR like sub-family while hRNase1 of
the RNaseA like sub-family represents the progenitor gene before duplication. Mutations arising
from functional divergence appears to confer optimization of protein structure and thereby protein
function. Even a small structural change due to a single mutation can lead to a large difference in
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conformational dynamics affecting binding affinity and specificity in structurally related proteins.285,
353, 354

A recent experimental study has shown that mutations in the active site and distant region

generating an ensemble of different conformations can evolve new enzyme function within the
same fold.355 Results from these examples and chapter 2 highlight that conformational dynamics
can provides a link between structural and functional diversity in protein/enzyme super-families.
The catalytic efficiency and nucleotide binding preference for RNase family members have been
determined by diverse research group under various experimental conditions (pH, temperature,
buffer) and sometimes with substrate of unknown sequence making it difficult to understand their
chemical and biological functions at the molecular level. Chapter 3 focuses on systematically
characterizing the nucleotide binding properties of 7 hRNases and bRNaseA with two model
substrates ACAC and AUAU using all atom MD simulations at microsecond time-scale and
theoretical analysis. The results reveal that the interaction of all 7 hRNases with the model
substrates is very different, ranging from stable enzyme-substrate complex (at µs time-scale) to
weakly interacting. Detailed characterization reveals that different non-catalytic residues play a
significant role in enzyme-substrate stabilization and therefore, could have important
consequences for differences in the biological function in these enzymes. The interactions with
the catalytic triad may need to be flexible for mechanistic aspects in all RNases. Further, insights
into the role of enzyme dynamics in interaction with substrates unveil dynamical pattern similar to
apo enzyme with variations in the amplitude of fluctuations in some loops for only a few RNases.
Computer simulations performed at two temperatures, first is the room temperature (300 K) as
most RNases experiments are performed at room temperature, and second is the human body
temperature (310 K) as most RNases characterized in this study are human variants. It was noted
that subtle change in temperature can have profound effects on structural and dynamical
propertied of RNases. Variation in temperature also resulted in a change in substrate affinity and
specificity for few RNases. However, the effect of temperature on substrate binding to RNases
needs to be determined experimentally.

Often discrepancy is found in in-vitro and in-vivo

experiments. In several cases successful drug candidates from in-vitro experiments have failed
to show any results in-vivo. This is in part due to difference in temperature of the two systems.356
Therefore to attain conclusive insights all studies, in-vivo in-vitro and in-silico, should be
performed at the body temperature of individual organism.
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Conformational motions critical to enzyme function have been identified in a number of enzymes.
99, 202, 297, 357, 358

For enzymes like DHFR and CypA, it is now established that conformational

motions regulate enzyme turnover.204, 359 In both these enzymes, networks that connect distal
loops to active site residues are identified.103, 360 Further the population of conformations that
assist in the progress of catalytic cycle in known.127,

129

However, these intricate details that

connect dynamics to catalysis remain unknow for hRNases. Chapter 4 successfully used a
computational approach to identify conformational sub-states and fluctuations associated with the
RNase function. Previous evidence has indicated that conformational motions in the product
release step is the rate-limiting for bRNaseA.136,

138, 216

A combination of umbrella sampling

simulation and QAA identifies sub-states associated with product(s) release in hRNase3,
hRNase5 and bRNaseA, one member from each sub-family for which the biological function is
known (chapter 1). Interestingly QAA reveals the presence of separate conformational sub-states
for the three RNases studied. Even motions associated with the sub-states were different in each
enzyme. In addition, the structural interactions that allow product release were different for three
RNases. These observations suggest that RNases have evolved to achieve their respective
function by effectively utilizing the motions unique to each enzyme.
The combination of umbrella sampling with QAA could further be used to characterize
conformational motion unique to each enzyme in other protein families, enabling a better
understanding of the role of dynamics in the evolution of diverse functions in structurally related
super-families. Further, identifying conformational sub-states that pre-exist in the conformational
landscape of related enzymes will allow selection of appropriate starting conformation required
for successful enzyme design for a target reaction. In addition, the combination of umbrella
sampling with QAA along the reaction pathway could be applied to identify conformational substates and dynamical features critical to the catalytic mechanism other therapeutic enzymes.
Identifying the motions that enable the formation of transition state or are critical to overcoming
the rate limiting step, will open new avenues for developing next generation therapeutics. Small
molecules can be designed to either enhance or inhibit enzyme function by modulate enzyme
flexibility. In other words, use of this methodology can enable better understanding of the
biophysical nature of enzymes and can generate applications in medicine, industry and enzyme
design.
In enzymes, inherently dynamic process is involved in substrate binding product release, and the
chemical event itself. Further, studies suggest that transition between conformations of various
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catalytic steps is achieved as a result of coupling between slower long-range motions and faster
active site dynamics.361 Long range motions in enzymes expand from the enzymes surface to the
active site through a network of amino acids connected via non-bonding interactions.
Conformational fluctuations that enable transitions between different catalytic cycle events limit
the rate of catalysis in enzyme DHFR.127 To identify rate limiting motions in RNases function, it is
therefore required to characterize intrinsic dynamics and sub-states in each step of the catalytic
cycle of various members of the RNases family. Interesting insights have been obtained in the
dynamic associated with the apo enzyme, ground state, and product release steps of RNases in
Chapters 2 - 4. The work in chapter 5, focuses on characterizing dynamics in the ligand binding
and the chemical step in select RNases. NMR chemical shift titrations and CHESPA reveal the
existence of distinct long-range networks in hRNases and bRNaseA, suggesting that enzymes
with diverse biological functions also have diverse dynamics. Further considerable reduced
dynamics was observed in bRNaseA during the chemical step. Identified conformational substates of the chemical step do not high amplitude fluctuations in the distant loops of bRNaseA as
seen in the conformational sub-states of the product release step. This observation indicates that
the chemical step in bRNaseA occurs in a relatively static environment.
Overall the findings of this thesis reveal the occurrence of distinct long-range conformational
fluctuations in the apo and ground-state enzymes, ligand binding and product release steps of
hRNases with different biological functions and bRNaseA. Conformational sub-states with
reduced fluctuations were identified in the chemical step of bRNaseA (Figure 6.1). In addition,
pre-existence of product release conformations in the ensemble of apo enzyme is established.
Taken together, observations for this thesis suggest that in RNases, conformational fluctuations
facilitate substrate binding, formation of transition state species and product release, while the
actual chemical step is a result of reaction-ready active site configuration. However, the
correlation between rate-limiting steps of catalysis and rates of conformational change is yet to
be established.
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A

B

Figure 6.1: Conformational dynamics in the catalytic cycle of bRNaseA. (A) Root mean
square fluctuations of Cα atoms in the top 10 QHA modes (RMSF10) in each step of bRNaseA
catalytic cycle reveal existence of high amplitude fluctuations in apo (red), substrate bound
(orange) and product release steps (green), while reduced dynamics is observed for the chemical
step of RNA cleavage (turquoise). (B) All atom RMSF10 plotted on the structure of bRNaseA (PDB
ID: 7RSA) using tube representation for each step of catalytic cycle. The dynamical range
represented using the color spectrum is consistent across all steps with the blue and red ends of
the spectrum corresponding to low and high dynamic regions, respectively. The thickness of the
tube corresponds to the flexibility of residues in each step with thicker tubes corresponding to
flexible regions and thinner tubes representing less flexible regions. Important loops are identified.
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6.2 Future directions
RNase structural homologs in humans are involved in a distinct biological function with promising
therapeutic applications in several diseases including cancer, ALS and Parkinson’s disease. As
these closely related enzymes share similar binding pockets and/or active sites, developing drugs
targeting individual members is difficult. To target these enzymes individually, it is required to
develop highly specific small-molecule binders and modulators that can alter enzymatic activity
through long-range dynamical motions away from the active site. In this study, using a
combinations NMR experiments and computer simulation functionally relevant motions unique to
select RNases have been identified for events such as ligand binding and product release.
Modulating the dynamical motions that can efficiently funnel the enzyme through its catalytic
cycle, particularly in the rate limiting step will allow regulating these enzymes individually.
However, it remains unknow if the kinetics and motions in rate limiting step of these closely related
homologs is same. Outlined below is a summary of how knowledge obtained in this thesis could
be combined with further computational and experimental studies to better understand distinct
dynamics hRNases.
1. In chapters 2 and 3 all atom simulation trajectories for hRNases in the apo state and substrate
bound forms were computed. The conformations obtained from these MD runs can be further
analyzed with QAA to identify the conformational sub-states and populations in apo and
substrate bound forms respectively. These studies will also provide insights into conformational
fluctuations and motions critical for molecular recognition of substrates or other binding
partners. Populations of identified conformational sub-states could further be validated using
conformational probabilities obtained from NMR relaxation dispersion experiments of hRNases
in apo state and in presence of substrate analogs.
2. In chapter 4 it was determined that members in individual sub-families of the RNase
superfamily sample separate conformational sub-states in the product release step of the
catalytic cycle. Whether the members within a sub-family access same conformational substates during product release remains unknown. Therefore, exploring conformational substates in product release step for more RNases from each sub-family would be an important
step towards understanding the homogeneity in dynamics within each sub-family. It would
further be helpful in distinguishing how dynamics has evolved across sub-families of RNase
superfamily.
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3. Using hybrid QM/MM modeling with nudged elastic band (NEB) method, chapter 5 in this thesis
identifies conformational sub-states and fluctuations that assist in phosphodiester cleavage
step for bRNaseA of RNase A-like sub-family. This approach could be implemented to identify
conformational sub-states in chemical turnover (RNA cleavage) step in members of other three
sub-families as well. The results obtained will allow comparative analysis of conformational or
dynamical changes associated with the enzyme mechanism in all identified sub-families.
4. Enzymatic reactions proceed from substrate to product(s) via a transient high energy transition
state (TS). The enzyme's ability to make the reaction faster depends on the fact that it stabilizes
the TS. Hybrid QM/MM approach have proven useful to determine the dynamics of TS
formation in enzymes. Identification and characterization of motions that facilitate attainment
of TS would provide insights into the mechanistic details pertaining to the wide range of
catalytic efficiencies observed in these closely related RNases. Modulating motions that
promote TS formation could further be used to modulate enzyme activity in RNase family
members. Obtaining information about TS in RNases will also provide a wealth of information
necessary to design transition state analogs, which are also useful enzymatic inhibitors, unique
to individual RNases.
5. Studies in other enzymatic systems have indicated that rate of enzyme conformational changes
coincides with the rate limiting step in the enzymatic catalytic cycle. The rate limiting step for
bRNaseA is debated. While, the rate limiting state for hRNases remains unknown. In the light
of wide range of catalytic efficiency in these enzymes, it is very much possible that rate limiting
step in all human RNases might not be same. Therefore, to understand the role of dynamics
in the function of hRNases it is first required to identify the rate limiting step in all hRNases.
Thermodynamic and kinetic characterization of substrate binding, chemical step, and product
release, using hybrid QM/MM simulations, will provide a detailed picture of the complete
catalytic process in RNases. The heights of energetic barrier for each step would allow the
determination of the rate-limiting step. Stopped-flow is one experimental technique that could
also be used for this purpose.
6. Detailed analysis of the conformational sub-states will provide information about location and
amplitude of the functionally relevant dynamical motions associated with the RNA cleavage by
hRNases. This information could be used to identify mutational hot-spots that potentially control
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the function of divergent RNases. The effect of these mutations on the enzymatic activity could
be

evaluated

using

steady-state

Michaelis-Menten

kinetics

experiments.

Further,

characterizing the dynamics and conformational sub-states in mutant enzymes could further
emphasize on the interrelation between primary sequence and enzyme dynamics.
7. As observed in this study, unique dynamical properties and changes in sequence are localized
to the distal loop regions emphasizing on their role in diversification of RNases superfamily.
Engineering the distal loops by either inserting or deleting amino acids can induce changes in
dynamics of these enzymes, modulating their respective function. Increase the length of loops
would allow harnessing more energy from the bulk solvent to increasing the dynamics in
enzyme thereby increasing catalytic turnover, as seen in

. On the other hand, reducing the
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length of the loop might work in a vice versa fashion. Allosteric modulation of enzyme function
could also be achieved by identification/design of small molecules that can bind to specific loop
in individual RNases. Whether it is required to increase/decrease catalytic turnover and
dynamics in induvial RNases depends on the goal of study. For example, antibacterial activity
of hRNase3 does not depend on its ribonucleolytic activity, there improving catalytic turnover
of hRNase3 is not useful for enhancing its biological function.
8. It is suggested that human members of the EAR-like sub-family possess the ability to disrupt
bacterial membrane integrity. However, it still remains unclear how these RNases specifically
target the microbial cell wall and how it permeabilizes the membrane. Computational modelling
of how hRNases interact with liposaccharide membrane could provide preliminary information
on the mechanism of antibacterial activity in the enzymes. Understanding the bactericidal
mechanisms is crucial for its development of hRNases as a novel antimicrobial agent.
9. The

N-CPMG investigation does not report conformational changes in hRNase5 on the
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millisecond time-scale. In combination with computer simulations, use of other experimental
methods like hydrogen/deuterium exchange mass spectrometry could provide additional clues
on slow time-scale motions experienced by hRNase5.
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6.3 Assessing the quality of computer simulations
Computer simulations are valuable tools that have immensely contributed towards understanding
biological systems. Like experimental techniques, computer simulations have their own
limitations. Simulations approaches include many different types of theorical foundation each with
their own approximations, creating an uncertainty associated with the prediction.362 Unlike
experiments, it is proven hard to assess how much of the simulation is representative of the actual
biophysical properties. Quantification of the uncertainties in a simulation can increase the
confidence and significance of the observables obtained from simulations
The most important issues that arise while using computer simulations to describe the properties
of an enzymatic system include: First, accurate description of the starting point for the simulations
to ensure that the structure is at a reasonable minima; Second, the time-scale of computer
simulations are still not fully comparable to the time-scale of enzymatic function creating an
uncertainty in the amount of conformational sampling achieved during simulations; Third,
reproducibility of the observation/quantity of interest, i.e. statistically significant conclusion(s).
Some suggestions to assess the quality of computed simulation trajectories are outlined below:
1. It is required to dedicate ample amount of time in carefully modeling the system(s) of interest
and setting up the simulations. Among many other things choice of starting structure, desired
ensemble, temperature, pressure and the force field to accurately describe your system are
important factors that can change the desired predictions considerably.363 If the time-scale of
biological process cannot be reached by simplistic simulations, including enhanced sampling
techniques to access the conformational landscape is a logical approach. Therefore, a
simulation protocol and subsequent analysis of its results should take into account the intent
of the study.
2. Multiple trajectories should be computed starting from different starting structures.364 A variety
in starting structures can be created by either minimizing the system or heating it at higher
temperatures. Another way to generate new starting structures is to run a relatively small MD
simulation and extract conformations at different time points each serving as an independent
starting structure. The trajectories computed from all the different starting structures should
be critically analyzed for reproducible behavior of any observables which can also be
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measured with biophysical technique. To avoid bias, include all simulation data in analysis
except the trajectories that were either not equilibrated or incorrectly setup.362
3. The initial part of the simulation where the system is equilibrated to reach a local energy
minimum relaxed state can introduce a bias in the analysis.365 Therefore, this equilibration
portion of the simulation should not be included while computing the observables from
simulation trajectory.
4. Single simulation trajectories can be analyzed using time correlation analysis.366 Correlation
time separates statistically independent values of the observable, having many statistically
independent measurements of the observable suggests good sampling for that particular
observable.
5. Block averaging 362, 366, 367 is another good method to calculate the statistical uncertainty of the
ensemble averages calculated from single simulation trajectory. In this method the simulation
trajectory is divided into subsets. Mean of an observable is computed for each segment and
then a standard error is calculated for all means providing a direct estimation of statistical
uncertainty.
6. Inadequate sampling in simulation trajectories can be checked by identifying if the simulation
has converged. This can be done by either monitoring RMSD or certain dihedral angles in the
simulation trajectory with respect to reference structure.366 A simulation is expected to be
converged when the fluctuations in these quantities reduce along time.
7. To analyze if each trajectory adequately samples the conformational landscape a combined
clustering analysis can be useful.368 In this approach the conformations sub-states are
grouped into clusters based on RMSD or dihedral space. If the simulations are converged all
clusters should contain equal population of conformation from individual trajectory.
8. Observables from simulations should be reported with level of confidence instead of error
bars.362 Confidence level quantifies the frequency of interval in a sample data that the true
value of unknown parameter lies in within the interval. This interval is defined as the point
estimate plus/minus the standard deviation. Observables (that follow a gaussian distribution)
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with 95 % level of confidence passes the qualitative test. For non-gaussian observables use
of bootstrapping method is suggested.
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